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Abstract 
 The immune response to an infection is determined by a number of factors, which 
also affect the generation of memory T cells afterwards.  The immune response can also 
affect the stability of the pre-existing memory populations.  The memory developed after 
an infection can influence the response to subsequent infections with unrelated 
pathogens.  This heterologous immunity may deviate the course of disease and alter the 
disease outcome.  The generation and stability of memory CD8 T cells and the influence 
of the history of infections on subsequent heterologous infections are studied in this 
thesis using different viral infection sequences. 
Previous studies using mice lacking individual immunoproteasome catalytic 
subunits showed only modest alterations in the CD8 T cell response to lymphocytic 
choriomeningitis virus (LCMV).  In this study, I found that the CD8 T cell response to 
LCMV was severely impaired in mice lacking all three catalytic subunits of the 
immunoproteasome, altering the immunodominance hierarchy of the CD8 T cell response 
and CD8 T cell memory.  Adoptive transfer experiments suggested that both inefficient 
antigen presentation and altered T cell repertoire contribute to the reduction of the CD8 T 
cell response in the immunoproteasome knockout mice. 
Immune responses generated during infections can reduce pre-existing memory T 
cell populations.  Memory CD8 T cells have been shown to be reduced by subsequent 
heterologous infections.  In this study, I re-examined the phenomenon using immune 
mice infected with LCMV, murine cytomegalovirus (MCMV) and vaccinia virus 
(VACV) in different infection sequences.  I confirmed that memory CD8 T cells were 
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reduced by heterologous infections, and showed that LCMV-specific memory CD4 T 
cells were also reduced by heterologous infections.  Reduction of the memory CD8 T 
cells is thought to be the result of apoptosis of memory CD8 T cells associated with the 
peak of type I interferon early during infection.  I showed that memory CD4 T cells were 
similarly driven to apoptosis early during infection; however, Foxp3+ CD4+ regulatory T 
cells were relatively resistant to virus infection-induced apoptosis, and were stably 
maintained during LCMV infection.  The stability of Treg cells during viral infections 
may explain the relatively low incidence of autoimmunity associated with infections. 
The history of infections can deviate the course of disease and affect the disease 
outcome, but this heterologous immunity is not necessarily reciprocal.  Previous studies 
have shown the effects of heterologous immunity during acute infections.  In this thesis, I 
showed that the history of LCMV infection led to higher viral titers during persistent 
MCMV infection, caused more severe immunopathology at the beginning of infection, 
and reduced the number of MCMV-specific inflationary memory CD8 T cells after the 
period of memory inflation.  In a different context of infection, the history of LCMV 
infection can be beneficial.  LCMV-immune mice have been shown to have lower viral 
titers after VACV infection, but VACV-immune mice are not protected during LCMV 
infection.  I found that memory CD8 T cells generated from LCMV and VACV 
infections were phenotypically different, but the differences could not explain the non-
reciprocity of heterologous immunoprotection.  By increasing the number of cross-
reactive VACV A11R198-205-specific memory CD8 T cells, however, I showed that some 
VACV-immune mice displayed reduced viral titers upon LCMV challenge, suggesting 
vii
that the low number of potentially cross-reactive CD8 T cells in VACV-immune mice 
may be part of the reasons for the non-reciprocity of immunoprotection between LCMV 
and VACV.  Further analysis deduced that both number of potentially cross-reactive 
memory CD8 T cells and the private specificity of memory CD8 T cell repertoire played 
a part in determining the outcome of heterologous infections.  
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Chapter I. Introduction 
The generation of the CD8 T cell response during infections and the establishment 
of memory CD8 T cells can be influenced by the immunoproteasomes, which dictate the 
diversity of peptides for presentation to CD8 T cells.  The established memory CD8 T 
cells are stably maintained by homeostatic proliferation, and can affect the immune 
response to subsequent infections.  During heterologous infections, however, the number 
and frequency of pre-existing memory CD8 T cells to previous infections may be 
changed.  Previous studies have shown that pre-existing memory CD8 T cells may be 
reduced by heterologous infections, but memory CD4 T cells may be more stable, while 
the stability of the memory-like regulatory T cells has not been examined. 
Heterologous immunity, referring to the immunity that can be developed to an 
unrelated pathogen during infections, can deviate the course of disease and alter the 
disease outcome.  The effects of heterologous immunity on viral load and 
immunopathology have been studied during acute infections, but its long-term influence 
during persistent infections has not been examined.  Heterologous immunity is not 
necessarily reciprocal and the sequence of infections may change the outcome of 
infections.  Prior immunity, which may influence subsequent immune responses, and the 
biology of subsequent infections are factors that may have contributed to the non-
reciprocity of heterologous immunity.   
In this thesis, the generation and stability of memory T cells and the influence of 
history of infections on the outcome of subsequent infections are studied using three 
unrelated viruses from the families Arenaviridae, Herpesviridae and Poxviridae. 
2
 
Lymphocytic choriomeningitis virus (LCMV) 
Lymphocytic choriomeningitis virus (LCMV) is an enveloped Old World 
arenavirus with a bi-segmented ambisense single-stranded RNA genome (Bishop & 
Auperin, 1987; Southern et al., 1987).  It enters target cells through the interaction 
between its glycoprotein GP-1 and the α-dystroglycan on the cell surface (Cao et al., 
1998).  In mice, LCMV strain Armstrong infects macrophages and some fibroblastic 
reticular cells in the spleen but not lymphocytes (Matloubian et al., 1993; Mueller et al., 
2007).  Viral growth is detectable in the spleen by plaque assay beginning at around 5-6 
hrs post inoculation, and the progeny viral particles accumulate exponentially (Ehl et al., 
1997).   
LCMV infections induce a strong type I interferon (IFNαβ) response.  LCMV 
RNA interacts with both melanoma differentiation-associated gene 5 (MDA5) and 
retinoic acid-inducible gene I (RIG-I) complexes to stimulate type I IFN production 
through mitochondrial antiviral signaling protein (MAVS) and interferon regulatory 
factor 7 (IRF7) in conventional dendritic cells (DC) (Zhou et al., 2010; 2012).  Through 
Toll-like receptor 7 (TLR7) and myeloid differentiation primary response gene 88 
(MyD88), plasmacytoid DC also contribute to the production of type I IFN in the first 16 
hrs post LCMV infection (Wang et al., 2012).  The induced type I IFN, which is 
detectable by 24 hrs and peaks at day 2 post infection (Welsh, 1978), performs 
pleiotropic functions including stimulating natural killer (NK) cell activities (Mack et al., 
2011; Welsh, 1978), supporting clonal expansion of CD8 T cells (Kolumam et al., 2005), 
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and promoting apoptosis and attrition of CD44hi memory T cells (Bahl et al., 2006; 
2010; McNally et al., 2001). 
CD8 T cells are essential and sufficient in the control of LCMV infection.  LCMV 
is not cleared from the spleens and livers of mice depleted of CD8 T cells (Moskophidis 
et al., 1987).  Adoptive transfer of 1.5x107 cloned LCMV-specific CD8 T cells from 
LCMV-immune mice can reduce 104-105 pfu LCMV in the spleen to <50 pfu in a day 
(Byrne & Oldstone, 1984).  This CD8 T cell control of LCMV is perforin-dependent.  
Perforin knockout (KO) mice are unable to control LCMV Armstrong or LCMV-WE 
infection (Balkow et al., 2001; Kägi et al., 1994; 1995; Walsh et al., 1994), and 
splenocytes from perforin KO mice cannot transfer protection to naïve recipients either 
(Kägi et al., 1995).  Viral clearance is partially impaired in IFNγR KO mice and 
completely blocked in IFNαβR KO mice (van den Broek et al., 1995).  The containment 
of infection is a race between replicating LCMV and the activation and proliferation of 
CD8 T cells, because of the need for contact-dependent killing of LCMV-infected targets.  
It has been shown that the number of functional cytotoxic CD8 T cells adoptively 
transferred at the first sign of LCMV WE infection (10 hrs post inoculation) correlates 
with viral clearance (Ehl et al., 1997).  In BALB/c mice, it takes about 104-105 NP118-
specific memory CD8 T cells at the time of infection to substantially reduce viral load on 
day 3 post inoculation of 2x105 pfu LCMV Armstrong (Badovinac et al., 2003).  That 
would equate to about 0.1-1% of CD8 T cells, assuming a total of 108 cells in the spleen 
on average and about 10% being CD8 T cells.  A more recent study using adoptive 
transfer of LCMV GP33-41-specific T cell receptor (TCR)-transgenic P14 CD8 T cells and 
4
peptide-pulsed splenocyte targets into C57BL/6 mice and a mathematical model deduces 
that 1.3x105 memory CD8 T cells are needed for LCMV Armstrong clearance (Ganusov 
et al., 2011). 
The functions of B cells are more apparent during persistent LCMV infections 
than during acute infections.  Depletion of B cells by anti-IgM treatment did not affect 
the NK and cytotoxic T cell response to acute LCMV infection, nor did it compromise 
the survival of mice after lethal intracerebral LCMV Armstrong challenge (Cerny et al., 
1986).  Primary CD8 and CD4 T cell responses and viral clearance were also comparable 
between µMT-/- B cell-deficient mice and wild-type (WT) mice after intraperitoneal 
(i.p.) LCMV Armstrong inoculation (Asano & Ahmed, 1996; Whitmire et al., 2009).  
However, memory B cells and neutralizing antibody are needed for clearing persistent 
infection and preventing viral recurrence (Bergthaler et al., 2009; Planz et al., 1997).  In 
neonatal (2-weeks-old) mice, which mount a weak and short-lived CD8 T cell response 
during low dose LCMV-WE infection, the presence of an elevated level of LCMV NP-
specific antibodies becomes critical in viral control (Belnoue et al., 2007).  The µMT-/- B 
cell-deficient mice also failed to limit viral dissemination during persistent LCMV clone 
13 and strain A22-2b infections, and displayed a more severe CD8 T cell exhaustion 
(Whitmire et al., 2009).  Although the activation and expansion of virus-specific CD8 T 
cells require no B cells, the activated CD8 T cells suffer greater loss during the 
contraction phase, resulting in lower number of memory CD8 T cells in µMT-/- B cell-
deficient mice (Asano & Ahmed, 1996).  Memory CD4 T cells are not generated in µMT-
/- B cell-deficient mice (Whitmire et al., 2009), and the compromised CD4 T cell 
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compartment contributes to the loss of CD8 T cells during persistent LCMV infections 
(Matloubian et al., 1994). 
 
Vaccinia virus (VACV) 
Vaccinia virus (VACV) is an orthopoxvirus with an envelope and a double-
stranded DNA genome.  The coding regions with mixed reading directions (designated L 
for leftward reading and R for rightward reading) are organized with no gaps in between 
(Goebel et al., 1990).  The origin of VACV is not known, but it was used as a vaccine, 
which led to the eradication of smallpox among the human population in the late 1970’s 
(Buller & Palumbo, 1991).  VACV strain Western Reserve (WR) infects human CD14+ 
monocytes, B cells and in vitro activated T cells, but not quiescent T cells or CD56+ NK 
cells (Chahroudi et al., 2005; Sánchez-Puig et al., 2004).  In mice, DC and some 
macrophages are the primary targets of infection among the hematopoietic cells (Liu et 
al., 2008). 
VACV infection elicits a broad spectrum of cellular immune responses with 
overlapping functions in mice.  In the first few days of infection γδT cells respond by 
producing IFNγ (Selin et al., 2001).  Thereafter, CD4 and CD8 T cells join the efforts by 
secreting IFNγ (Xu et al., 2004).  CD4 T cells also shape the humoral response, and CD4-
depleted mice or major histocompatibility complex (MHC) class II KO mice fail to 
generate a VACV-specific IgG response (Xu et al., 2004).  The control of VACV 
infection is not dependent on perforin or Fas/FasL pathways of cytotoxicity (Kägi et al., 
1995).  In fact, Fas-deficient lpr mice clear VACV better and survive high dose VACV 
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infection probably because of the greater number of IFNγ-producing NK cells and 
activated T cells in these mice prior to infection (Seedhom et al., 2012). 
IFNs are important in the immune defense against VACV.  IFNαβR or IFNγR 
KO mice are unable to control VACV infection (van den Broek et al., 1995).  Intranasal 
administration of IFNα or IFNγ before and after VACV inoculation can rescue BALB/c 
mice from the lethal intranasal infection (Liu et al., 2004).  IFNγ may exert its antiviral 
functions through macrophages.  It has been shown in the mouse leukemia monocyte 
macrophage cell line RAW 264.7 that IFNγ stimulates the expression of nitric oxide 
synthase (iNOS) and blocks VACV protein synthesis and DNA replication (Harris et al., 
1995; Karupiah et al., 1993).  Therefore, memory T cells with IFNγ-secreting capability 
are protective during subsequent challenges.  Heterologous immunity against VACV is 
mediated by IFNγ-producing CD8 and CD4 T cells (Selin et al., 1998), and the frequency 
of IFNγ-producing memory CD8 T cells generated by peptide-immunization correlates 
positively with the survival of C57BL/6 mice from lethal intranasal VACV challenge 
(Moutaftsi et al., 2009; Salek-Ardakani et al., 2008).  
VACV is sensitive to antibody neutralization.  The transfer of immune serum 
prior to VACV infection is sufficiently protective, and immunized mice are protected 
from homologous challenge even after depletion of CD8 or CD4 T cells (Belyakov et al., 
2003).   
 
Murine cytomegalovirus (MCMV) and memory inflation 
7
Murine cytomegalovirus (MCMV) is a β-herpesvirus that causes persistent 
infection in mice.  Macrophages and mesothelial cells lining the peritoneum in case of 
i.p. infection are the first targets of infection (Hsu et al., 2009; Stoddart et al., 1994).  
Infection spreads to the spleen and liver through the circulation within hours (Hsu et al., 
2009).  Infectious virus and viral DNA can be found in spleen (Chong et al., 1981), and 
in circulating leukocytes of susceptible mouse strains (BALB/c and C57BL/6) (Bale & 
O'Neil, 1989) within 2-3 days post inoculation.  Dissemination through mononuclear 
phagocytes to other organs like kidney, lung and salivary glands follows (Hsu et al., 
2009; Stoddart et al., 1994).  Productive infection is cleared quickly except from the 
salivary glands (Reddehase et al., 1994), where viral burden peaks on around day 21 and 
lasts for weeks.  Latency develops after about 2-3 months post infection in adult mice 
(Henson & Strano, 1972; Reddehase et al., 1994) and viral DNA can be detected in 
macrophages and in endothelial cells in various organs (Koffron et al., 1998; Seckert et 
al., 2009).  Reactivation occurs spontaneously at low frequency in the salivary gland, and 
is inducible in other organs (e.g. lung and spleen) by immunosuppression (Balthesen et 
al., 1993; Jordan et al., 1977; Reddehase et al., 1994) or i.p. injection of 
lipopolysaccharide or pro-inflammatory cytokines, tumor necrosis factor (TNF) or 
interleukin (IL)-1β (Cook et al., 2006). 
The virulence of MCMV is influenced by how the virus has been passaged.  A 
single passage in cell cultures or in the mouse salivary glands can quickly change the 
virulence of MCMV (Osborn & Walker, 1971) and its resistance to antibody 
neutralization in vitro (Chong et al., 1981).  Virulent MCMV, that is lethal to suckling 
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mice, can only be produced from the salivary glands of infected mice but not from 
inoculated salivary gland cultures (Jordan & Takagi, 1983; Selgrade et al., 1981).  The 
virus-specific non-neutralizing antibodies-decorated membrane of the in vivo-generated 
virus might have increased the resistance to neutralization (Chong et al., 1981).  The 
timing of harvest also affects virulence, and the viruses collected from murine salivary 
glands at 2-3 weeks post infection are more virulent than viruses collected at 5-6 weeks 
post inoculation (Selgrade et al., 1981). 
Host defense against MCMV infection employs a combination of innate and 
adaptive immune strategies with some functional redundancies, and yet certain arms of 
the immune response are more important in certain organs at a particular stage of disease.  
The NK cell response dominates early viral control of MCMV in the spleen and liver 
through perforin-dependent and IFNγ/NOS-dependent mechanisms, respectively, until 
the T cell response develops (Tay & Welsh, 1997; Welsh et al., 1991).  CD4 T cells 
control MCMV in the salivary gland by suppressing viral replication in radio-resistant 
acinar glandular epithelial cells through secretion of IFNγ (Walton et al., 2008; 2011a).  
Mice can survive infection without NK or CD4 T cells but the depletion of either 
population increases the viral burden in the salivary glands (Podlech et al., 1998; Polić et 
al., 1996; Welsh et al., 1991).  The absence of a humoral response does not affect the 
initiation or clearance of MCMV infection in any organ but invigorates the spread of 
virus after reactivation by gamma-irradiation (Jonjić et al., 1994), suggesting a role for B 
cells in viral control during recurrence.  Adoptive transfer of memory B cells provides 
prophylactic and therapeutic benefits in the immunodeficient RAG-1 KO mice against 
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lethal MCMV infection (Klenovsek et al., 2007), and the administration of anti-MCMV 
serum can also limit the spread of virus and minimize pathology in the neonates 
(Cekinović et al., 2008).  Some T cell function is necessary for survival, but whether or 
not the CD8 T cell response is essential has been controversial.  Viral control without 
CD8 T cells in the long-term depleted mice and in β2m KO mice is as efficient as the 
undepleted and WT control respectively (Jonjić et al., 1990; Polić et al., 1996), 
suggesting a redundant role of CD8 T cells in viral control.  However, the absence of 
CD8 T cells increases the vulnerability of mice to lethal infection with a high dose of 
more virulent MCMV salivary gland isolate (Polić et al., 1996), and depleting CD8 T 
cells in MCMV-infected bone marrow transplant recipient mice can be fatal because of 
multi-organ dissemination of replicating virus (Podlech et al., 1998).  Functional 
MCMV-specific effector and memory CD8 T cells are effective in clearing virus from the 
spleen, lungs, liver, brain and small intestine (Podlech et al., 1998).  At least three 
immunoevasins (m04, m06 and m152) target the MHC class I presentation to CD8 T 
cells (Reddehase, 2002).  These findings support the significance of CD8 T cells in host 
defense against MCMV. 
MCMV-specific memory CD8 T cells exists in different expansion and 
contraction patterns.  The non-inflationary memory, also referred to as conventional 
memory, expands and contracts during acute infection and then remains stable at low 
numbers.  Examples are M45985–993- and M57816–824-specific CD8 T cells, whose numbers 
peak on around day 7 post infection.  CD8 memory T cells specific for m139419–426, 
M38316-323, IE3416-423 in C57BL/6 mice and for pp89168-176 and m164257-265 in BALB/c 
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mice are examples of the inflationary memory (Munks et al., 2006a; Sierro et al., 2005).  
All except IE3416-423-specific CD8 T cells are readily detectable during the acute phase of 
infection.  The CD8 T cells specific for m139419–426 in C57BL/6 mice and for pp89168-176 
and m164257-265 in BALB/c mice peak at around day 7 post infection, contract briefly, and 
increase in number again until reaching a peak at around day 100-120.  M38316-323-
specific CD8 T cell number continues to increase steadily beyond day 120.  IE3416-423-
specific CD8 T cells are undetectable until 4 weeks post infection.  All inflationary 
memory T cells increase in number between 6-12 weeks post MCMV infection (Munks 
et al., 2006a; Sierro et al., 2005; Snyder et al., 2008).  Memory T cell population can be 
segregated phenotypically into the effector memory T cells, which are dispersed in the 
periphery and perform immediate effector functions, and the central memory T cells, 
which express homing receptors to secondary lymphoid organs, CCR7 and CD62L, 
proliferate readily and differentiate into effector cells upon re-stimulation (Sallusto et al., 
2004).  Over time the non-inflationary memory T cells take on a more central memory 
phenotype and become CD62Lhi CD27hi CD122hi, while the inflationary memory T 
cells resemble effector memory with a phenotype of CD62Llo CD27lo CD122lo 
KLRG1hi (Sierro et al., 2005; Snyder et al., 2008).  Inflationary memory CD8 T cells 
accumulate in the spleen and lungs but not in lymph nodes, where virus does not persist 
(Torti et al., 2011a).   
The generation of MCMV-specific CD8 memory T cells involves both direct- and 
cross-presentation of MCMV-specific peptide epitopes.  The CD8 T cell response to 
MCMV is primarily primed by cross-presenting CD103+ CD8α+ CD11c+ DC (Snyder et 
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al., 2010; Torti et al., 2011b).  The immunoproteasome subunit low-molecular mass 
polypeptide 7 (LMP7) is needed for both the acute response and memory generation 
(Hutchinson et al., 2011).  MHC class I-presented antigens on non-hematopoietic cells 
are responsible for stimulating memory inflation (Seckert et al., 2011; Torti et al., 
2011a).  Re-activation of the viral genes in infected cells occurs sporadically throughout 
life and is thought to be the source of antigen that triggers T cells to expand, leading to 
memory inflation (Seckert et al., 2012).   Although memory inflation begins as early as 3 
weeks post infection – several weeks before the beginning of latency as defined by the 
absence of infectious virus in any organ, neither the suppression of viral replication or the 
removal of the salivary glands reduce memory inflation (Loewendorf et al., 2011; Snyder 
et al., 2011; Walton et al., 2011b), suggesting that the antigen for continuous stimulation 
of the inflationary memory T cells does not come from active viral replication during 
viral persistence in the salivary glands.  The comparable proliferation kinetics of 
inflationary memory CD8 T cells in WT versus CD4 T cell-deficient (CD4 KO and MHC 
II KO) mice (Snyder et al., 2009) also suggests that the duration of virus persistence may 
not dictate how long CD8 T cell memory inflates.  However, MCMV viral load may 
determine the size of memory inflation.  BALB/c mice retain a higher MCMV viral load 
than C57BL/6 mice (Vliegen et al., 2003), and the inflation of memory specific to pp89 is 
also more dramatic – up to 20% of CD8 T cells at one year post infection (Karrer et al., 
2003).   
 
Heterologous Immunity 
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The history of infection(s) can deviate the course of disease and influence the 
outcome of subsequent infections.  The effects may be beneficial and will reduce viral 
load and increase survival of infected animals, but they may also be harmful and prevent 
efficient viral clearance and/or cause immunopathology.  Sometimes, however, improved 
viral clearance may be accompanied by more severe immunopathology, as in the case of 
VACV infection in LCMV-immune mice.  Infection of LCMV-immune mice with 
VACV results in a reduction of about 1.5 log pfu/ml of VACV titer 3-4 days after 
infection compared to non-immune mice (Chen et al., 2001a; Selin et al., 1998), and the 
LCMV-immune mice are also protected from death after intranasal VACV infection 
(Chen et al., 2001a).  However, the history of LCMV infection or the adoptive transfer of 
LCMV-immune splenocytes can cause more severe inflammation and necrosis of the 
abdominal fat pads in intraperitoneally VACV-infected mice (Nie et al., 2010; Selin et 
al., 1998).  The effects of heterologous immunity may be long lasting during persistent 
infections.  Using LCMV-immune mice, the effects of the history of infection were 
studied during MCMV persistent infection and will be discussed in Chapter VI.  
Memory CD8 T cells can mediate both immunoprotection and immunopathology 
through IFNγ, but the two phenomena are not necessarily linked. LCMV-specific CD8 T 
cells are protective during VACV challenge.  CD8 T cell depletion abolishes the 
protective effect of adoptively transferred LCMV-immune splenocytes in VACV-infected 
hosts (Selin et al., 1998), and the transfer of cross-reactive T cell lines generated from 
LCMV-immune mice can reduce viral burden of VACV-infected hosts (Cornberg et al., 
2010), but IFNγR KO LCMV-immune mice no longer clear virus more efficiently or 
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develop immunopathology in visceral fat pads upon VACV challenge (Selin et al., 1998).  
On the contrary, a history of influenza infection enhances viral load and causes pathology 
in the lung during LCMV infection (Chen et al., 2003; Wlodarczyk et al., 2013).  
Depleting memory CD8 T cells from influenza-immune mice, tolerizing the influenza-
immune mice with cross-reactive peptides, or blocking IFNγ signals with monoclonal 
antibody reduces lung pathology upon LCMV infection but has no influence on LCMV 
clearance (Wlodarczyk et al., 2013).  
Similar to CD8 T cells, CD4 T cells can be involved in heterologous immunity.  
VACV infection of the antibiotic-treated Mycobacterium bovis bacillus Calmette-Guerin 
(BCG)-immune mice results in a 1-3 log reduction of viral titer in 1-3 days post infection, 
and the protection is abrogated by depleting CD4 T cells prior to infection, or by 
neutralizing the IFNγ secreted by CD4 T cells (Mathurin et al., 2009).   
CD25+ CD4+ regulatory T (Treg) cells also contribute to heterologous immunity.  
A recent study on influenza-immune mice revealed elevated numbers of Treg cells in the 
lung, mediastinal lymph nodes and the spleen six weeks after influenza infection, and 
upon intranasal LCMV infection, the accumulation of Treg cells in the lung and the 
secondary lymphoid organs correlates with more severe CD8 T cell-mediated lung 
pathology; this is reversible by depleting Treg cells from influenza-immune mice using 
an anti-CD25 antibody prior to LCMV challenge (Kraft et al., 2013).  It was deduced that 
the elevated number of Treg cells in the influenza-immune mice might have prevented 
the partial exhaustion of LCMV-specific CD8 T cells, and supported the migration of 
CD8 T cells out of the lymph nodes into the lung.  Consequently, the higher number of 
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activated CD8 T cells in the presence of high viral load led to more severe lung 
pathology.   
The effect of the history of infection(s) is not necessarily reciprocal, and the 
sequence of infections may determine the disease outcome.  A history of infection with 
LCMV, MCMV, Pichinde virus (PV), BCG or influenza A virus provides a certain level 
of heterologous protective immunity against VACV and reduced viral titer by one to two 
log pfu early (day 3-4) after infection (Chen et al., 2003; Mathurin et al., 2009; Selin et 
al., 1998).  However, a prior history of VACV infection does not protect against 
subsequent challenge with LCMV, MCMV or PV (Selin et al., 1998).  A history of 
LCMV infection protects against PV challenge to a greater extent than the history of PV 
infection does to LCMV infection (Selin et al., 1998).  Differences in the biology of the 
infections and the host responses may have contributed to the non-reciprocal nature of 
heterologous immunity.  The specific situation between LCMV and VACV was studied 
and will be discussed in Chapter VII. 
 
Cross-reactivity between viruses 
T cells recognizing one pathogen may respond to epitopes from another unrelated 
pathogen.  Cross-reactive T cells can bind to the corresponding tetramers simultaneously, 
albeit with varying avidities.  LCMV NP205-212, GP34-41, GP118-125 and VACV A11R198-205 
are cross-reactive between LCMV and VACV (Cornberg et al., 2010; Kim et al., 2005), 
and cross-reactive CD8 T cell lines can co-stain with both VACV A11R198-205 tetramer 
and LCMV GP34-41 or GP118-125 tetramer (Cornberg et al., 2010).  NP205-212 is cross-
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reactive between LCMV and PV, and the effector CD8 T cells from LCMV-infected 
mice also co-stain with LCMV NP205-212 and PV NP205-212 tetramers (Cornberg et al., 
2006).  A recent study demonstrated the dual specificity of peptide-MHC binding in a 
single CD8 T cell using bi-specific heterodimers, which are chemically linked dimers 
constructed between A11R198-205-H-2Kb monomers and GP34-41-H-2Kb monomers (Shen 
et al., 2010).  The monomers by themselves, or the dimers between the monomer and a 
non-specific monomer do not associate TCR with sufficient avidity, but the heterodimer 
binds with similar strength as the GP34-41-H-2Kb homodimer does, suggesting the 
existence of TCR with dual binding specificities or the co-existence of TCRs with 
different specificities on a single T cell surface.  Incomplete allelic exclusion can give 
rise to T cells expressing two functional Vα, but in mice the frequency of dual chain T 
cells in circulation seems rather low (Alam & Gascoigne, 1998; Heath et al., 1995).  The 
degeneracy of TCR recognition of peptide-MHC complexes may allow the same TCR to 
recognize more than one specific peptide sequence.  The complementarity determining 
region 3 (CDR3) loops on the TCR are flexible, enabling the TCR to interact with 
epitopes of different amino acid sequences (Reiser et al., 2003).  Substitutions on the 
peptide that achieve similar TCR-interacting surfaces are equally recognized (Sandalova 
et al., 2005).  Besides, because of the way peptides are presented in the MHC binding 
grove, only a few residues are actually exposed and interact with the TCRs (Fremont et 
al., 1992; Rudolph & Wilson, 2002; Zhang et al., 1992).  Certain substitutions of the 
anchoring residues are tolerated as long as they do not disrupt the binding to the MHC 
molecule (Reiser et al., 2003).  Therefore, some peptides with little or no sequence 
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homology may be recognized by the same TCR.  In fact, cross-reactive epitope pairs do 
not always share sequence homology (Reiser et al., 2003; Welsh et al., 2010).   
T cell cross-reactivity may lead to alteration of the immunodominance hierarchy 
and the Vβ repertoire of an immune response.  During heterologous infection, pre-
existing memory T cells recognizing their cross-reactive epitope will clonally expand, 
resulting in alteration of the immunodominance hierarchy of the T cell response and the 
hierarchy of memory T cells (Brehm et al., 2002; Kim et al., 2002; Selin et al., 2006).  
During the expansion, alteration and narrowing of the TCR Vβ repertoire is possible, 
because only a subset of the epitope-specific T cells may respond to the cross-reactive 
epitope, and a limited number of clonotypes will dominate the majority of the TCRs in 
the double immune mice (Cornberg et al., 2006). 
 
Private specificity of T cell response 
The distinct repertoires of TCR constitute the private specificity of the cross-
reactive response during heterologous infections.  During T cell development in the 
thymus, the variable (V)-diversity (D)-joining (J) recombination of the TCRβ chain and 
the V-J joining of TCRα chain give rise to the diversity of TCR.  Additionally, the 
terminal deoxynucleotidyl transferase (TdT) further creates a distinct repertoire of TCR 
for each individual mouse by randomly incorporating extra nucleotides to the junction of 
the rearranged DNA segments.  The sequence in the V segment forms the CDR1 and 
CDR2 regions while the rearranged V-D-J (or V-J) segments form the highly variable 
CDR3 loops in the center of the TCR.  In LCMV-immune mice, although some T cells 
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specific for NP205-212, GP34-41 and GP118-125 are cross-reactive with VACV A11R198-205, 
VACV infection preferentially expands only one or two (but not all three) of the cross-
reactive epitope-specific T cell populations within an individual mouse, and the pattern of 
cross-reactive T cell expansion differs between mice (Kim et al., 2005).  In PV-infected 
LCMV-immune mice, the Vβ repertoire of the NP205-212-specific CD8 T cells may 
become more oligoclonal because only certain clonotypes of the TCRs may interact with 
the cross-reactive peptide-MHC complex with sufficient affinity to trigger proliferation 
of the memory CD8 T cells, and the pattern of skewing varies between mice, with distinct 
Vβ dominating in different mice (Cornberg et al., 2006).  
The phenomenon of private specificity gives rise to differential disease outcome 
among mice of the same genetic background.  Protection from subsequent infections can 
be influenced by the private specificity of the cross-reactive T cell repertoire of the 
immune host.  VACV A11R198-205-specific T cell lines generated from LCMV-immune 
mice are protective during VACV infections but the level of protection varies, reflecting 
the TCR repertoire of the specific T cell line.  These TCR repertoires influence the ability 
of the memory T cell population to protect against heterologous VACV infection 
(Cornberg et al., 2010).  The private specificity of the T cell repertoire of the immune 
donor also governs the occurrence of immune pathology, and in VACV-infected 
recipients of LCMV-immune splenocytes, a more focused response towards GP118-125 
seemed to associate with more severe necrosis in the visceral fat pads (Nie et al., 2010).   
 
Maintenance of memory CD8 T cells 
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 The number and frequency of memory CD8 T cells is generally stably maintained 
but memory CD4 T cell number may decline over time.  The stability of CD8 T cell 
memory was examined in LCMV-, PV- and VACV-immune mice using irradiated, virus-
infected PEC as feeders in limiting dilution CTL assays and found to be stable over time 
(Selin et al., 1996).  The observation was later confirmed in LCMV-immune mice using 
virus-specific peptides in intracellular cytokine assays (Homann et al., 2001; Selin et al., 
1999).  In the same study, the number of memory CD4 T cells was found to gradually 
decline over time (Homann et al., 2001). 
Memory CD8 T cells are maintained through homeostatic proliferation supported 
by IL-7 and IL-15 (Burkett et al., 2003; Prlic et al., 2002; Schluns et al., 2000), but MHC 
engagement is not required for their maintenance (Murali-Krishna et al., 1999; Tan et al., 
2002).  IL-7 is produced in the thymus, bone marrow, spleen, lymph nodes, intestinal 
epithelium and skin epidermal basement membrane (Hara et al., 2012; Link et al., 2007; 
Mazzucchelli et al., 2009; Wagner et al., 1999).  Both DC and macrophages are 
responsible for transpresenting IL-15 to CD8 T cells (Frasca et al., 2010; Mortier et al., 
2009).  Although both IL-7 or IL-15 stimulation can support homeostatic proliferation of 
CD44hi CD8 T cells in irradiated hosts (Kieper et al., 2002; Schluns et al., 2000; Tan et 
al., 2002), and homeostatic proliferation is impaired in IL-15 KO and IL-15Ra KO mice 
(Schluns et al., 2002), IL-15 does not seem to be required for survival of non-dividing 
memory CD8 T cells because the number of undivided adoptively transferred memory 
CD8 T cells were not reduced in IL-15 KO hosts after 30 days (Becker et al., 2002).  
Both IL-7 and IL-15 signal through STAT5.  Constitutively activated STAT5 boosts 
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proliferation of memory CD8 T cells (Hand et al., 2010).  Myeloid cells of mixed DC 
phenotypes may also enhance the survival of memory CD8 T cells, especially those of 
CD62L hi phenotype, through CD70 signaling to CD27-expressing CD8 T cells (Frasca 
et al., 2010). 
Viral infections can cause a reduction of memory CD8 T cells (Brehm et al., 
2002; Kim & Welsh, 2004; Liu et al., 2003; Selin et al., 1996; 1999; Varga et al., 2001).  
The peak of virus-induced type I IFN early during LCMV infection coincides with the 
reduction of CD44hi memory CD8 T cells and is thought to be the cause of memory 
attrition and early apoptosis of CD44hi CD8 T cells.  Experiments have shown that the 
direct injection of IFNαβ or IFNαβ-inducer poly(I:C) resulted in the loss of memory 
CD8 T cells and CD44hi CD8 T cell apoptosis, but IFNαβR KO mice were resistant to 
the reduction of CD8 T cells at day 3 post LCMV infection (Bahl et al., 2006; Jiang et 
al., 2005; McNally et al., 2001).  Infection-induced lymphopenia also contributes to the 
reduction of pre-existing memory CD8 T cells because the pathogen-specific memory T 
cells proliferates at a lower rate in the absence of their cognate antigens and are 
outcompeted by other dividing T cells (Peacock et al., 2003). 
Bacterial or protozoal infections can also disturb the stability of memory T cell 
populations.  Pre-existing Listeria monocytogenes (LM)-specific memory CD8 T cells 
increase during heterologous chronic Leishmania donovani infection, and memory CD8 
T cells of central memory phenotype are preferentially accumulated (Polley et al., 2005).  
These LM-specific CD8 T cells do not proliferate upon stimulation by Leishmania-
infected DC and are presumably not accumulated by cross-reactivity.  On the other hand, 
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infections with BCG or Salmonella typhimurium, which can also cause chronic infection, 
erode pre-existing LM-specific memory CD8 and CD4 T cells through an IFNγ-
dependent mechanism (Dudani et al., 2008; Smith et al., 2002).  Moreover, exposure to 
bacterial superantigens can also result in loss of memory CD8 T cells.  Staphylococcal 
enterotoxin B (SEB) interacts with TCR Vβ and causes activation and proliferation of 
memory CD8 T cells (Coppola & Blackman, 1997), but then selectively destroys Vβ8.3+ 
memory CD8 T cells through activation-induced cell death (Huang et al., 2002). 
 
Regulatory T (Treg) cells and their maintenance 
Treg cells constitute a heterogeneous T cell population that plays an important 
role in maintaining self-tolerance and limiting an overactive immune response.  
Immunosuppressive “natural” Treg cells develop in the thymus and are marked by the 
expression of CD4 and a Forkhead/winged-helix family member, forkhead box P3 
(Foxp3; Scurfin), which is an activator and a repressor of transcriptional control (Zheng 
et al., 2007).  Foxp3 forms a 400-2000 kDa complex, the “Foxp3 interactome” with many 
partners, including some transcription factors, histone methyl transferases, and chromatin 
remodeling complexes (Rudra et al., 2012), and it functions in a transcription control 
network with other transcription factors (Fu et al., 2012) to generate signature phenotypes 
in Treg cells (Williams & Rudensky, 2007).  Scurfy mice have a 2-base pair insertion in 
their exon 8 of the X-linked Foxp3 gene (Brunkow et al., 2001) and develop a 
lymphoproliferative disorder and perivascular infiltration of hematopoietic cells in 
multiple peripheral organs (Godfrey et al., 1991).  Experimentally depleting the Foxp3-
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expressing population in mice can lead to autoimmune disorders (Feuerer et al., 2009; 
Kim et al., 2006b; Lahl et al., 2007). 
During infections, Treg cells can mitigate the pathology incurred by immune 
response and prolong survival of the infected mice.  Weight loss and accumulation of 
monocytes and macrophages in the lungs after influenza PR8 infection are reduced after 
adoptive transfer of CD25+ CD4+ Treg cells, which modulate the timing of production of 
chemokine CCL8 in the lungs (Antunes & Kassiotis, 2010).  A later study also shows that 
transferred virus-reactive Treg cells can down-regulate the accrual of effector CD4 and 
CD8 T cells in the lungs and modulate systemic cytokine responses after PR8 infection 
(Bedoya et al., 2013).  In mice infected ocularly with herpes simplex virus (HSV)-1, 
Foxp3+ Treg cells reduce the severity of corneal stromal keratitis lesions by suppressing 
the production of inflammatory cytokines and chemokines and limiting the infiltration of 
CD4 T cells, neutrophils and macrophages to the cornea (Veiga-Parga et al., 2012).  In 
some situations Treg cells control disease severity through enhancement of effector 
responses to infections and efficient viral clearance.  Treg cells promote migration of 
effector CD4 T cells, NK cells, CD11b+ DC and plasmacytoid DC from the draining 
lymph nodes to the site of infection through modulation of chemokine production in both 
locations early during genital HSV-2 infection, and mice depleted of Foxp3+ Treg cells 
have higher viral titers in the reproductive organ and the spinal cord and suffer a more 
severe disease earlier (Lund et al., 2008).  Along the same lines, Treg cells support the 
migration of virus-specific CD8 T cells to the lungs during respiratory syncytial virus 
infection, and CD25+ Treg cell-depleted mice experience delayed viral clearance and 
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more severe weight loss and airway resistance at 1 week after infection (Fulton et al., 
2010). 
Foxp3+ Treg cells require IL-2 signaling for survival and non-lymphopenic self-
renewal (Fontenot et al., 2005; Setoguchi et al., 2005).  They themselves do not produce 
IL-2 (Su et al., 2004; Takahashi et al., 1998), because Foxp3 displaces AP-1 and 
suppresses the expression of IL-2 through cooperative binding with NFAT on the Il2 
promoter (Wu et al., 2006) with the help of Helios (Baine et al., 2013).  Therefore, Treg 
cell maintenance depends on IL-2 secreted by other cells, and treating mice with high 
dose anti-IL-2 antibody reduces the number of Foxp3+ CD4+ Treg cells, especially in the 
periphery, and initiates autoimmune disorders (Setoguchi et al., 2005).  IL-2 increases 
Foxp3 expression per Treg cell and causes expansion of Treg cell populations (Fontenot 
et al., 2005; Murawski et al., 2006; Zorn et al., 2006).  The importance of IL-2 to Treg 
cell survival is evident in IL-2 KO mice, where adoptively transferred WT Treg cells do 
not survive (Malek et al., 2002).  Both CD25 KO and IL-2 KO mice can succumb to 
lymphoproliferative disorders, albeit relatively delayed compared to Foxp3 KO mice 
(Fontenot et al., 2005). 
IL-2 also influences Treg cell function.  CD4 T cells from IL-2 KO mice, but not 
from CD25 KO mice, perform Treg cell suppressive functions and prevent the 
development of autoimmune conditions in IL-2-normal disease-prone recipient mice 
(Furtado et al., 2002), suggesting a role of IL-2 in the function of Treg cells in the 
periphery.  The Foxp3+ Treg cell population rescued by blocking apoptosis in B-cell 
lymphoma (Bcl)-2-interacting mediator of cell death (Bim) and IL-2 double KO mice 
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were not sufficient in preventing autoimmunity in mice (Barron et al., 2010), suggesting 
a role of IL-2 beyond maintaining survival of Treg cells.  However, IL-2 is not absolutely 
required in the thymic development of Foxp3+ Treg cells, and Foxp3+ CD4+ Treg cells 
from both IL-2 KO and CD25 KO mice are capable of suppressing proliferation of WT 
conventional T cells in vitro (Fontenot et al., 2005).  IL-2 may have stimulated 
proliferation of Treg cells, and contributed to the enhanced suppressive functions of the 
IL-2 KO T cell population through increased Treg cell number.  The capability of Treg 
cells to suppress may be a combination of both total Treg cell number and per cell 
suppressive capability. 
Although Treg cells may not survive as well by themselves in purified cultures 
because of their dependence on common γ chain cytokines secreted from other cells 
(Kaminitz et al., 2010; Pandiyan & Lenardo, 2008), they are more resistant to apoptosis 
than other cells in vivo.  After whole body gamma-irradiation, CD8 and CD4 T cells were 
much reduced, but CD25hi CD4 Treg cells were proportionally increased (Qu et al., 
2010).  Human Treg cells have been found more resistant to apoptosis induced by 
irradiation or topoisomerase inhibitors than non-Treg CD4 T cells (Winzler et al., 2011).  
Both murine and human Treg cells are resistant to activation-induced cell death (Banz et 
al., 2002; Fritzsching et al., 2005).  In Chapter V, the relative resistance of Treg cells to 
apoptosis during LCMV infection will be discussed.  It is unclear why Treg cells may be 
more resistant to cell death in some situations.  The study in mice correlated higher Bcl-2 
expression in CD25hi CD4 Treg cells to their resistance to irradiation-induced cell death 
(Qu et al., 2010).  However, Bcl-2 and B-cell lymphoma-extra large (Bcl-xL) expressions 
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were found comparable in human Treg vs effector T cells in a different study (Winzler et 
al., 2011).   
 
The immunoproteasome and immune response 
 The peptides presented by antigen-presenting cells can influence the diversity of 
T cell response.  Professional antigen-presenting cells like DC and macrophages express 
both constitutive proteasomes and immunoproteasomes (Nil et al., 2004).  The 
constitutive 26S proteasome consists of a 20S core and a 19S regulatory complex 
(PA700) at one or both ends of the 20S core (Coux et al., 1996).  The 19S regulatory 
complex is involved in degrading ubiquitinated protein substrates in an ATP-dependent 
manner (Kish-Trier & Hill, 2013).  The 20S core contains 28 subunits arranged in a 
cylindrical structure of four concentric rings, each with seven different subunits.  The 14 
α-type subunits form the two outer rings, and the 14 β-type subunits constitute the two 
rings in the middle.  The β-type subunits δ (β1), MB1 (β5) and MC14 (β2) are 
catalytically active.  The immunoproteasome shares the same basic format, except for the 
replacement of the 19S regulatory complex by the 11S activator (PA28 complex) on one 
end of the 20S core and the three catalytic β-type subunits by the inducible homologues – 
the LMP2 (β1i), LMP7 (β5i), and multicatalytic endopeptidase complex-like-1 (MECL-
1; β2i).   
IFNγ stimulation can induce the expression of the alternative β-type subunits, 
which equip the immunoproteasome with modulated endopeptidase activities (Aki et al., 
1994; Driscoll et al., 1993; Gaczynska et al., 1993; Groettrup et al., 1996).  Early studies 
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with LMP2 KO mice suggested that LMP2 increased chymotrypsin- and trypsin-like 
activities and decreased peptidyl glutamyl peptide hydrolase- or caspase-like activity 
(Van Kaer et al., 1994), but since LMP2 and MECL-1 were coordinately recruited to the 
immunoproteasome (Groettrup et al., 1997), MECL-1 might have partaken in the 
changes.  A later study using an inactive MECL-1 T1A construct to displace MC14 in the 
transfectant fibroblasts determined that MECL-1 or MC14 alone were responsible for the 
trypsin-like activity of the proteasome (Salzmann et al., 1999).  This was later confirmed 
in the MECL-1 KO mice, and the observation that only caspase-like activity was elevated 
in the 20S proteasomes isolated from MECL-1 KO mice, but the trypsin- and 
chymotrypsin-like activities were not different from WT mice, suggested that both 
MECL-1 and MC14 might have similar trypsin-like activity (Basler et al., 2006).  On the 
other hand, the comparison of chromatography-purified proteasomes from WT and 
LMP7 KO mice revealed that LMP7 participated in the chymotrypsin-like activity of the 
20S proteasomes (Stohwasser et al., 1996).  
With the presence of LMP2, LMP7 and MECL-1, the immunoproteasomes 
produce more hydrophobic and basic substrates suitable for binding to the MHC class I 
molecules (Driscoll et al., 1993; Falk et al., 1991; Gaczynska et al., 1993).  In fact, the 
immunoproteasome generates quite a different repertoire of peptides, as demonstrated by 
comparing peptide pools generated from the in vitro digestion of enolase by LMP2/LMP7 
double-deficient proteasomes and immunoproteasomes isolated from transformed B cells 
(Toes et al., 2001), and by the analysis of acid-eluted peptides from the bone marrow-
derived dendritic cells (BMDC) of WT and LMP7/MECL-1 double KO mice (de Verteuil 
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et al., 2010).  By modulating the cut site preference, the immunoproteasomes may 
generate peptides that are more easily transported by transporter associated with antigen 
processing (TAP) across the endoplasmic reticulum (ER) membrane, thereby increasing 
the representation of certain epitopes such as LCMV NP118-126 in the peptide pool 
(Schwarz et al., 2000).  In contrast, the immunoproteasome may destroy some epitopes 
by favoring a cut site within the epitope, such as LCMV GP276-286 by LMP2, and thwart 
their presentation (Basler et al., 2004).  Besides their catalytic roles, the 
immunoproteasome subunits may protect some epitopes by their structural contribution to 
the proteasomes.  Using LMP2-specific enzyme inhibitors and the inactive LMP2 T1A 
construct, the structural presence of LMP2, and not its enzymatic activity, was found to 
protect the male-specific antigen UTY246-254 (Basler et al., 2012).  Similarly, influenza 
M158-66 was found to be protected by the structural presence of and not by the enzymatic 
activity of LMP7 from being destroyed by the constitutive β5 subunit (Basler et al., 2012; 
Gileadi et al., 1999). 
The changes in the peptide pool caused by the immunoproteasomes may influence 
the immunodominance hierarchy of CD8 T cell responses to pathogens.  The specific 
responses to LCMV GP276-286 and NP205-212 were lower in MECL-1 KO mice at day 8 
post infection (Basler et al., 2006).  At day 7 post MCMV infection, LMP7 KO mice also 
displayed a much reduced CD8 T cell response, especially towards the non-inflationary 
epitopes (Hutchinson et al., 2011).   
The overall increase in peptide output by the immunoproteasome can affect the 
density of MHC class I molecules on the surface of antigen-presenting cells.  The LMP7 
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KO reduced the presence of MHC class I molecules on the cell surface (Fehling et al., 
1994).  Reduced surface expression of MHC class I molecules was also observed on the 
BMDC of LMP7/MECL-1 double KO mice, and in that study the lower abundance of 
peptides was found to cause the reduction of MHC class I surface expression because the 
protein amounts of the MHC class I heavy chains were comparable in the whole cell 
lysate of DC from WT and double KO mice (de Verteuil et al., 2010). 
The immunoproteasome subunits play an important part in shaping the CD8 T cell 
repertoire.  LMP2 and MECL-1 are found in complex with the thymus-specific β5t in the 
thymoproteasomes (Murata et al., 2007), and both deficiency in LMP2 or MECL-1 may 
affect the generation of the T cell repertoire.  The dominant response to influenza virus 
shifted from NP366-374 and PA224-233 in WT mice to NS2114-122 and PB1F262-70 in LMP2 
KO mice after i.p. infection.  The adoptive transfer experiment with splenocytes followed 
by influenza infection showed that the immunodominance hierarchy of the WT or LMP2 
KO donor cells was not influenced by the host genetic background, suggesting that the 
change of T cell repertoire in the LMP2 KO mice, not the change in peptide presentation, 
had caused the altered immunodominance hierarchy (Chen et al., 2001b).  The frequency 
of Vβ10+ CD8 T cells was lower in MECL-1 KO mice and contributed to the reduced 
response to GP276-286 after LCMV infection (Basler et al., 2006).  LMP7 is also expressed 
in the thymus (Murata et al., 2007), and its absence influenced the selection of OT-1 CD8 
T cells specific for an ovalbumin-derived H-2Kb-restricted peptide in that they were 
biased towards Vβ8.1/8.2 usage instead of Vβ5.1 in OT-1 LMP7 KO mice (Osterloh et 
al., 2006). 
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The objective of this thesis is to study the generation of CD8 T cell response and 
specific memory during infections, the stability of memory T cells and their influences in 
subsequent heterologous infections.  In the context of LCMV infection, I examine the 
effects of the absence of the immunoproteasome catalytic subunits on the magnitude and 
diversity of CD8 T cell response and the diversity of memory CD8 T cells.  The stability 
of the pre-existing memory CD8 and CD4 T cells is re-examined using different infection 
sequences and a larger set of virus-specific peptides.  I also examine the stability of Treg 
cells, which play an important role in autoimmunity, during LCMV infection.  The 
influence of the history of infections is studied in LCMV-immune mice during persistent 
MCMV infection.  Memory CD8 T cells are involved in the protecting LCMV-immune 
mice during VACV infection, and the non-reciprocity of immunoprotection between 
LCMV and VACV is investigated by comparing the memory phenotypes of memory 
CD8 T cells from LCMV and VACV infections and by increasing the potentially cross-
reactive CD8 T cells in the VACV-immune mice. 
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Chapter II. Materials and Methods 
Mice and viruses 
C57BL/6 male mice between 5-6 weeks of age were purchased from the Jackson 
Laboratory (Bar Harbor, ME).  Foxp3GFP knock-in mice (from Dr. Vijay K. Kuchroo) 
(Bettelli et al., 2006) and immunoproteasome LMP2/MECL1/LMP7 triple KO mice 
(from Dr. Kenneth Rock) (Kincaid et al., 2011) were bred and maintained in a specific 
pathogen-free facility at the University of Massachusetts Medical School 
(UMMS)(Worcester, MA).  Mice were used or received the first inoculum when they 
reached at least 6-7 weeks of age. 
LCMV, Armstrong strain, was propagated in baby hamster kidney BHK21 cells 
(Welsh et al., 1976; Welsh & Seedhom, 2008).  MCMV, Smith strain, was passaged in 
BALB/c mice salivary glands (Selgrade et al., 1982; Yang et al., 1989).  Supernatant 
from uninfected baby hamster kidney cultures (BHK) and salivary gland homogenate 
from naïve mice (nsg) were used as respective sham controls in some experiments.  
VACV, Western Reserve strain, was propagated in L929 cells (Yang et al., 1989).  
Recombinant VACV expressing LCMV glycoprotein (VACV-GP) was kindly provided 
by Dr. J. Lindsay Whitton (Whitton et al., 1988).  Mice were infected with 5x104 pfu 
LCMV, 5x105 pfu MCMV, 106 pfu VACV or 5x106 pfu VACV-GP intraperitoneally, and 
were considered immune after 6 weeks post infection.  Experiments were done in 
compliance with the Animal Welfare Act and the National Institutes of Health guidelines 
for the ethical care and use of animals in biomedical research according to protocols 
approved by the Institutional Animal Care and Use Committee of UMMS. 
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Cell lines 
 Vero cells (African green monkey kidney epithelial cell line; ATCC) were 
maintained in minimum essential medium (MEM; Life Technologies) supplemented with 
10% fetal calf serum (FCS; Sigma), 2mM Penicillin/Streptomycin (Pen/Strep; Gibco) and 
2mM L-glutamine (L-glu; Gibco).  Mouse embryonic fibroblasts from α-1-3-
galactosyltransferase-deficient transgenic mice (GT-KO) were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM; Life Technologies) with 10% FCS, 2mM Pen/Strep 
and 2mM L-glu.  DC2. 4 (Shen et al., 1997) were maintained in RPMI-1640 (Gibco) 
supplemented with 10% FCS, 2mM Pen/Strep, 2mM L-glu, non-essential amino acid 
(Gibco) and 10mM HEPES (Gibco). 
 
DC immunization 
 Cultured immortalized dendritic cells DC2.4 were split 1:4 on the day before 
immunization.  Trypsinized DC2.4 cells (at 107 cells/ml) were pulsed with 5 µM filter-
sterilized A11R198-205 peptide in FCS in a 37°C water bath for 40 min with tapping every 
10 min.  Pulsed DC2.4 cells were washed 4 times with 50ml of Hank’s Balanced Salt 
Solution (HBSS) and counted.  Twenty-five million A11R198-205-pulsed DC2.4 cells were 
administered subcutaneously on the upper right abdomen.  HBSS was used as a control 
for the injection. 
 
Plaque assay 
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 Harvested organs were ground in 1ml of media (2ml for liver), spun at 2000 rpm 
for 20 min at 4°C, and stored at -80°C.  Monolayers of Vero cells were set up overnight 
in 6-well plates by seeding 2x105 cells/well for LCMV or 3x105 cells/well for VACV.  
Organ homogenate (100µl) and its 10-fold dilutions were gently mixed onto and 
incubated with the monolayer in 1ml of media for 1.5 hrs at 37°C, 5% CO2.  Plates were 
then overlayed with 4ml of a 1:1 mixture of 1% SeaKem-ME agarose in distilled water 
and EMEM supplemented with 6% FCS, 5mM Pen/Strep, 5mM L-glu, and 1% 
Fungizone (Gibco).  After 4 days for LCMV or 2 days for VACV, plates were stained 
with 0.02% neutral red in the agarose mixture above.  Plaques were counted the 
following day.   
Monolayers of GT-KO cells (2x105 cells/well) were used for MCMV plaque 
assays. After 6 days of incubation, the 4ml agarose overlay was carefully removed.  The 
monolayer of GT-KO cells was washed with phosphate buffered saline (PBS), stained 
with 0.1% crystal violet with 1% formaldehyde in PBS, rinsed with PBS and air-dried. 
 
Surface staining 
Splenocytes in suspension were washed in staining buffer (1% FCS in PBS), 
blocked with anti-CD16/32 (clone 2.4G2; Fc block), and stained with combinations of 
anti-CD4 (clone RM4-5), anti-CD8α (clone 53-6.7), anti-CD8β (clone YTS156.7.7), 
anti-CD44 (clone IM7), anti-CD25 (clone PC61.5), anti-CD127 (clone A7R34), anti-
CD122 (clone TM-β1), anti-CD132 (clone TUGm2), anti-CD215 (clone JM7A4), anti-
CD62L (clone MEL-14), anti-KLRG1 (clone 2F1), anti-CD27 (clone LG.3A10), anti-
32
CD43 (clone 1B11), anti-NK1.1 (clone PK136), anti-CD3ε (clone 145-2C11), anti-Vα2 
(clone B20.1), anti-Ly5.1 (clone A20), anti-Thy1.1 (clone HIS51), anti-Thy1.2 (clone 30-
H12), live/dead fixable aqua (Invitrogen) for 20 min at 4°C.  Stained cells were fixed 
with CytoFix (BD Biosciences) for 5 min at 4°C.   
 
Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay 
To evaluate DNA fragmentation, cells were rested in media (10% FCS in RPMI-
1640 with 2mM Pen/Strep and 2mM L-glu) supplemented with 10mM HEPES in a 48-
well plate for 5 hrs at 37°C, 5%CO2, Fc-blocked, surface stained, and Cytofixed for 15 
min at 4°C. After permeabilization with 70% (v/v) ethanol for 3.5 days at -20°C, terminal 
deoxynucleotidyl transferase dUTP nick-end labeling was performed using Apo-BrdU-
RedTM In Situ DNA Fragmentation Assay Kit (BioVision) according to manufacturer’s 
instructions.  Samples were analyzed within 3 hrs by LSRII (BD Biosciences) and 
FlowJo software (Tree Star). 
 
Annexin V staining 
Annexin V staining was done directly ex vivo.  After Fc-block, surface staining 
and one wash with Annexin V binding buffer (eBioscience), cells were stained with 
Annexin V (eBioscience) at room temperature for 15 min.  Samples were analyzed 
immediately by LSRII.  
 
PhosFlow staining  
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Splenocytes in suspension were stimulated with IL-2 (5ng/ml; BD Biosciences) 
for 15 min at 37°C, 5%CO2.  After a quick wash in staining buffer, cells were 
immediately fixed with CytoFix for 15 min at 4°C, Fc-blocked and surface stained as 
described above.  Cells were then permeabilized with PhosFlow Perm buffer III (BD 
Biosciences) for 30 min on ice, and stained with anti-STAT5 (clone 3H7) or anti-
pSTAT5 (clone pY694) for 60 min at room temperature in the dark.   
 
Ex vivo intracellular staining 
Anti-apoptotic and pro-apoptotic molecules were examined without in vitro 
stimulation.  Fc-blocked and surfaced-stained cells were fixed and permeabilized in 
Foxp3 Fix/Perm (eBioscience) for 1 hr at 4°C, washed with 1X Perm buffer and then 
stained with anti-Foxp3 (clone FJK-16s), anti-Bcl-2 (clone 3F11), anti-Bcl-xL (clone 
54H6), anti-Mcl-1 (clone D35A5), anti-Bim (clone C34C5) or anti-Bak NT (Millipore 
#06-536) for 60 min at room temperature.  Unconjugated antibodies were subsequently 
stained with Alexa Fluor 647 secondary goat anti-rabbit IgG (H+L) antibody (Life 
Technologies) for 30 min at room temperature in the dark. 
 
Intracellular cytokine staining (ICS) 
 Splenocytes were stimulated on 96-well U-bottomed plates with 1µg/ml (1µM) 
synthetic peptide, 10 U/ml human recombinant IL-2 (BD Biosciences) and 1µl/ml of 
GolgiPlug (BD Biosciences) for 5 hrs at 37°C, 5% CO2 as described (Brehm et al., 2002).  
Anti-CD3ε (250ng/ml; clone 145-2C11), or 50ng/ml phorbol 12-myristate 13-acetate 
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(PMA) plus 500ng/ml ionomycin was used in place of peptides as positive controls.  
After Fc-block and surface staining as described above, cells were fixed and 
permeabilized with CytoFix/CytoPerm (BD Biosciences) for 20 min at 4°C.  Cells were 
then washed twice with 1X Perm/Wash buffer and stained with anti-IFNγ (clone 
XMG1.2), anti-TNF (clone MP6-XT22) and anti-IL-2 (clone JES6-5H4) for 25 min at 
4°C.  Washed samples were analyzed on an LSRII within 5 days.  To assess the 
accumulation of lytic granules, samples were stimulated with GP33-41 peptide for 4-6 
days, and stained with anti-human Granzyme B (clone GB12) after fixation and 
permeabilization.  
 
Proliferation assay with CFSE 
 Splenocytes were labeled with 2 µM carboxyfluorescein succinimidyl ester 
(CFSE) in warm HBSS at 2x107 cells/ml for 15 min at 37°C with tapping every 5 min.  
Labeled splenocytes were washed in HBSS and counted.  The Ly5.1 P14 CD8 T cell 
frequency of each mouse was determined by flow cytometry.  Equal numbers of P14 
memory CD8 T cells and supplementary naïve splenocytes were stimulated with GP33-41 
on a 96-well plate for 4-6 days.  Proliferated populations were surface-stained and 
analyzed by LSRII. 
 
In vivo brefeldin A (BFA) cytokine assay 
Cytokine-producing cells were detected in vivo as described (Liu & Whitton, 
2005; Priyadharshini et al., 2010) with modifications.  Lymphocytes from spleen and 
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lymph nodes of naïve Thy1.1 P14 TCR-transgenic mice specific for LCMV GP33-41 were 
treated with 1 µl/ml GolgiPlug for 15-20 min at 37°C with tapping every 5 min.  The 
BFA-treated lymphocytes (2x107) in 200 µl and 250 µg BFA in 200 µl warm HBSS were 
then injected intravenously into day 2 LCMV-infected wild-type and triple KO mice.  
Splenocytes were harvested after 4 h for ICS as described above. 
 
Adoptive transfer experiment 
WT Thy1.1+Thy1.2+ and triple KO Thy1.1+Thy1.2+ mice were injected with 40 
µg anti-Thy1.2 (clone 30H12, BioXCell) per day on day -3, -2, -1 and +4 relative to 
infection to deplete endogenous T cells.  LCMV-immune WT Thy1.1 splenocytes 
(3x107) were adoptively transferred intravenously on day -1, and mice were inoculated 
i.p. with 5x104 pfu LCMV on day 0.  Splenocytes were harvested 5.5 days after infection 
for in vitro stimulation and ICS as described above. 
 
DNA extraction and quantitative PCR (qPCR) 
 Organs collected in dry 1.5ml vials were snap-frozen in liquid nitrogen and stored 
at -80°C.  A fraction of the snap-frozen organ was minced by glass beads in 10mM 
Tris/25mM EDTA (pH8.0) buffer, and incubated with proteinase K (Sigma) and 0.3% 
sodium dodecyl sulfate (Sigma) overnight in a 60°C water bath.  After phenol extraction 
in phase lock gel (PLG) light tubes with equal volumes of the organ mixture and Tris-
saturated phenol (pH 8.0), the aqueous phase was treated with 10-15u RNase (Promega) 
in a 37°C water bath for 1-1.5 hrs.  DNA was extracted with phenol/chloroform in PLG 
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tubes, precipitated by adding 100% ethanol and 3M sodium acetate, and rinsed with 75% 
ethanol.  Pelleted DNA was air-dried at room temperature before solvating in distilled 
water and storing at -20°C. 
 In a total volume of 25µl, the PCR mixture contained 125ng DNA, 400nM of 
forward primers, 400nM of reverse primers and QuantiFast SYBR Green PCR master 
mix (Qiagen).  MCMV glycoprotein B (gB) forward primer sequence was 5’-
AGGGCTTGGAGAGGACCTACA-3’ and reverse primer sequence was 5’-
GCCCGTCGGCAGTCTAGTC-3’ (Vliegen et al., 2003).  Mouse β-actin forward primer 
sequence was 5’-CGAGGCCCAGAGCAAGAGAG-3’ and reverse primer sequence was 
5’-CGGTTGGCCTTAGGGTTCAG-3’ (Mishra et al., 2010).  The PCR was performed 
on CFX96 (BioRad) with an initial incubation at 95°C for 10 min to activate the Taq 
enzyme followed by 35 amplification cycles of denaturation at 95°C for 10s, annealing 
and extension at 60°C for 30s.  A melting curve was generated from 65°C to 95°C with 
an increment of 0.5°C every 5s.  Serial dilutions of plasmid containing the gB sequence 
(109 – 102 copies) were included to generate a standard curve.  The β-actin standards 
contained 375-0.17ng genomic DNA.  MCMV copy number was calculated by the CFX 
System (Bio-Rad) in duplicates and normalized with the amount of genomic DNA in µg. 
 
Statistical analysis 
Student’s t test was calculated using Excel or Prism.  Data were presented with mean and 
standard error of the mean (SEM). 
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Chapter III. Immunoproteasomes influence immune responses 
(The study in this chapter was accomplished in collaboration with Eleanor Kincaid, and 
part of the work has already been published in Nature Immunology 13(2):129-135.) 
The magnitude and diversity of CD8 T cell response to an infection can be 
affected by the peptides generated in the immunoproteasomes and presented on MHC 
class I molecules by the antigen-presenting cells.  Professional antigen-presenting cells 
express both constitutive proteasomes and immunoproteasomes (Nil et al., 2004).  The 
20S core of the proteasomes consists of 14 α-type subunits on the two outer rings and 14 
β-type subunits on the inner rings.  The catalytically active β-type subunits δ (β1), MB1 
(β5) and MC14 (β2) are constitutively expressed but are replaceable by the inducible 
homologues LMP2 (β1i), LMP7 (β5i), and MECL-1 (β2i) upon IFNγ stimulation on non-
hematopoietic cells (Aki et al., 1994; Coux et al., 1996; Nandi et al., 1996).  The 
inducible catalytic subunits incorporated into the newly assembled immunoproteasomes 
can modulate the enzymatic activities and substrate sequence preferences (Boes et al., 
1994; Gaczynska et al., 1993).  In some cells, LMP2 and MECL-1 are incorporated 
cooperatively into the immunoproteasomes, and the maturation of LMP2 and MECL-1 
progresses more efficiently in the presence of the presequence of LMP7 (Griffin et al., 
1998; Groettrup et al., 1997; Pang et al., 2006).  Single allele disruption knockout mice 
have been generated to study the function of the inducible immunoproteasome subunits 
separately (Basler et al., 2006; Fehling et al., 1994; Van Kaer et al., 1994).  The 
LMP7/MEC-1 and LMP2/MEC-1 double KO mice were subsequently made by genetic 
crosses (Hensley et al., 2010; Pang et al., 2006).  Because of the close proximity of the 
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genes encoding LMP2 and LMP7 (Psmb9 and Psmb8 respectively) in the MHC class II 
region, a LMP2/LMP7 double KO is impossible to achieve by normal crosses of the 
single KO mice.  Therefore, Eleanor Kincaid and colleagues generated the LMP2/LMP7 
double KO mouse by sequential target deletion of exons 1-5 of Psmb8 and exon 1 of 
Psmb9.  The backcrossed LMP2/LMP7 double KO mouse with the C57BL/6J 
background was then bred with MECL-1 KO mice to generate the LMP2/LMP7/MECL-1 
triple KO mice.   
The phenotype of the triple KO mice is a combination of the characteristics of the 
three single KO strains.  Similar to LMP2/MECL-1 and LMP7/MECL-1 double KO mice 
(Hensley et al., 2010), the mature CD8 T cell count in the thymus and spleen of the triple 
KO mice is only about half of that in WT mice, but the B cell number is normal.  This is 
different from LMP2 single KO mice, whose B cells as well as CD4 and CD8 T cells are 
reduced (Hensley et al., 2010; Nussbaum et al., 2005).  The LMP7 KO reduced the 
presence of MHC class I molecules on cell surface (Fehling et al., 1994), but the LMP2 
KO or MECL-1 KO did not (Basler et al., 2006; Van Kaer et al., 1994).  The triple KO 
mice are more similar to the LMP7 KO mice in this aspect and express only about 50% 
as many MHC class I molecules H-2Kb and H-2Db as WT hematopoietic cells do.  
Expression of Tap1, which is located between Psmb9 and Psmb8, is also reduced by 50% 
in the triple KO mice, but Tap1 expression does not affect MHC class I surface 
expression (Kincaid et al., 2011).  Peptides eluted from the triple KO and WT 
splenocytes are substantially different, consistent with the previous observation with 
double-deficient and WT immunoproteasomes (de Verteuil et al., 2010; Toes et al., 
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2001).  Adoptively transferred WT splenocytes are rejected by the triple KO hosts in 
several days, but the triple KO splenocytes survive in the WT hosts, since the presence of 
both constitutive proteasomes and immunoproteasomes in the WT mice would allow WT 
mice to tolerate peptides generated by both complexes. 
Previous studies of LCMV infection in single KO mice revealed normal CD8 T 
cell responses to the major epitopes in the LMP7 KO mice, but the responses to GP276-286- 
and NP205-212 were reduced in LMP2 KO and MECL-1 KO mice (Basler et al., 2006; 
Nussbaum et al., 2005).  In this study, I evaluated the CD8 T cell response to LCMV and 
the generation of LCMV-specific memory CD8 T cells in the triple KO mice.  I also 
examined the activation of WT CD8 T cells in the triple KO hosts during LCMV 
infection.  
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Results 
Reduced LCMV-specific CD8 T cell response in triple KO mice 
 To examine the CD8 T cell response to LCMV, age-matched 
LMP2/LMP7/MECL-1 triple KO, MECL-1 KO and WT mice were infected with 5x104 
pfu LCMV Armstrong, and splenocytes were analyzed at 9 days post infection by ICS.  
As previously reported (Basler et al., 2006), the CD8 T cell response to GP276-286 and 
NP205-212 was significantly reduced in MECL-1 KO mice (Fig. 3.1).  In the triple KO 
mice, not only the GP276-286- and NP205-212-specific CD8 T cell responses but also the 
GP33-41-, GP34-41-, and GP118-125-specific CD8 T cell responses were significantly reduced 
both in frequencies (Fig. 3.1a) and in numbers (Fig. 3.1b).  On the other hand, NP396-404-
specific CD8 T cell responses in the triple KO mice were comparable to the WT mice.  
As a result, the immunodominance hierarchy was shifted in the triple KO mice, and more 
than 50% of the CD8 T cell response was specific for NP396-404 (Fig. 3.1c). 
 Although the overall magnitude of the CD8 T cell response to LCMV was much 
reduced, the CD4 T cell response was not affected in the triple KO or the MECL-1 KO 
mice (Fig. 3.2a), and the LCMV viral titer in the spleen was not significantly different 
between the triple KO mice and the WT controls at day 5 post infection (Fig. 3.2b), 
indicating comparable antigen load between the two genotypes, at least under the 
conditions of this relatively low dose inoculum. 
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Figure 3.1.  The absence of the immunoproteasome reduces the CD8 T cell response 
to LCMV and alters the immunodominance hierarchy.  WT and triple KO mice were 
infected i.p. with 5x104 pfu LCMV.  The frequency (a) and number (b) of LCMV-
specific CD8 T cells were determined at 9 days post infection by ICS.  (c) The epitope-
specific CD8 T cell response at day 9 post infection was displayed in a stack plot to show 
the altered immunodominance hierarchy in the triple KO mice.  Data are representative of 
at least two separate experiments.  (*) denotes statistical significance (p < 0.05) between 
WT and KO groups (n=5). 
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Figure 3.2.  The absence of immunoproteasome subunits does not affect CD4 T cell 
response or LCMV viral titer.  WT, triple KO and MECL-1 KO mice were infected i.p. 
with 5x104 pfu LCMV.  (a) LCMV GP61-80- and NP309-328-specific CD4 T cell responses 
were determined at 9 days post infection by ICS.  (b) Whole spleens from WT and triple 
KO mice were collected for viral titer at 5 days post infection.  Data are representative of 
at least two separate experiments (n=5). 
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Impaired antigen presentation in triple KO mice 
 The reduced immune response may have reflected defects in antigen presentation, 
in T cell proliferation or in the T cell repertoire.  To evaluate if there was a problem with 
antigen presentation in the triple KO mice, I examined T cell activation in the WT and 
the triple KO mice by in vivo cytokine assay.  BFA-treated lymphocytes from the spleen 
and the lymph nodes of WT P14 mice were adoptively transferred into day 2 LCMV-
infected WT and triple KO hosts and examined 4 hrs later by ICS.  In this study, a 
significantly lower percentage of the donor P14 CD8 T cells were activated in the 
infected triple KO hosts than in the infected WT hosts, as measured by the down-
regulation of CD62L and the production of TNF (Fig. 3.3a) and IFNγ (Fig. 3.3b), 
suggesting that the GP33-41 peptide was not presented as efficiently in the triple KO hosts 
as in the WT hosts.  Rejection of WT cells should not be a problem in this short assay. 
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Figure 3.3.  P14 CD8 T cells are less activated in the day 2 LCMV-infected 
immunoproteasome triple KO hosts.  BFA-treated P14 lymphocytes were adoptively 
transferred into day 2 LCMV-infected WT and triple KO hosts along with a separate 
injection of 250 µg BFA in 200 µl warm HBSS.  Splenocytes were harvested after 4 hrs 
and analyzed by ICS.  The frequencies of activated CD62L lo TNF+ (a) and CD62L lo 
IFNγ+ (b) within the Thy1.1 P14 CD8 T cell populations were compared.  Data (with 
mean and SEM) are representative of two separate experiments. 
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 A proliferative response can be another measure for activation.  Initial attempts to 
compare the proliferation of CD8 T cells by adoptive transfer experiments were impaired 
by low recovery of donor cells.  LCMV might have served as an adjuvant and accelerated 
the allospecific rejection of the transferred cells.  To get around the host-versus-graft 
allogeneic barrier, CD8 T cells were depleted from WT and triple KO hosts with three 
consecutive injections of anti-Thy1.2 antibody before adoptive transfer of WT Thy1.1+ 
splenocytes.  On day 5.5 after i.p. infection with 5x104 pfu LCMV, splenocytes were 
analyzed with ICS.  A negligible number of host T cells was found in the spleen after 
depletion.  Comparing to the WT hosts, the specific donor CD8 T cell responses to GP33-
41, GP34-41 and GP118-125 were significantly reduced in the triple KO hosts, while the 
specific responses to NP396-404, GP92-101, and NP205-212 were not significantly different 
(Fig. 3.4a).  In contrast, the GP276-286-specific CD8 T cell response was significantly 
elevated in the triple KO hosts.  On the other hand, the donor CD4 T cell responses to 
GP61-80 and NP309-328 were not significantly affected by the deficiency of the 
immunoproteasome subunits, although the response to NP309-328 seemed slightly elevated 
in the triple KO hosts (Fig. 3.4b).  Therefore, the absence of the immunoproteasome 
subunits can significantly change the presentation of a number of LCMV epitopes and 
affect the activation of CD8 T cells. 
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Figure 3.4.  WT CD8 T cells differentially proliferate less in response to LCMV 
infection in the immunoproteasome KO hosts.  CD8 T cells were depleted from WT 
and triple KO hosts with three consecutive injection of anti-Thy1.2 antibody beginning 
three days before infection.  WT Thy1.1+ splenocytes were adoptively transferred one 
day before i.p. infection with 5x104 pfu LCMV.  Donor CD8 (a) and CD4 (b) T cells in 
the spleens were analyzed by ICS on day 5.5 post infection.  (*) denotes statistical 
significance (p < 0.05) between WT and triple KO host groups in the combined data from 
two experiments (n=6).  
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Reduced LCMV-specific memory CD8 T cells in triple KO mice 
 To examine if the absence of the immunoproteasome subunits would affect the 
generation of memory CD8 T cells, WT and triple KO mice were infected with 5x104 pfu 
LCMV, and the splenocytes were harvested at 10 weeks post infection for analysis by 
ICS after in vitro peptide stimulation.  I found that the triple KO mice generated a 
significantly reduced number of GP33-41- and GP276-286-specific memory CD8 T cells, and 
a minimal number of GP92-101-, GP118-125- and NP205-212-specific memory CD8 T cells at 
week 10 post LCMV infection, while the NP396-404-specific memory CD8 T cells were not 
affected (Fig. 3.5a).  Surprisingly, the GP61-80-specific memory CD4 T cells were more 
abundant in the triple KO mice, but the NP309-328-specific memory CD4 T cells were not 
different from the WT mice (Fig. 3.5b).  A similar pattern was observed at 29 weeks post 
LCMV infection. 
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Figure 3.5.  The generation of LCMV epitope-specific memory T cells is 
differentially affected by the absence of the immunoproteasome subunits.  WT and 
triple KO mice were infected i.p. with 5x104 pfu LCMV.  Memory CD8 (a) and CD4 (b) 
T cells were analyzed by ICS at 10 weeks post infection.  (*) denotes statistical 
significance (p < 0.05) between WT and triple KO groups (n=4). 
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Discussion 
In this study, the overall magnitude of the CD8 T cell response to LCMV was 
considerably reduced in the triple KO mice as compared to the WT controls.  Previous 
studies with the immunoproteasome subunit single KO mice showed only modest 
changes in the CD8 T cell response to LCMV infection (Basler et al., 2006; Nussbaum et 
al., 2005).  The defects in the triple KO mice were much more profound than those in the 
LMP2, LMP7 and MECL-1 single KO mice combined.  In addition to the reduced 
response to GP276-286- and NP205-212 previously reported in the LMP2 and the MECL-1 
single KO mice (Basler et al., 2006; Nussbaum et al., 2005), the CD8 T cell response to 
GP33-41-, GP34-41-, GP118-125, and GP92-101 were all reduced in the triple KO mice.  The 
synergistic nature of the KO phenotypes suggested that the immunoproteasome subunits 
were functionally interrelated.  As a result, the immunodominance hierarchy was shifted, 
with more than 50% of the total CD8 T cell response being NP396-404-specific.  
Immunodominance hierarchy is influenced by multiple factors, including protein 
expression kinetics (Probst et al., 2003), peptide abundance (Gallimore et al., 1998), 
binding affinity between peptide and MHC molecules, and T cell precursor frequency 
(Kotturi et al., 2008).  The absence of the immunoproteasome subunits probably 
influences the immunodominance hierarchy through changing the peptide repertoire and 
abundance in the antigen-presenting cells, and through altering the T cell repertoire 
during T cell development.  
The acute response and the generation of memory CD8 T cells specific for most 
of the major LCMV epitopes were impaired in the triple KO mice, and the GP118-125-
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specific memory CD8 T cells were completely missing.  The WT donor CD8 T cell 
response specific for GP33-41, GP34-41, GP118-125 and NP205-212 in the triple KO hosts was 
weaker than that in the WT hosts, suggesting that the impaired peptide presentation in the 
absence of the immunoproteasome subunits was causing the reduced response to LCMV 
infection.  Presentation of GP118-125 is probably completely dependent on the 
immunoproteasome subunits because the WT CD8 T cell response to GP118-125 in the 
triple KO hosts was so close to the background reading (Fig. 3.4a).  That would also 
explain the nearly non-existent GP118-125-specific response on day 9 post LCMV infection 
and the missing GP118-125-specific memory CD8 T cells at 10 weeks post infection. 
The presentation of the NP205-212 epitope reveals the complexity of the interrelated 
functionality of the immunoproteasome subunits.  Previous studies in the single KO mice 
suggested that both LMP2 and MECL-1 are required for the presentation of NP205-212 but 
that LMP7 is dispensable (Basler et al., 2006; Nussbaum et al., 2005).  A recent study 
using a LMP7-specific inhibitor, ONX 0914, showed that blocking the chymotrypsin-like 
activity of LMP7 can rescue the presentation of NP205-212 in the LMP2/MECL-1 double 
KO mice while this inhibitor has no effect in the WT mice (Basler et al., 2011).  
However, NP205-212 was suboptimally presented in the triple KO mice in this study.  
These data suggest that in order to optimally generate the NP205-212 peptide, LMP2 and 
MECL-1 have to be present in the same proteasome, but the pairing of the constitutive 
homologs δ (in place of LMP2) and MC14 (in place of MECL-1) is also allowed.  The 
proteasome with LMP2 and MECL-1 can generate NP205-212 in the presence of LMP7, the 
chemically inactivated LMP7, or the constitutive homolog MB1, as the use of ONX 0914 
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in WT mice and the LMP7 deficiency have no effect on the generation of NP205-212.  
However, the proteasomes containing the constitutive subunits δ and MC14 can produce 
NP205-212 only when LMP7 (and not MB1) is present but chemically inactivated. 
The NP396-404-specific CD8 T cell response and memory generation were not 
affected by the absence of immunoproteasome subunits.  One possibility is that the NP396-
404 peptide can be generated by the constitutive proteasomes alone.  This may be part of 
the reasons why the adoptively transferred NP396-404-specific CD8 T cell line can reduce 
LCMV titer in mice most efficiently (Gallimore et al., 1998), because any infected cells 
can become the targets of the cytotoxic T cells without any help of the cytokines.  
Alternatively, the apparent immunoproteasome independence may reflect an 
overwhelmed presentation system, where the great abundance of the nucleoprotein early 
during infection (Bruns et al., 1990; Probst et al., 2003) and the high MHC binding 
affinity of the NP396-404 peptide (Kotturi et al., 2008) were masking any effect of the 
absence of the immunoproteasome subunits. 
Both the reduced peptide generation and the altered T cell repertoire may have 
contributed to the reduced GP276-286-specific CD8 T cell response in the triple KO mice.  
The adoptively transferred WT splenocytes mounted a greater response to GP276-286 in the 
triple KO hosts than in the WT hosts, suggesting a better presentation of GP276-286 in the 
triple KO hosts.  This is consistent with the previous report that LMP2 in the 
immunoproteasome could destroy the GP276-286 peptide in vitro (Basler et al., 2004).  
However, the GP276-286-specific CD8 T cell response was reduced in the LMP2 KO mice 
(Nussbaum et al., 2005) and in the triple KO mice in this study.  A lower percentage of 
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Vβ10b+ CD8 T cells in the triple KO mice after LCMV infection was previously 
reported (Basler et al., 2006).  A similar observation was made in this study; however, no 
significant difference in the Vβ usage was found among the GP276-286-tetramer-positive 
CD8 T cells at 8 days post LCMV infection (data not shown).  Vβ usage was not 
different among GP33-41-, GP34-41-, and NP396-404-tetramer-positive CD8 T cells, either.  
Nonetheless, both the nature of the peptide presentation and the T cell repertoire probably 
have certain influences in the reduction of GP276-286-specific CD8 T cell response in the 
triple KO mice.  On the other hand, the altered T cell repertoire likely played a greater 
role in the reduction of GP92-101-specific CD8 T cell response in the triple KO mice, as 
the WT CD8 T cell response to GP92-101 was comparable in both WT and the triple KO 
hosts, suggesting no apparent defects in the presentation of GP92-101 peptide in the triple 
KO hosts. 
The immunoproteasomes are important in the generation of peptides for MHC 
class I presentation.  Both constitutive proteasomes and immunoproteasomes are 
expressed in the medullary thymic epithelial cells (Nil et al., 2004) and can therefore 
influence the negative selection of T cells during development.  Antigen-presenting cells 
such as DC and macrophages constantly express the immunoproteasomes as well as the 
constitutive proteasomes (Nil et al., 2004).  Therefore, the immunoproteasomes can 
influence the generation of the T cell repertoire, self-tolerance and immune response.  
Previous reports using the single KO mice substantially underestimated the contributions 
of the immunoproteasomes during infections (Basler et al., 2006; Nussbaum et al., 2005).  
As demonstrated in this study, the immunoproteasomes not only increase the magnitude 
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of CD8 T cell response during infection but also diversify the specificity such as by 
enabling the generation of GP118-125-specific response.  Therefore, the 
immunoproteasomes are crucial in viral control and immunity. 
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Chapter IV. Attrition of memory CD8 and CD4 T cells during 
heterologous infections 
(Part of the data has been published in Immunol Rev 235 (1): 244-266) 
Memory CD8 T cells generated upon encounter with pathogens are generally 
stable but memory CD4 T cells may decline over time (Homann et al., 2001; Selin et al., 
1996; 1999).  The stability of memory CD8 T cells, however, can be affected by 
heterologous infections with unrelated pathogens.  The reduction of memory CD8 T cells 
has been previously demonstrated in various viral infection sequences by limiting 
dilution assay, intracellular cytokine staining, MHC-dimer or tetramer staining and in 
vivo cytotoxicity assays: 
LCMV + PV (Brehm et al., 2002; Selin et al., 1996; 
1999; Varga et al., 2001) 
 
LCMV + PV + VACV (Selin et al., 1996; 1999; Varga et al., 
2001) 
 
LCMV + PV + MCMV (Selin et al., 1996) 
LCMV + PV + VACV + MCMV (Selin et al., 1996; 1999; Varga et al., 
2001) 
 
LCMV + MCMV (Selin et al., 1996; 1999) 
PV + LCMV (Kim & Welsh, 2004) 
Vesicular stomatitis virus + LCMV (Kim & Welsh, 2004) 
VACV + LCMV (Kim & Welsh, 2004) 
VACV + MCMV (Selin et al., 1996) 
Influenza + γ-herpesvirus 68 (Liu et al., 2003) 
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Bacterial infections can also cause a reduction of memory CD8 T cells, as it has 
been shown in BCG- or Salmonella typhimurium-challenged LM-immune mice (Dudani 
et al., 2008; Smith et al., 2002).  A similar phenomenon has been reported in humans as 
well.  Patients acutely infected with hepatitis B virus were found to have reduced number 
of cytomegalovirus-specific CD8 T cells than the healthy (hepatitis B negative) cohort 
(Zhang et al., 2008).  
IFNs are associated with attrition of memory CD8 T cells.  Previous work with 
viruses has shown that the reduction of pre-existing memory T cells is associated with 
type I IFN, which is induced early during some infections and causes apoptosis in 
CD44hi CD8 T cells (McNally et al., 2001).  After infection with a good type I IFN-
inducing pathogen, like LCMV, pre-existing memory CD8 T cells will be reduced early 
after infection and remain stable at a lower number after a minor recovery (Bahl et al., 
2006; Kim & Welsh, 2004).  On the other hand, IFNγ is found associated with memory 
CD8 T cell attrition caused by bacterial infections (Dudani et al., 2008).   
A subsequent publication suggested that the CD8 compartment is expandable and 
challenged the phenomenon of attrition by arguing that the erosion of pre-existing 
memory CD8 T cells may be substantial in percentage but much less in actual numbers 
(Vezys et al., 2009).  In response to that, previous work was recalculated to show the 
reduction in number of LCMV-specific memory CD8 T cells after subsequent viral 
challenges (Welsh & Selin, 2009).  Additionally, I performed a series of new experiments 
to re-examine this phenomenon of memory reduction using other virus combinations and 
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to examine the memory CD8 T cells with a larger set of viral epitope specificities.  In 
some of these experiments, where peptides were available, I also analyzed the stability of 
memory CD4 T cells.  
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Results 
Reduction of LCMV-specific memory T cells by MCMV infection 
Like LCMV, MCMV induces an IFNαβ response early during infection 
(Schneider et al., 2008).  To examine the effect of MCMV infection on LCMV-specific 
memory CD8 and CD4 T cells, C57BL/6 mice were inoculated with 5x104 pfu LCMV 
and rested for 6 weeks to allow T cells to return to homeostasis.  LCMV-immune mice 
were subsequently infected with 5x105 pfu MCMV or given the salivary gland 
homogenate from naïve animals as a sham control.  Compared to LCMV-immune mice 
without MCMV infection, splenic memory CD8 T cells specific for LCMV dominant 
epitopes GP33-41, NP396-404 and subdominant epitopes GP276-286, GP118-125 and NP205-212 at 
9 weeks post MCMV infection were reduced in number and in frequency (Fig. 4.1a and 
4.1b).  A similar reduction was also observed in the bone marrow of the same animals 
(Fig. 4.1c).  Due to the low and variable number of cells collected and rarity of T cells in 
the bone marrow, only the reduction of GP33-41-specific memory CD8 T cell numbers 
reached statistical significance, although the decrease in percentages of memory CD8 T 
cells of other specificities were statistically significant in the bone marrow (Fig. 4.1d).  
MCMV infection also significantly reduced the memory CD4 T cell population in the 
spleen, causing about a 50% reduction in number and in frequency of GP61-80-specific 
memory CD4 T cells (Fig. 4.2a and 4.2b).  NP309-328-specific CD4 T cells were also 
significantly reduced in percentage in the spleen. 
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Figure 4.1.  MCMV infection significantly reduces the number and frequency of 
LCMV-specific memory CD8 T cells.  LCMV-immune mice were infected i.p. with 
5x105 pfu MCMV or given salivary gland homogenate from naïve mice as sham control.  
Memory CD8 T cells from the spleen (a and b) and bone marrow (c and d) were 
examined at 9 weeks post MCMV infection by ICS.  (*) denotes statistical significance (p 
< 0.05) between MCMV-infected and nsg control groups (n=5).  
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Figure 4.2.  MCMV infection significantly reduces the number and frequency of 
LCMV-specific memory CD4 T cells.  LCMV-immune mice were infected i.p. with 
5x105 pfu MCMV or given salivary gland homogenate from naïve mice as sham control.  
Memory CD4 T cells from the spleen were examined at 9 weeks post MCMV infection 
by ICS.  (*) denotes statistical significance (p < 0.05) between MCMV-infected and nsg 
control groups (n=5).  
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Reduction of VACV-specific memory T cells by LCMV and MCMV infections 
 The attrition of VACV-specific memory T cells was previously examined using 
VACV-infected stimulator peritoneal exudate cells in ICS assays (Kim & Welsh, 2004).  
In this study, VACV-derived peptide stimulation was used in ICS to identify the VACV 
epitope-specific memory CD8 T cell populations.  Mice inoculated with 106 pfu VACV 
and rested for 6 weeks were infected i.p. with 5x104 pfu LCMV or given the supernatant 
from uninfected BHK cell cultures as a sham control.  At 9 weeks post LCMV infection, 
the numbers and frequencies of pre-existing VACV B8R20-27- and E7R130-137-specific 
memory CD8 T cells were significantly reduced in the spleen (Fig. 4.3a and 4.3b).  A 
similar reduction of memory CD8 T cells was also observed in the peritoneum of the 
same mice (Fig. 4.3c and 4.3d). 
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Figure 4.3.  LCMV infection significantly reduces the number and frequency of 
VACV-specific memory CD8 T cells.  VACV-immune mice were infected i.p. with 
5x104 pfu LCMV or given supernatant from uninfected BHK culture as sham control.  
Memory CD8 T cells from the spleen (a and b) and peritoneum (c and d) were examined 
at 9 weeks post LCMV infection by ICS.  (*) denotes statistical significance (p < 0.05) 
between LCMV-infected and BHK control groups (n=5). 
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 To test whether the memory CD8 T cells that had been reduced through attrition 
by a heterologous infection can be further reduced by another infection with an unrelated 
pathogen, VACV-immune mice were given LCMV or BHK supernatant in a separate 
experiment.  Six weeks later, the double immune mice were given MCMV or salivary 
gland homogenate from naïve mice.  Another 6 weeks later, splenocytes were analyzed 
for their virus-specific memory CD8 T cells.  Both LCMV and MCMV infections were 
found to cause a decline of pre-existing VACV B8R20-27-specific memory CD8 T cell by 
about 50% in number and in frequency in the spleen (Fig. 4.4a and 4.4b).  MCMV 
infection further reduced the remaining VACV-specific memory population after LCMV 
infection, and the percentage of B8R20-27-specific CD8 T cells was significantly lower in 
the VACV-LCMV-MCMV triple immune mice than in the VACV-LCMV double 
immune group (Fig. 4.4b). 
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Figure 4.4. VACV B8R20-27-specific memory CD8 T cell number and frequency are 
first reduced by LCMV infection and subsequently by MCMV infection.  VACV-
immune mice were infected i.p. with 5x104 pfu LCMV or given supernatant from 
uninfected BHK culture as sham control.  Six weeks later, double immune mice were 
infected i.p. with 5x105 pfu MCMV or given salivary gland homogenate from naïve mice 
as sham control.  Splenocytes were examined at 6 weeks post MCMV infection by ICS 
for B8R20-27-specific memory CD8 T cell number (a) and frequency (b).  (*) denotes 
statistical significance (p < 0.05) between groups (n=5). 
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No further erosion of LCMV-specific memory T cells by MCMV persistence 
MCMV causes persistent and latent infection in mice.  Re-activation of the latent 
virus continues to stimulate and causes sporadic proliferation of CD8 T cells, resulting in 
an increase of the inflationary memory T cell population.  Most vigorous inflation of 
memory T cells happens between 8-12 weeks post MCMV infection (Snyder et al., 
2008).  The constant activation of T cells may in theory compete with the pre-existing 
memory T cells for space and cytokines, leading to a passive reduction of pre-existing 
memory.  To examine whether MCMV memory inflation can further erode pre-existing 
memory, LCMV-immune mice were infected with 5x105 pfu MCMV, and then harvested 
for splenocytes at different time-points to check the number and frequency of LCMV-
specific memory T cells.  As shown in the previous section, MCMV infection caused a 
reduction of both CD8 and CD4 memory T cells.  However, apart from the initial attrition 
that happened early during infection, no further significant reduction of LCMV-specific 
memory CD8 T cells was found between 6-23 weeks post MCMV infection (Fig. 4.5).  
CD4 memory T cells were not further eroded by MCMV persistence either (Fig. 
4.6).  Although memory CD4 T cell number tended to decline over time, the reduction in 
GP61-80-specific memory CD4 T cell number was not a result of MCMV memory 
inflation because the decline happens after the period of time when inflation was to 
happen between week 8-12 post MCMV infection; and most importantly, the GP61-80-
specific memory CD4 T cells in both MCMV-infected and the sham control group started 
to decline around the same time in a similar fashion.  
  
66
 
 
Figure 4.5.  MCMV persistence does not further erode LCMV-specific memory CD8 
T cells.  LCMV-immune mice were infected i.p. with 5x105 pfu MCMV or given salivary 
gland homogenate from naïve mice as sham control.  Memory CD8 T cells specific for (a 
and b) GP33-41, (c) NP396-404 and (d) GP118-125 from the spleen were examined at week 6 
and 23 post MCMV infection by ICS (n=5). 
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Figure 4.6.  MCMV persistence does not further erode LCMV-specific memory CD4 
T cells.  LCMV-immune mice were infected i.p. with 5x105 pfu MCMV or given salivary 
gland homogenate from naïve mice as sham control.  GP61-80-specific memory CD4 T 
cells from the spleen were examined at week 6, 12, 23 and 48 post MCMV infection by 
ICS (n=5). 
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Increase of cross-reactive memory CD8 T cells upon heterologous infection 
 VACV A11R198-205-specific CD8 T cells can cross-react with LCMV epitopes 
NP205-212, GP34-41 and GP118-125.  A11R198-205-specific T cell lines grown out of LCMV-
immune mice are responsive to either GP34-41, GP118-125 or NP205-212 peptide stimulation 
(Cornberg et al., 2010).  In this system the immune response to potentially cross-reactive 
epitopes is highly private.  Acute VACV infection selectively expands LCMV-specific 
memory CD8 T cells of one of the cross-reactive epitope specificities depending on the 
memory T cell repertoire of the individual LCMV-immune mouse (Kim et al., 2005).  
A11R198-205 is a subdominant epitope and VACV-immune mice maintained a very low 
number of A11R198-205-specific memory CD8 T cells in the spleen (Fig. 4.7a).  In the 
VACV-LCMV double immune mice, A11R198-205-specific memory was greatly expanded 
in number and in percentage of CD8 T cells (Fig. 4.7a and 4.7b).  The relatively large 
variability within groups of mice is consistent with the paradigm of private specificity.  
Perhaps because of the high frequency of potentially cross-reactive GP34-41-, GP118-125- 
and NP205-212-specific memory CD8 T cells, LCMV-immune mice exhibited a higher 
number of A11R198-205-responsive memory CD8 T cells than VACV-immune mice.   
MCMV does not cross-react with A11R198-205, and no expansion of A11R198-205-
specific memory CD8 T cells occurred when VACV-immune mice were subsequently 
made MCMV-immune (Fig. 4.8a and 4.8b).  On the other hand, the LCMV infection-
boosted A11R198-205-specific memory CD8 T cell number and frequency could be 
reduced by MCMV infection, consistent with the attrition observed in memory CD8 T 
cells of other specificities.  
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Figure 4.7.  LCMV infection variably increases the cross-reactive VACV A11R198-
205-specific memory T cell number and frequency.  VACV-immune or HBSS-injected 
mice were infected i.p. with 5x104 pfu LCMV or given supernatant from uninfected BHK 
culture as sham control.  A11R198-205-specific memory CD8 T cell number (a) and 
frequency (b) in the spleen were analyzed at 9 weeks post LCMV infection by ICS.  (*) 
denotes statistical significance (p < 0.05) between groups.  
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Figure 4.8.  MCMV infection reduces the LCMV infection-boosted A11R198-205-
specific memory CD8 T cell number and frequency.  VACV-immune mice were 
infected i.p. with 5x104 pfu LCMV or given supernatant from uninfected BHK culture as 
sham control.  Six weeks later, the double immune mice were infected i.p. with 5x105 pfu 
MCMV or given salivary gland homogenate from naïve mice as sham control.  A11R198-
205-specific memory CD8 T cell number (a) and frequency (b) in the spleen were 
analyzed at 6 weeks post MCMV infection by ICS.   
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Reduction of LCMV-specific memory CD4 T cells by VACV infection 
 VACV encodes decoy receptors for both type I and type II IFNs as part of its 
evasion strategies (Perdiguero & Esteban, 2009).  The blockage may in turn deter type I 
IFN-induced reduction of pre-existing memory T cells.  To examine the effect of VACV 
infection on LCMV-specific CD8 and CD4 memory T cells, LCMV-immune mice were 
infected i.p. with 106 pfu VACV or given HBSS as a control, and the splenocytes were 
analyzed at 8 weeks post infection.  VACV infection did not reduce the examined 
LCMV-specific memory CD8 T cell populations (Fig. 4.9).  The number and percentage 
of NP396-404- and NP205-212-specific CD8 T cells even increased in LCMV-VACV double 
immune mice.  However, the SEM of the percentage of NP205-212-specific T cells in the 
double immune group is relatively large because there was a 19-fold difference between 
the highest and the lowest frequency in the group (Fig. 4.9b).  The presence of the high 
frequency outlier is expected because LCMV NP205-212 is the most cross-reactive epitope 
to VACV.  Despite the mild effect in the CD8 T cell compartment, VACV infection 
reduced the GP61-80-specific memory CD4 T cells (Fig. 4.10), suggesting that VACV may 
also cause memory attrition in some animals.  
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Figure 4.9.  VACV infection does not reduce LCMV-specific memory CD8 T cells.  
LCMV-immune mice were infected i.p. with 106 pfu VACV or given HBSS as control.  
Memory CD8 T cells from the spleen were examined at 8 weeks post VACV infection by 
ICS.  (*) denotes statistical significance (p < 0.05) between VACV-infected and HBSS 
control groups (n=5). 
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Figure 4.10.  VACV infection may reduce LCMV-specific memory CD4 T cells.  
LCMV-immune mice were infected i.p. with 106 pfu VACV or given HBSS as control.  
GP61-80-specific memory CD4 T cell number (a) and frequency (b) from the spleen were 
examined at 8 weeks post VACV infection by ICS.  
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Discussion 
T cell memory can be stable and yet susceptible to changes by external influences. 
In this study, I showed that both CD8 and CD4 memory T cell populations could be 
reduced by heterologous infections with unrelated pathogens, regardless of the inherent 
stability of T cells.  Infection with MCMV or LCMV consistently reduced pre-existing 
memory CD8 and CD4 T cells to previously encountered pathogens by about 50% - 
consistent with the published data on memory CD8 T cells (Brehm et al., 2002; Kim & 
Welsh, 2004; Liu et al., 2003; Selin et al., 1996; 1999; Varga et al., 2001).  In contrast, 
VACV did not cause any decline of memory CD8 T cells of the tested specificities.  This 
is different from previous results measured with limiting dilution assays, where VACV 
was able to cause a reduction of pre-existing memory CD8 T cells (Selin et al., 1996).  In 
limiting dilution assays, splenocytes are cultured for days before subjecting to 
cytotoxicity assay – higher IL-2-producing central memory cells are preferably retained 
and assayed, whereas ICS will measure every cell that produces IFNγ.  It is possible that 
VACV infection may tend to reduce the IL-2-producing memory population but has little 
overall effect on the IFNγ producers.  Different read-outs may result from the two assays 
if a good portion of the memory T cells produce IFNγ but not IL-2.   Memory CD8 T 
cells of different phenotypes have been shown to be differentially affected by poly(I:C), 
which induces IFNαβ and preferentially depletes memory CD8 T cells of the central 
memory (CD44hi CD62Lhi) phenotype in young mice (Jiang et al., 2005).  Alternately, 
the strong heterologous immunity could have contained the infection too quickly and 
weaken the production of IFNαβ.  
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The recent claim that the erosion of pre-existing memory CD8 T cells by 
heterologous infections is only substantial in percentages (Vezys et al., 2009) is 
insufficient to challenge the current paradigm because even in their experiment the P14 
memory T cells actually underwent attrition with an end result of a statistically 
significant reduction in number.  This fact was just overshadowed in a chart plotted with 
other high numbers on a linear scale.  Besides, the vesicular stomatitis virus and VACV 
vectors used in their immunization regimen are not as strong an IFNα-inducer as LCMV 
is (Thompson et al., 2006) and may not be as effective in actively causing memory T cell 
reduction.  
Heterologous infection can increase the memory CD8 T cells specific for cross-
reactive epitopes between two viruses.  Type I IFN induces attrition of memory T cells 
regardless of the presence of cognate antigen early during infection (Bahl et al., 2006).  
Nevertheless, the surviving cross-reactive memory T cells will begin to proliferate upon 
encounter with cognate antigen and therefore may appear unaffected by early attrition 
when enumerated, especially after returning to homeostasis. That was what happened 
with A11R198-205-specific memory CD8 T cells in some of the VACV-LCMV-immune 
mice and NP205-212-specific memory CD8 T cells in some of the LCMV-VACV-immune 
mice.  A similar expansion of cross-reactive NP205-212-specific memory CD8 T cells has 
been shown in LCMV-PV and in PV-LCMV double immune mice (Brehm et al., 2002), 
where NP205-212 in LCMV and in PV differ only by the primary MHC anchoring residues 
at positions 5 and 8. 
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The influence of persistent infection on T cell memory may vary depending on 
the nature of the infections.  Persistent LCMV clone 13 infection has been shown to 
cause more severe attrition of pre-existing CD8 T cell memory than acute LCMV 
Armstrong infection does.  Not only are pre-existing memory T cells reduced early 
during infection, but adoptively transferred memory T cells survive poorly in the week 3-
post-clone 13 host (Kim & Welsh, 2004).  Persistent MCMV infection with constant 
activation and proliferation of inflationary memory T cells can in theory create some 
pressure on the memory T cell population; however, no continuous erosion of pre-
existing T cell memory was found in this study during the period of memory inflation.  
There are at least two possible reasons for the observed differences.  The cytokine 
environment in the MCMV-infected mice may be more supportive for homeostatic 
survival of memory T cells while the environment in clone 13-infected host can cause the 
demise of pre-existing memory T cells along with the clonal exhaustion of the clone 13-
specific T cells.  Besides, LCMV clone 13 persistence maintains a low level of type I IFN 
activity for about a month post infection (Lee et al., 2009), and may promote apoptosis in 
memory T cells.   
Reduction of memory T cells may compromise protective immunity especially 
when the T cell response is critical to pathogen or tumor clearance.  Mice with reduced 
Plasmodium berghei circumsporozoite-specific CD8 memory T cells after a series of 
heterologous infections with unrelated viruses and bacteria are much less protected from 
Plasmodium sporozoites challenge than control immune mice (Schmidt & Harty, 2011), 
because the attrition of memory CD8 T cells has caused the number of circumsporozoite-
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specific CD8 T cells to fall below the number required for sterilizing immunity (Schmidt 
et al., 2008).  Similarly, LM-OVA-immune mice infected with Salmonella typhimurium 
have a lower number of LM-OVA-specific memory T cells and are less protected from 
re-challenge (Dudani et al., 2008).  LM-OVA-immune mice infected with BCG also lose 
the ability to eliminate B16-OVA melanoma, although they remained protected from LM 
challenge (Smith et al., 2002).  Therefore, maintaining memory T cell number can be 
critical for immune protection. 
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Chapter V. Regulatory T cells resist virus infection-induced apoptosis 
Treg cells are a heterogeneous population characterized by the expression of CD4 
and the transcriptional activator and repressor Foxp3.  Under the transcription control of 
Foxp3, Treg cells are also CD25hi and CD127lo (Williams & Rudensky, 2007).  
Expression of ICOS and TNFR2 correlates with higher suppressive activity (Chen & 
Oppenheim, 2011).  Treg cells do not produce IL-2 or TNF (Williams & Rudensky, 
2007) but depend on common γ chain cytokines from other cells for survival (Pandiyan & 
Lenardo, 2008).  Recent studies have also suggested the involvement of TNF and type I 
IFN in the maintenance of Foxp3+ Treg cells (Chen et al., 2012; Lee et al., 2012). 
As mentioned in Chapter IV, CD8 and CD4 T cells, particularly those of the 
memory phenotype, undergo apoptosis and decline in number early (day 2-4) during viral 
(Bahl et al., 2010; Jiang et al., 2003a; McNally et al., 2001) or some bacterial infections 
(Jiang et al., 2003b).  This attrition is mediated in part by type I IFN, and it occurs after 
the treatment of mice with the type I IFN-inducer poly(I:C) (Bahl et al., 2006).  It can be 
blocked by antibody to type I IFN (Jiang et al., 2005), and both attrition and apoptosis of 
CD44hi CD8 T cells are dramatically reduced in type I IFN receptor (IFNAR) KO mice 
(Bahl et al., 2006; McNally et al., 2001).  The CD44hi memory CD8 and CD4 T cells 
show the highest levels of apoptotic loss at these early stages of infection, perhaps 
making room for a new immune response to develop rapidly (Bahl et al., 2006).   
Infection has been implicated as a potential trigger in autoimmune diseases 
(Huber, 2006; Sherbet, 2009; Van Der Werf et al., 2007; Zipris et al., 2003), but the 
underlying mechanism has yet to be illuminated.  One of the theories is that infection 
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may disrupt the balance of immune regulation (perhaps through Treg cells) at the 
susceptible organs (Jun & Yoon, 2003; Zipris et al., 2003).  Foxp3+ CD4+ Treg cells 
exhibit a partial memory phenotype with an intermediate to high expression of CD44 
(Min et al., 2007).  Therefore, I questioned whether Treg cells might behave like the 
CD44hi CD4 and CD8 T cells and be driven into apoptosis, causing a reduction in cell 
number during early stages of infection.  If so, their demise might contribute to the 
phenomenon of virus-induced autoimmunity.  
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Results 
Insignificant reduction of Foxp3+ CD4+ Treg cells after LCMV infection 
To investigate whether Foxp3+ Treg cells undergo attrition like memory T cells 
do early after LCMV infection, Foxp3GFP knock-in mice were inoculated with 5x104 pfu 
LCMV.  LCMV induces type I IFN that peaks at day 2 post infection (Welsh, 1978).  
Splenocytes from infected and aged-matched naïve control mice were harvested two days 
post infection and analyzed by flow cytometry.  While the frequency of CD44hi CD4 and 
CD44hi CD8 T cells among lymphocytes decreased significantly after LCMV infection, 
the frequency of Foxp3+ CD4 T cells remained the same (Fig. 5.1a).  The actual number 
of T cells in the spleen was then calculated for each individual mouse using their total 
splenocyte counts separately.  As expected, CD44hi CD4 and CD44hi CD8 T cells 
declined significantly in number (Fig. 5.1b).  However, the total number of Foxp3+ CD4 
T cells did not significantly change after infection (Fig. 5.1b).  At day 3 post LCMV 
infection, a small but consistent decline in the frequency of Foxp3+ CD4 T cells was 
observed in the spleen (Fig. 5.1c), but the actual number of Foxp3+ CD4 T cells in the 
spleen of infected animals was not significantly different from that of naïve animals (Fig. 
5.1d).  Therefore, the presence of Foxp3+ CD4 T cells in the spleen is relatively stable 
early during LCMV infection.   
Infection can cause Foxp3+ CD4 T cells to traffic between the secondary 
lymphoid organs.  Preliminary data suggested that at day 2 post infection while the 
number of Treg cells slightly decreased in inguinal lymph nodes, the number in 
mesenteric lymph nodes increased.  The number of Treg cells did not change in 
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axillary/brachial lymph nodes in the first two days but slightly increased on day 3 post 
infection when the number of Treg cells started to return to the level before infection in 
the inguinal lymph nodes.  Overall, no significant change in the number and frequency of 
Treg cells was found in the lymph nodes examined.  Due to the variability in cell counts, 
more experiments are needed to confirm the observation regarding the number of Treg 
cells in the lymph nodes.  
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Figure 5.1.  Foxp3+ CD4+ Treg cells resist loss after LCMV infection.  Foxp3GFP 
mice were infected i.p. with 5x104 pfu LCMV.  Two (a and b) or three (c and d) days 
later, surface stained splenocytes from infected and uninfected (naïve) mice were 
analyzed by flow cytometry.  The frequency (a and c) and number (b and d) of CD44hi 
CD4 and CD44hi CD8 T cells were significantly reduced in the spleen after infection, 
while there was no significant reduction of Foxp3+ CD4+ Treg cells.  (a and b) 
Combined data from 3 separate experiments (n=9).  (c and d) Representative data of 
seven separate experiments (n = 3).  (*) denotes statistical significance (p < 0.05) 
between naïve and LCMV-infected groups.  
CD
44
hi 
CD
8
CD
44
hi 
CD
4
Fo
xp
3+
 C
D4
0
1
2
3
4
%
 ly
m
ph
oc
yt
es
naive
d3 LCMV
*
*
CD
44
hi 
CD
8
CD
44
hi 
CD
4
Fo
xp
3+
 C
D4
0
2×106
4×106
 
*
84
Foxp3+ CD4 T cells are more resistant to apoptosis during LCMV infection 
Cell death by apoptosis is a coordinated process.  At the end stage of apoptosis, 
activated caspase-3 cleaves the inhibitors of DNA fragmentation factor 45 (DFF45) and 
DFF35, releasing active nuclease DFF40 (caspase-activated DNase) into the nucleus (Gu 
et al., 1999), and cleaves and inactivates poly-(ADP-ribose)-polymerase (PARP), which 
functions in DNA single-strand break repair (Fink & Cookson, 2005).  Both events 
ultimately lead to DNA fragmentation.  The 3’-OH end of the fragmented or nicked DNA 
can be visualized by TUNEL assay, which covalently attaches a dUTP to the 3’-OH end.  
Subsequent labeling with a fluorescence-conjugated anti-dUTP antibody allows 
quantitative measurement of DNA fragmentation by flow cytometry.  A previous study 
showed that both CD44hi CD8 and CD44hi CD4 T cells in the spleen were more TUNEL 
positive after poly (I:C) treatment (Bahl et al., 2010).  Infection with LCMV also 
increased the frequency of TUNEL positive CD44hi CD8 T cells in the spleen early after 
infection (Bahl et al., 2010), and tissue sections have shown two peaks of TUNEL 
positive splenocytes after LCMV infection: one at day 3, closely following the peak of 
the IFN response, which I examined here, and the other at day 11, as the response enters 
the contraction phase (Razvi et al., 1995).   
To test if Treg cells are also sensitive to virus infection-induced apoptosis, 
splenocytes were harvested from Foxp3GFP mice at day 2 post LCMV infection, rested 
in media at 37°C for 5 hrs and stained with the TUNEL assay.  Without infection, 
CD44hi CD4 and Foxp3+ CD4 T cells appeared to be more TUNEL positive than CD8 T 
cells (Fig. 5.2a).  Infection with LCMV increased the percentage of TUNEL positive 
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CD4 and CD8 T cells but had no effect on Foxp3+ CD4 T cells (Fig. 5.2).  As expected, 
the increase in apoptotic events among CD44hi T cells was more dramatic than that 
among CD44lo T cells after LCMV infection (Fig. 5.2b).  On the other hand, Foxp3+ 
CD4 T cells were slightly apoptotic before and after infection with LCMV regardless of 
the status of CD44 expression.  Although Foxp3+ CD4 T cells from naïve mice had a 
measurable TUNEL background, they were as apoptotic as the relatively resistant 
CD44lo CD4 and CD44lo CD8 T cells at day 2 post LCMV infection, and they were 
much more resistant to apoptosis than were CD44hi CD4 and CD44hi CD8 T cells. 
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Figure 5.2.  Foxp3+ CD4+ Treg cells are less TUNEL positive than CD44hi CD4 and 
CD44hi CD8 T cells in the spleen at day 2 post LCMV infection.  Foxp3GFP mice 
were infected i.p. with 5x104 pfu LCMV.  Splenocytes harvested at 2 days post infection 
were stained with TUNEL after incubating in media at 37°C for 5 hr.  (a) Histograms of 
TUNEL staining intensity of CD4, CD8 and Treg cells from a naïve and a day 2 LCMV-
infected animal in a representative experiment.  (b) Combined data from 3 separate 
experiments (total n = 9).  (*) denotes statistical significance (p < 0.05) between naïve 
and day 2 post LCMV infection.   
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Activated caspase disturbs the asymmetry of the plasma membrane, causing 
exposure of phosphatidylserine on the cell surface (Fink & Cookson, 2005). Therefore, 
apoptosis of splenocytes from LCMV-infected Foxp3GFP mice was also examined ex 
vivo with amine-reactive live/dead stain and Annexin V, which binds to exposed 
phosphatidylserine.  Similar to data from the TUNEL assay, CD44hi CD4 T cells were 
highly Annexin V positive even among cells from naïve spleens (Fig. 5.3).  Apoptotic 
events among CD4 and CD8 T cells increased after LCMV infection but remained low 
among Foxp3+ CD4+ Treg cells (Fig. 5.3).   
At day 3 post LCMV infection, although Foxp3+ CD4 T cells from naïve animals 
displayed some TUNEL and Annexin V background staining, their staining intensity was 
not increased by LCMV infection, while CD8 and CD4 T cells, especially the CD44hi 
subsets, became much more TUNEL and Annexin V positive after infection (Fig. 5.4).  
Both the TUNEL and Annexin V data suggest that Foxp3+ CD4+ Treg cells are much 
more resistant to virus infection-induced apoptosis than CD44hi CD4 and CD44hi CD8 T 
cells in the spleen.
88
(a) 
 
 
(b) 
             
 
Figure 5.3.  Foxp3+ CD4+ Treg cells are less Annexin V positive than CD8 and CD4 
T cells in the spleen at day 2 post LCMV infection.  Foxp3GFP mice were infected i.p. 
with 5x104 pfu LCMV.  Splenocytes harvested at 2 days post infection were stained ex 
vivo with live/dead fixable stain and Annexin V.  (a) Histograms of Annexin V staining 
intensity of live CD4, CD8 and Treg cells from a naïve and a day 2 LCMV-infected 
animal in a representative experiment.  (b) Data from a representative of three separate 
experiments (n=3).  (*) denotes statistical significance (p < 0.05) between naïve and day 
2 post LCMV infection.   
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Figure 5.4. Foxp3+ CD4+ Treg cells are less apoptotic than CD44hi CD4 and CD8 T 
cells in spleen at day 3 post LCMV infection.  Foxp3GFP mice were infected i.p. with 
5x104 pfu LCMV.  Splenocytes harvested at 3 days post infection were stained (a) with 
TUNEL after incubating in media at 37°C for 5 hrs or (b) ex vivo with live/dead fixable 
stain and Annexin V.  Data are representative of at least three separate experiments (n = 
3).  (*) denotes statistical significance (p < 0.05) between naïve and day 3 post LCMV 
infection.    
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Differential regulation of receptors for survival signals during LCMV infection 
 With the observed differences in sensitivity to virus infection-induced apoptosis, I 
questioned what might contribute to the survival advantage of Foxp3+ CD4+ Treg cells 
at the early stage of infections.  IL-7 signaling is critical for the survival of naïve 
(Boursalian & Bottomly, 1999; Tan et al., 2001) and memory T cells (Kondrack et al., 
2003; Schluns et al., 2000) in the periphery, whereas IL-2 is important for Treg cell 
maintenance (Setoguchi et al., 2005).  Therefore, I checked the surface expression of IL-
7 receptor α (CD127), IL-2 receptor α (CD25), β (CD122) and the common cytokine 
receptor γ chain (CD132) on T cells in naïve and LCMV-infected Foxp3GFP mice at day 
2 post infection.  As published previously (Simonetta et al., 2010), surface expression of 
CD127 on Foxp3+ CD4 T cells was much lower than that on Foxp3 negative CD4 T cells 
in the spleen.  CD127 expression on CD44hi CD4 T cells was lower than that on CD44hi 
CD8 T cells (Fig. 5.5a).  After LCMV infection, CD127 was down-regulated in all CD8 
and CD4 T cells regardless of Foxp3 or CD44 expression status.  Expression of CD25 
was high on Foxp3+ CD4+ Treg cells but was negligible on all other CD4 and CD8 T 
cells (Fig. 5.5b).  LCMV infection up-regulated CD25 expression on Treg cells 
significantly but did not affect expression on other CD4 or CD8 T cells at day 2 post 
infection.  As previously published (Zhang et al., 1998), the expression of CD122 was the 
highest on CD44hi CD8 T cells but very low on CD44lo CD4 T cells.  Foxp3+ CD4+ 
Treg cells expressed higher levels of CD122 than CD44hi CD4 and CD44lo CD8 T cells 
(Fig. 5.5c).  CD122 expression was not altered by LCMV infection.  All CD4 and CD8 T 
cells and Treg cells expressed CD132 (Fig. 5.5d).  Although the expression of CD132 
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was elevated on CD4 and CD8 T cells after LCMV infection, it was unchanged on Treg 
cells.  The pattern of receptor expression indicates that although LCMV infection down-
regulates IL-7 receptor on all T cells, the high-affinity IL-2 receptor remains intact on 
Treg cells; this may provide a survival advantage to Treg cells. 
The IL-15 receptor shares CD122 and CD132 with the IL-2 receptor.  IL-15 
stimulates proliferation of CD44hi CD122hi CD8 T cells in vitro (Zhang et al., 1998) and 
IL-15 receptor α KO mice are unable to maintain memory CD8 T cells long term (Becker 
et al., 2002; Burkett et al., 2003).  IL-15 is needed for CD44hi CD8 T cells to recover in 
number after an apoptotic depletion by type I IFN (Kim & Welsh, 2004).  The presence 
of IL-15 receptor α (CD215) was very rare on T cells in naïve animals but increased 
substantially especially among CD44hi CD8 T cells after LCMV infection (Fig. 5.5e). 
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Figure 5.5.    
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Figure 5.5.  IL-7 receptor is down-regulated on T cells while high-affinity IL-2 
receptor remains on Foxp3+ CD4+ Treg cells after LCMV infection.  Foxp3GFP 
mice were infected i.p. with 5x104 pfu LCMV.  Splenocytes harvested at 2 days post 
infection were stained ex vivo for CD127 (a), CD25 (b), CD122 (c), CD132 (d) and 
CD215 (e).  Geometric mean fluorescence intensity data are representative of at least 
three separate experiments.  (*) denotes statistical significance (p < 0.05) between naïve 
and day 2 post LCMV-infected mice (n=3).  
CD
44
hi 
CD
8
CD
44
lo 
CD
8
CD
44
hi 
CD
4
CD
44
lo 
CD
4
Fo
xp
3+
 C
D4
0
200
400
M
FI
CD215
naive
d2 LCMV
*
* * * *
95
STAT5A and STAT5B mediate IL-2, IL-7 and IL-15 signaling (Tripathi et al., 
2010; Wuest et al., 2008; Xue et al., 2002).  Phosphorylated STAT5 is involved not only 
in sustaining Foxp3 expression (Burchill et al., 2008), but also in regulating CD8 T cell 
homeostasis (Hand et al., 2010; Kelly et al., 2003).  When the expression of STAT5 
before and after LCMV infection was compared, I found that the total expression of 
STAT5 was the highest among Foxp3+ CD4 T cells in naïve animals and was further 
increased after LCMV infection (Fig. 5.6a).  In contrast, the total STAT5 expression was 
slightly reduced among CD8 T cells (both CD44 hi and lo) and CD44lo CD4 T cells after 
infection. Consistent with the expression pattern of CD25 (Fig. 5.5b), only Treg cells 
were able to respond to IL-2 stimulation in vitro and phosphorylate STAT5 (Fig. 5.6b).  
Time course experiments also revealed that STAT5 in Foxp3+ CD4 T cells could be 
phosphorylated in response to IL-2 instantaneously without any incubation (data not 
shown).  Therefore, Foxp3+ CD4+ Treg cells were able to receive survival signals 
through IL-2 receptor and STAT5 early during LCMV infection.  
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Figure 5.6.  Foxp3+ CD4+ Treg cells display the highest level of Stat5 expression 
and respond well to IL-2 stimulation in vitro even after LCMV infection.  Foxp3GFP 
mice were infected i.p. with 5x104 pfu LCMV.  (a) Splenocytes harvested at 2 days post 
infection were stained ex vivo for STAT5.  (b) Phosphorylation of STAT5 was assessed 
after stimulating splenocytes with 5 ng/ml IL-2 for 15 minutes at 37°C.  Data are 
representative of two separate experiments showing geometric mean fluorescence 
intensity between BHK sham control or naïve versus day 2 post LCMV-infected groups 
of 2-3 mice. 
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Balance between pro- and anti-apoptotic molecules altered by LCMV infection 
BH3-only Bim is involved in regulating survival of T cells including Treg cells 
(Chougnet et al., 2011; Wojciechowski et al., 2007).  LCMV-induced apoptosis of 
CD44hi CD8 T cells involves Bim (Bahl et al., 2010).  To initiate apoptosis, Bim 
antagonizes the anti-apoptotic molecule Bcl-2 and its family members such as Bcl-xL and 
myeloid cell leukemia sequence 1 (Mcl-1), which would otherwise prevent the effectors 
Bcl-2-associated X protein (Bax) and Bcl-2 antagonist or killer (Bak) from forming pores 
on the mitochondrial outer membrane (Youle & Strasser, 2008).  The balance between 
pro-apoptotic and anti-apoptotic molecules can influence cell survival.  To see if LCMV 
infection would shift this balance, I examined the geometric mean fluorescence intensity 
(MFI) ratio between these molecules.  C57BL/6 mice were used in place of FoxpGFP 
mice because of the sensitivity of the Bcl-2 epitope to methanol treatment and because 
the green fluorescent protein could not survive the 1-hr saponin permeabilization.  At day 
2 post LCMV infection, there was a decrease in Bcl-2 in CD44hi CD8 T cells (Fig. 5.7a).  
Since the relative abundance of Bim among different T cell populations (Fig. 5.7b) was 
very similar to that of Bcl-2, the Bim:Bcl-2 MFI ratio was similar across different T cell 
populations (Fig. 5.7c).  After infection, there was a slight increase of the Bim:Bcl-2 MFI 
ratio across all T cells.  On the other hand, LCMV infection slightly increased the 
expression of Bcl-xL (Fig. 5.7d) and reduced the Bim:Bcl-xL MFI ratio in CD8 T cells 
and CD44lo CD4 T cells (Fig. 5.7e).  The expression of Mcl-1 was increased in all T 
cells after LCMV infection (Fig. 5.7f) and reduced the Bim:Mcl-1 MFI ratio (Fig. 5.7g). 
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 Bak on the mitochondria does not interact with Bim directly (Willis et al., 2007) 
but is restrained by Mcl-1 and Bcl-xL (Willis et al., 2005).  The N-terminus becomes 
exposed on activated Bak, which homo-oligomerizes to form pores on the outer 
membrane of mitochondria (Tait & Green, 2010).  The level of the active form of Bak 
was much higher in CD8 T cells than in CD4 T cells and was slightly increased in 
CD44hi CD8 T cells, CD4 T cells and Treg cells after LCMV infection (Fig. 5.7h).  
Because of the increased Mcl-1 expression (Fig. 5.7f), the active Bak:Mcl-1 MFI ratio 
was reduced in CD8 T cells but was not changed in CD4 T cells after infection (Fig. 
5.7i).  The active Bak:Bcl-xL MFI ratio was the highest in CD44lo CD8 T cells and was 
decreased after LCMV infection (Fig. 5.7j).  LCMV infection altered the ratio between 
pro- and anti-apoptotic molecules, but so far no correlation can be established between 
the expression ratios and the differential susceptibilities of the five T cell populations to 
infection-induced apoptosis.  Further examination on the other molecules in the cell death 
pathways may be needed to decipher the mechanism(s) involved.  
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Figure 5.7.   
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Figure 5.7.   
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Figure 5.7. LCMV infection alters the balance between pro-apoptotic and anti-
apoptotic molecules in T cells.  Two days after i.p. infection with 5x104 pfu LCMV, 
splenocytes from C57BL/6J mice were stained ex vivo for Bcl-2 (a and c) and Bim (b, c, 
e and g); Bcl-xL (d, e and j); Mcl-1 (f, g and i); Bak NT (h-j).  Geometric mean 
fluorescence intensity and the MFI ratio comparison are representative of at least two 
experiments (n=3).  
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Discussion 
Previous work had established that CD44hi CD8 and CD44hi CD4 T cells are 
driven to apoptosis by virus- and by poly(I:C)-induced type I IFN (Bahl et al., 2006; 
2010; McNally et al., 2001).  The current study extends our knowledge to the Foxp3+ 
CD4+ natural Treg cells.  Treg cells are major regulators of self-reactive T cells and are 
strong suppressors of autoimmunity.  There are several experimental models of virus-
induced autoimmunity in animals, and epidemiological correlates linking viral infections 
to the induction or exacerbations of a variety of autoimmune diseases, including diabetes, 
multiple sclerosis, rheumatoid arthritis, myocarditis, etc. (Kim et al., 2006a; Van Der 
Werf et al., 2007).  A possible mechanism for virus-induced autoimmunity could be a 
consequence of the virus infection-induced apoptosis of Treg cells, because a momentary 
loss of Treg cells is enough to initiate an autoimmune disorder (Setoguchi et al., 2005).  
However, most of the time viruses do not induce autoimmunity.  It is not uncommon to 
see some self-reactive antibodies generated during infection (Berlin et al., 2007; Sane et 
al., 2012; Sjöwall et al., 2012), but most of the time the host survives a viral infection 
without serious autoimmune manifestations.  It is, therefore, of interest to determine 
whether Foxp3+ CD4+ natural Treg, present at the beginning of viral infections, are 
resistant or sensitive to the T cell apoptosis that occurs early during infection.  Human 
Treg cells have been shown more resistant to apoptosis induced by irradiation or 
topoisomerase inhibitors than non-Treg CD4 T cells (Winzler et al., 2011).  Both murine 
and human Treg cells are resistant to activation-induced cell death (Banz et al., 2002; 
Fritzsching et al., 2005).  Here I showed that Treg cells were substantially more resistant 
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to virus infection-induced apoptosis than the CD44hi CD4 and CD8 memory T cells with 
which they coexisted. 
Treg cells might be more resistant to virus infection-induced apoptosis because of 
their ability to receive signals from IL-2.  Both IL-7 and IL-2 have been shown to affect 
Treg population size in the periphery through regulating Foxp3 expression (Kim et al., 
2012; Zorn et al., 2006).  Foxp3 as a transcription factor can down-regulate the 
expression of CD127 but up-regulate CD25 expression (Williams & Rudensky, 2007), 
resulting in mature Treg cells being CD127lo and CD25hi, although recent work has also 
identified a CD127hi Foxp3+ population in bone marrow and in skin (Simonetta et al., 
2010).  Upon LCMV infection, CD127 expression was further reduced on Foxp3+ CD4+ 
Treg cells but the expression of CD25, CD122 and CD132 was either increased or 
unchanged.  The ability to continue to receive survival signals through the IL-2/STAT5 
pathway may allow Treg cells to survive and maintain functionality during infection.  
Attempts to block IL-2 signaling in vitro failed to consistently induce more apoptotic 
deaths in Treg cells during the 5-hr incubation prior to TUNEL assays.  However, high 
dose (1mg/mouse) IL-2-neutralizing antibody has been shown to deplete Foxp3+ CD25+ 
CD4+ Treg cells over 3 days in vivo (Setoguchi et al., 2005).  The presence of IL-2 (0.1-
10 ng/ml) has been shown to protect CD25+CD4+ Treg cells but not CD25- conventional 
CD4 T cells from spontaneous and dexamethasone-induced cell death in a 12-hr in vitro 
assay (Chen et al., 2004). 
Could the sensitivity to apoptosis be the consequence of changes in cytokine 
receptors on T cells?  IL-7Rα (CD127) is thought to be down-regulated in response to T 
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cell activation.  However, CD127 expression on WT donor CD8 T cells is much higher in 
IFNAR KO hosts than in WT hosts after acute LCMV infection (Nakayama et al., 2010).  
Thus type I IFN probably indirectly down-regulates CD127 on T cells.  While the 
expression of CD127 is important for naïve and memory CD8 T cell survival, signaling 
through the IL-7 receptor is not required during the initial proliferative response to an 
infection or an immunization (Schluns et al., 2000).  Decreasing the sensitivity of T cells 
to IL-7 through down-regulation of CD127 may be a way to allow selection and 
programming of responding T cells by other cytokines to generate specific responses to 
newly encountered antigen while simultaneously eliminating some pre-existing memory 
T cells.   
LCMV infections change the ratio of pro- and anti-apoptotic molecules but no 
correlation to apoptosis induction is deduced.  Previous attempts to decipher the 
mechanism of memory CD44hi CD8 T cell apoptosis and early attrition induced by type I 
IFN had not established any connection to NK cells, IFNγR, perforin, FasL, granzyme B, 
TRAIL, TNFR1 or TNFR2 (McNally et al., 2001)(Kapil Bahl’s thesis).  However, Bim is 
instrumental to the process.  In Bim KO mice, the frequency of CD44hi CD8 T cells is 
relatively stable after LCMV infection, and the CD44hi CD8 T cells are significantly less 
TUNEL positive at day 3 post LCMV infection (Bahl et al., 2010).  Bim can physically 
interact with Bcl-2, Bcl-xL and Mcl-1 to initiate apoptosis (Hübner et al., 2008; Willis et 
al., 2007).  The current data indicate no increase of Bim after LCMV infection, but Bcl-
xL and Mcl-1 were up-regulated at day 2 post infection (Fig. 5.7).  Changes in cytokine 
signals in the immune environment might have caused the up-regulation of anti-apoptotic 
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molecules.  IL-2, IL-7 and IL-15 signaling can up-regulate the expression of Bcl-2, Bcl-
xL and Mcl-1 (Lenz et al., 2004; Opferman et al., 2003), and certain co-stimulatory 
engagements can also increase Bcl-xL expression within hours of incubation (Lee et al., 
2002; van Oosterwijk et al., 2007).  Some anti-apoptotic molecules play a more important 
role in certain cells in a particular situation.  Naïve CD8 T cells have a greater 
dependence on Bcl-2 to antagonize Bim than naïve CD4 T cells do (Wojciechowski et 
al., 2007).  Bcl-xL can rescue T cells from Fas-mediated cell death (Boise et al., 1995), 
although its presence does not prevent LM-induced apoptosis of CD8 T cells (Jiang et al., 
2003b).  Mcl-1 is important for T cell development and maintenance (Opferman et al., 
2003), and its role in Treg cell survival has recently been demonstrated (Pierson et al., 
2013).  Since Treg cells are more resistant to virus infection-induced early apoptosis, it 
was expected that the relative abundance of anti-apoptotic and pro-apoptotic molecules 
would be different between Treg cells and the CD44hi CD8 and CD4 T cells.  However, 
the Bim to anti-apoptotic molecule MFI ratios did not increase with the increased 
occurrences of apoptosis observed in the CD44hi CD8 and CD4 T cells after LCMV 
infection.  In fact, the increased Bcl-xL and Mcl-1 expression after LCMV infection is 
counter-intuitive to what is expected of the CD44hi CD8 and CD44hi CD4 T cells with 
increased sensitivity to apoptosis and decreased IL-7 receptor expression.  Therefore, the 
Bim to anti-apoptotic molecule MFI ratios may not be the appropriate correlates to 
apoptosis in this context. 
CD8 and CD4 T cells may take different paths towards death.  Bak becomes 
active and exposes the N-terminus while awaiting the second signal to become committed 
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to apoptosis.  The level of active Bak was found to be much higher in CD8 T cells than in 
CD4 T cells and Treg cells.  A preliminary observation was made that dying CD8 T cells 
were mostly caspase-3 and TUNEL double positive at day 3 post LCMV infection (data 
not shown).  These pieces of evidence suggest that CD8 T cells undergo mitochondria- 
and caspase-dependent apoptosis after infection.  On the other hand, CD4 T cells might 
have gone through more diverse forms of death apart from caspase-dependent apoptosis, 
since a good portion of TUNEL-staining dying cells were not caspase-3 positive (data not 
shown), and there were much lower levels of active Bak in CD4 T cells.  
 The spontaneous incidents of autoimmunity developed among patients receiving 
IFNα therapy for cancer (Rönnblom et al., 1991) and hepatitis (Dumoulin et al., 1999; 
Fattovich et al., 1996) and the association between infection and autoimmunity had us 
question whether virus-induced type I IFN might drive Treg into apoptosis and reduction 
in number, thereby allowing activation of autoreactive cells.  This study indicates that the 
Foxp3+ CD4+ natural Treg population is relatively stable early during LCMV infection.  
A preliminary experiment with mice treated with a type I IFN inducer poly(I:C) for 1 day 
also showed more stable Foxp3+ Treg cells by TUNEL assay (data not shown), 
suggesting that type I IFN may not compromise the survival of natural Treg cells early 
during infection.  This may explain the relatively low incidence of autoimmunity among 
type I IFN users and infected patients.  Many other factors are involved in the 
development of autoimmunity, and further investigation will be needed to dissect the 
specific process for each autoimmune disease. 
  
109
Chapter VI. Heterologous Immunity between LCMV and MCMV 
 The history of infections can influence the response to subsequent heterologous 
infections and the disease outcome.  This is referred to as heterologous immunity, and it 
can be either beneficial or detrimental.  Immunoprotection in terms of more rapid viral 
control or survival can be accompanied with enhanced or altered immunopathology 
depending on the biology of the disease.  For examples, a history of LCMV infection can 
reduce the viral titer early after VACV infection and protect mice from lethal VACV 
challenge (Chen et al., 2001a; Selin et al., 1998), while immunopathology in the 
manifestation of panniculitis (acute fatty necrosis) in the visceral fat can also be 
developed in some of the i.p. infected LCMV-immune mice (Nie et al., 2010; Selin et al., 
1998).  On the other hand, a history of influenza infection not only enhances viral loads 
in subsequent LCMV and MCMV infections, but also increases the severity of lung 
immunopathology (Chen et al., 2003). 
 Heterologous immunity has not been studied over the course of persistent 
infections.  MCMV causes persistent infection and memory inflation in mice.  Previous 
work has shown that LCMV infection is protective against MCMV and can reduce 
MCMV viral titer in the liver by about half a log pfu/ml early during infection (Selin et 
al., 1998).  This may potentially affect the generation of T cell responses and the 
establishment of persistent MCMV infection and viral latency.  Sporadic reactivation of 
viral genome in infected cells is thought to be the source of antigen that leads to memory 
inflation, which describes the gradual accumulation of some MCMV-specific memory 
CD8 T cells beyond the initial expansion and contraction of responding T cell 
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populations (Karrer et al., 2003; Seckert et al., 2012).  Changes in the viral control may 
potentially affect the process of memory inflation.  On the other hand, the accumulated 
MCMV-specific memory CD8 T cells over time may interfere with responses to 
subsequent infections.  T cell cross-reactivity between LCMV and MCMV will also be 
examined in this study using regular immune and long-term immune mice.  
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Results 
More severe immunopathology in LCMV-immune mice 
To study the long-term effect of heterologous immunity in MCMV infection, 
LCMV-immune mice and the sham control mice that were given only the supernatant 
from uninfected BHK cell cultures were infected with 5x105 PFU MCMV, and then 
examined at day 4, 12, 21, 42, 84 post infection.  The first thing I noticed was the 
dramatic difference in immunopathology.  When mice were inoculated intraperitoneally, 
the proximal fat in the lower abdomen became infected and inflamed.  The necrosis in the 
fat pad was measured on a scale of 0-7 as published (Selin et al., 1998).  I found that on 
day 4 post MCMV infection, LCMV-immune mice showed severe necrosis in the fat pad 
while the sham control mice showed no sign of immunopathology (Fig. 6.1).  Similar 
observations were made in subsequent repeat experiments.  Necrosis was severe in both 
LCMV-immune and sham control groups at day 12 after the peak of T cell response.  By 
day 21 most of the necrosis was resolved in the LCMV-immune mice, but prolonged 
necrosis was observed in some of the BHK control animals.  I conclude that the history of 
LCMV infection causes more severe immunopathology early during MCMV infection. 
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Figure 6.1.  MCMV infection results in more severe acute fatty necrosis in the fat 
pads of LCMV-immune mice early during infection.  LCMV-immune C57BL/6 mice 
and BHK sham controls were infected with 5x105 pfu MCMV.  The necrosis in the fat 
pad was measured on a scale of 0-7 as published (Selin et al., 1998): 1-2 means mild 
disease with only a few spots on the lower abdominal fat pad; 3-4 means moderate 
disease with larger white patches extending out to the upper quadrant of the fat pad; 5-6 
is more severe with infiltration of inflammatory cells throughout the entire fat pad; and 7 
is assigned if the organs are sticking together.   
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Higher MCMV viral loads in LCMV-immune mice 
To evaluate the effect on viral control, MCMV viral copy number in genomic 
DNA extracted from snap-frozen solid organs was measured by qPCR using MCMV 
glycoprotein B (gB) primers for MCMV and mouse β-actin primers for the mouse 
genome.  At day 4 post MCMV infection, more MCMV viral copies per µg of genomic 
DNA were found in the spleen, liver, kidney and lung of LCMV-immune mice than of 
the non-immune mice (Fig. 6.2a).  A plaque assay also revealed a greater abundance of 
infectious MCMV particles in the liver of LCMV-immune mice in one of the 
experiments (data not shown).  As expected, MCMV was not detected in the salivary 
gland for the first few days, and the viral copy numbers in both groups peaked on day 21 
post MCMV infection (Fig. 6.2b).  Viral growth kinetics were not affected by the history 
of LCMV infection; however, the viral load in the salivary glands of the LCMV-immune 
mice was higher than that of the BHK sham control mice throughout the entire 
experiment (Fig. 6.2b).  Therefore, the history of LCMV infection enhanced viral burden 
during MCMV infection. 
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Figure 6.2.  Viral loads are higher in mice with a history of LCMV infection.  
LCMV-immune C57BL/6 mice and BHK sham controls were infected i.p. with 5x105 pfu 
MCMV.  MCMV copy number was measured by qPCR on DNA extracted from snap 
frozen organs.  (a) MCMV viral load in the spleen, liver, kidney and lung on day 4 post 
infection.  (b) MCMV viral load in the salivary glands on day 4, 12, and week 3, 6, 12 
post infection.  (*) denotes statistical significance (p < 0.05) between LCMV-immune 
and BHK control groups in the specific organ or at the specific time-point (n=5). 
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Fewer MCMV-specific inflationary memory CD8 T cells in LCMV-immune mice 
To examine the effect on T cell response to MCMV infection and T cell memory 
generation, MCMV-specific CD8 T cells in the spleen were analyzed by ICS after in 
vitro peptide stimulation.  After the period of memory inflation at week 12 post MCMV 
infection, the numbers of inflationary memory CD8 T cells specific for m139419–426, 
M38316-323 and IE3416-423 were lower in the LCMV-immune mice than in non-immune 
controls (Fig. 6.3a).  The number of M38316-323-specific memory CD8 T cells is the most 
consistently accrued to a higher number in BHK control mice across repeat experiments.  
No difference was found in the number of non-inflationary memory T cells between the 
LCMV-immune and the sham control groups at 12 weeks post infection (Fig. 6.3b).  The 
suppressed memory inflation was also evident in the number of CD8 T cells accumulated 
in the spleen over time.  The total CD8 T cell number was significantly higher in the 
BHK control group than in LCMV-immune group at 12 weeks post MCMV infection 
(Fig. 6.3c).  Memory CD44hi CD8 T cells were also accrued to a higher number in the 
BHK control group than the LCMV-immune group at week 6 and 12 post infection (Fig. 
6.3d).  Therefore, the history of LCMV infection reduced the accumulation of 
inflationary memory CD8 T cells in the spleen. 
 
  
116
(a) 
 
 
(b) 
    
 
Figure 6.3.  
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Figure 6.3.  A history of LCMV infection suppresses the generation of inflationary 
memory T cells.  LCMV-immune C57BL/6 mice and BHK sham controls were infected 
i.p. with 5x105 pfu MCMV.  Splenocytes harvested at day 12, 21, 42 and 84 post MCMV 
infection were assayed by ICS.  LCMV-immune mice accumulated less inflationary 
memory T cells (a) at week 12 (day 84) post infection but the numbers of non-
inflationary memory T cells (b) were comparable between the LCMV-immune and BHK 
control groups.  Total CD8 T cells (c) and memory CD44hi CD8 T cells (d) were accrued 
to a higher number in the non-immune control group. (*) denotes statistical significance 
(p < 0.05) between LCMV-immune and BHK control groups with the specific epitopes or 
at the specific time-point (n=5).   
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Stronger NP396-404-specific CD8 T cell response in MCMV-immune mice 
 T cell cross-reactivity may be one of the ways heterologous immunity affects 
immune responses to subsequent infections with unrelated pathogens.  To examine 
whether cross-reactive epitopes exist between LCMV and MCMV, LCMV-immune mice 
and the BHK controls were examined at day 8 post MCMV infection by cytokine staining 
after in vitro stimulation of splenocytes with 20 different peptides separately (Appendix 
Table 1) (Munks et al., 2006b).  Despite the variability between experiments, no 
substantial and repeatable cross-reactive response was identified with the sequence of 
infections.  The history of LCMV infection had no dramatic effect on the magnitude or 
the hierarchy of CD8 T cell response to MCMV on day 8 post infection (Fig. 6.4).  The 
higher viral burden among LCMV-immune mice did not increase the magnitude of CD8 
T cell response to MCMV. 
The reciprocal experiment was done with MCMV-immune and nsg sham control 
mice.  Eight days after infection with 5x104 pfu LCMV, splenocytes were stimulated with 
16 different peptides separately (Appendix Table 2) (Kotturi et al., 2007).   While the 
age-matched nsg sham control mice mounted a variable response to LCMV with a 
dominant GP33-41 response in one out three mice and a dominant NP396-404 response in 
another, LCMV infection induced a robust response of a higher overall magnitude in all 
three MCMV-immune mice (Fig. 6.5a).  The response to NP396-404, L689-697 and L338-346 
was significantly greater in the MCMV-immune mice than in the nsg controls (Fig. 6.5b).  
Changes in the magnitude of response to some peptides in the immune mice may suggest 
the existence of low-affinity cross-reactivity, and further investigation will be needed.  
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Figure 6.4.  LCMV-immune mice display no apparent cross-reactive CD8 T cells 
response to MCMV during acute infection.  LCMV-immune mice and BHK sham 
controls were infected i.p. with 5x105 pfu MCMV.  Splenocytes were analyzed by ICS at 
day 8 post infection. 
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Figure 6.5.   
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Figure 6.5.  LCMV infection induces a stronger NP396-404-specific response in 
MCMV-immune mice.  MCMV-immune mice and nsg sham controls were infected with 
5x104 pfu LCMV.  Splenocytes were analyzed by ICS at day 8 post infection.  (a) 
MCMV-immune mice displayed a robust CD8 T cell response to LCMV.  (b) NP396-404-
specific CD8 T cell response was significantly stronger in the MCMV-immune mice than 
in nsg sham controls.  (*) denotes statistical significance (p < 0.05) between MCMV-
immune and nsg control groups with the specific epitopes. 
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Decline in T cell response in aging mice unrelated to history of MCMV infection 
The association between human cytomegalovirus and the aging of the immune 
system (a.k.a. immune senescence) has been suggested (Moss, 2010; Pawelec et al., 
2009; 2010).  One of the signs of immune senescence is the decreased ability to respond 
to new antigens (Goronzy & Weyand, 2013).  To examine whether a history of MCMV 
infection, independent of immune senescence, may affect the immune response to a 
subsequent heterologous infection, mice inoculated with MCMV or nsg sham controls 
were subsequently infected with 5x104 pfu LCMV, a non-lethal dose in adult mice, at 
weeks 30, 45, 60, 75, 90, 91, 105, 120 and 130 post MCMV infection.  As expected, the 
magnitude of the peptide-specific T cell response to LCMV at day 8 post LCMV 
infection weakened gradually with age, especially after week 60 post MCMV infection, 
but the response was not dramatically different between the long-term MCMV-immune 
mice and the nsg sham controls (Fig. 6.6).  Over time the percentage of response to CD8 
peptides GP33-41, GP276-286 and NP396-404 did not decline as much as the percentage of 
response to CD4 peptide GP61-80 did (Fig. 6.7).  Either a hampered proliferative response 
or a decreased number of precursor CD8 T cells with age might have led to the reduction 
of responding CD8 T cell number.  Although a decline in the T cell response was 
observed with age, the long-term MCMV infection did not appear to cause more 
impairment of the T cell response to LCMV infection. 
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(a) GP33-41 
 
(b) GP276-286 
 
(c) NP396-404 
 
(d) GP61-80 
 
 
Figure 6.6.  The magnitude of T cell response to LCMV infection declines with age.  
MCMV-immune and nsg control mice infected with 5x104 pfu LCMV at different time-
points post MCMV infection were analyzed at day 8 by ICS.  CD8 T cell responses to 
GP33-41 (a), GP276-286 (b) and NP396-404 (c) and CD4 T cell response to GP61-80 (d) are 
shown by individuals in group plots on the left and as line graphs with mean and SEM on 
the right.  
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Figure 6.7.  The percentage of response to CD4 epitope GP61-80 declines with age, but 
the percentages of response to CD8 epitopes are more stable over time.  T cell 
responses of MCMV-immune and nsg control mice to LCMV were analyzed at day 8 
post infection by ICS.  The percentage of responses by individuals in group plots are 
shown on the left and as line graphs with mean and SEM on the right. 
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Novel cross-reactive MCMV peptide M57727-734 identified 
 When MCMV-long-term-immune mice were infected with LCMV, several mice 
displayed an elevated response to LCMV peptide L2062-2069: 15.7%, 21.4%, 6.9%, 12.4% 
of CD8 T cells were responsive to L2062-2069, compared to normally only 1-2% responding 
(Fig. 6.8a).  In approximately one in every five MCMV-immune mice, the hierarchy of 
the epitope response to LCMV was altered, and nearly 50% of the response became L2062-
2069-specific (Fig. 6.8b and 6.8c).  L2062-2069 is a Kb-restricted epitope.  Using Basic Local 
Alignment Search Tool (BLAST®) search against the MCMV protein sequence, 14 
peptide sequences with substantial homology to the original L2062-2069 sequence and 28 
sequences with homology to the its variations were identified.  Two new peptides M57727-
734 and m165114-121 with a SYPETHI score of 19 and 20 respectively were synthesized 
and tested along with M10072-79  (Fig. 6.9a) by ICS at day 8 post LCMV infection.  
MCMV-immune mice with an elevated response to L2062-2069 responded to M57727-734 
with a similar magnitude and altered the proportional response hierarchy (Fig. 6.9b), 
suggesting that M57727-734 is cross-reactive with L2062-2069-specific CD8 T cells.  In 
contrast, no response was raised against m165114-121, suggesting that C57BL/6 mice might 
not recognize m165114-121 as an epitope.  To see if the cross-reactive epitopes were 
recognized by the same subset of TCR clones, Vβ usage of L2062-2069- and M57727-734-
specific T cells was analyzed in one nsg control mouse and two MCMV-immune mice 
after infection with LCMV at week 120 post MCMV infection.   While both M57727-734-
and L2062-2069-specific T cells preferentially used Vβ5.1/5.2 and Vβ8.1/8.2, L2062-2069-
specific T cells could additionally use Vβ13, Vβ14 and Vβ17a (Fig. 6.10).  
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Figure 6.8.    
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Figure 6.8.  MCMV-long-term-immune mice show possible cross-reactive response 
to LCMV L2062-2069.  T cell responses of MCMV-immune and nsg control mice to 
LCMV were analyzed at day 8 post infection by ICS.  (a) High frequency response to 
L2062-2069 was found in several MCMV-immune mice at different time-points post 
MCMV infection.  (b and c) Representative data at week 75 post MCMV infection show 
a possible cross-reactive response to L2062-2069 and normal responses to other LCMV 
epitopes. 
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Figure 6.9.  MCMV M57727-734 is probably cross-reactive to LCMV L2062-2069.  (a) 
Three MCMV peptides with sequence homology to L2062-2069 were chosen for 
experiments.  (b) Five MCMV-immune (week 105 post MCMV infection) mice and one 
nsg control mouse were analyzed at day 8 post LCMV infection.  About 50% of major 
LCMV-specific response was found specific for L2062-2069 in the same mouse that showed 
over 50% of major MCMV-specific response specific for M57727-734. 
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Figure 6.10.  LCMV L2062-2069- and MCMV M57727-734-specific T cells both use 
Vβ5.1/5.2 and Vβ8.1/8.2.  MCMV-immune (week 120 post MCMV infection; mouse #8 
and #10) and nsg control (mouse #7) mice were analyzed at day 9 post LCMV infection 
by ICS.  The frequencies of IFNγ+ Vβ+ (% CD8 CD44hi) T cells were compared by 
different Vβ in each mouse.  
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Discussion 
The history of exposure to pathogens can influence the host response to 
subsequent infections and the disease outcome.  MCMV causes persistent infection and 
CD8 memory T cell inflation in mice.  This study examined the effect of heterologous 
immunity in persistent infection using LCMV and MCMV infections, and found that the 
history of LCMV infection caused more severe panniculitis early during MCMV 
infection.  The more severe panniculitis may not be a surprise in LCMV-immune mice, 
since similar immunopathology has been observed after VACV infection.  Preliminary 
experiments showed that, after MCMV infection, macrophages infiltrated into the 
visceral fat pads, and the CD8 T cells and NK1.1+ cells were much more abundant in the 
fat pads of LCMV-immune mice than non-immune controls at day 4 post MCMV 
infection.  The cellular infiltrates along with the TNF produced by macrophages could 
accelerate the necrosis of fat cells, causing visible pathology. 
Higher MCMV viral loads were observed in the spleen, liver, kidney, lung and 
salivary glands in the LCMV-immune mice.  The qPCR is a very sensitive tool for viral 
genome detection, although this technique does not differentiate between infectious and 
non-infectious particles.  A previous study examining heterologous immunoprotection by 
plaque assay showed that immunity to LCMV was protective against MCMV, and 
reduced the MCMV titer by about half a log in comparison to naïve mice challenged with 
MCMV (Selin et al., 1998).  In this study, although the MCMV copy numbers were 
consistently higher in the LCMV-immune mice, viral titers by plaque assays sometimes 
showed no difference between LCMV-immune and BHK sham control mice in repeat 
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experiments.  Plaque assay may not be as robust as qPCR because slight changes in 
infectivity or errors in serial dilutions may deviate the plaque counts.  
Higher MCMV viral titers early during infection were expected to enhance 
memory inflation later on because more cells would be seeded with latent MCMV and 
thereby a greater chance of stimulating memory CD8 T cell inflation by viral recurrence.  
However, the number of inflationary memory CD8 T cells was found reduced in the 
LCMV-immune mice.  The percentage of lymphocytes that were CD8 positive was 
steadily maintained in both groups at about 20% throughout the study, but the number of 
CD8 T cells and the number of CD44hi CD8 T cells were lower in the LCMV-immune 
group.  This observation may suggest that instead of the limited space or cytokine 
resources, some other mechanism(s) may be involved in suppressing the generation of 
inflationary memory in the LCMV-immune mice.  Memory inflation depends on peptide 
processing by constitutive proteasomes and presentation by non-hematopoietic cells 
(Hutchinson et al., 2011; Seckert et al., 2011; Torti et al., 2011a).  It may be possible that 
these cells are affected by the history of LCMV infection and become less active in 
stimulating the inflationary memory T cells.  Non-hematopoietic cells have been shown 
to participate in stimulating proliferation of LCMV-specific CD8 T cells (Thomas et al., 
2007).  LCMV and MCMV might have infected different types of non-hematopoietic 
cells that are in the proximity of each other in the same secondary lymphoid organs 
(Mueller & Germain, 2009), and may possibly affect latency establishment and viral 
reactivation of the virus that comes later in the infection sequence. 
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MCMV did not contribute to immune senescence in mice.  Human 
cytomegalovirus has been suggested to associate with immune senescence (Karrer et al., 
2009; Moss, 2010; Pawelec et al., 2010), but the hypothesis has not been directly tested.  
In this study, the long-term MCMV-immune mice generated comparable CD8 and CD4 T 
cell responses to LCMV as the age-matched sham control mice did.  The decline in T cell 
responses to LCMV over time in both groups is consistent with the phenomenon of 
immune senescence (Agarwal & Busse, 2010).  A recent study comparing young and 
aged mice showed that aged mice previously inoculated with the MCMV deletion mutant 
MCMV-Δ157, which lacks the ligand m157 for NK cell activating receptor Ly49H, are 
impaired in the GP33-41- and NP396-404-specific CD8 T cell response to LCMV infection, 
resulting in a higher LCMV viral load than the aged-matched controls (Mekker et al., 
2012).  MCMV-Δ157 is not as well controlled by NK cells as the parent strain in 
C57BL/6 mice, resulting in a higher initial viral burden (Bubić et al., 2004); however, 
viral persistence should have been resolved in the aged mice, and thus the different 
strains of MCMV used may not account for the different observations in the two studies.  
I did not compare LCMV viral titer after infection, but a MCMV-immune mouse that 
succumbed to LCMV infection was found unable to control infection even on day 11, 
which is unusual with the use of low dose LCMV Armstrong strain.  Nevertheless, the 
overall mortality rate was similar between MCMV-immune and non-immune control 
groups whether the mice were subsequently infected with LCMV or not.  Therefore, 
MCMV did not seem to intensify the effect of immune senescence in aged mice in this 
study. 
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  In the long-term MCMV-immune mice infected with LCMV, a new MCMV 
epitope sequence M57727-734 was found to possibly cross-react with LCMV L2062-2069.  
These two sequences are the first cross-reactive epitope pair identified between LCMV 
and MCMV.  M57727-734 shares 50% sequence homology with L2062-2069.  The rest of the 
amino acids are also biochemically similar, with a bulky basic residue (Lys vs Arg) in 
position 1, hydrophobic residues (Val vs Ile) in position 3 and 8, and an acidic residue 
(Glu vs Asp) in position 4.  Therefore, MHC-M57727-734 complex may potentially interact 
with the same TCR that recognize MHC-L2062-2069 through molecular mimicry (Hagerty 
& Allen, 1995; Welsh & Selin, 2002).  In this study, cross-reactivity was observed 
approximately once in every five MCMV-immune mice, consistent with the phenomenon 
of private specificity, where only some T cell repertoires may respond to the cross-
reactive epitope of the other virus.  Experiments suggested that M57727-734 is a 
subdominant epitope, but when stimulated in the context of LCMV infection, the M57727-
734-specific T cells greatly increased in number and dominated the virus-specific memory 
T cell pool.  At the same time, the response to subdominant LCMV epitope L2062-2069 
became the major CD8 T cell response.  This alteration of immunodominance hierarchy 
is very similar to NP205-212 in LCMV and PV infections, where a prior history of infection 
with one virus will greatly alter the hierarchy of the CD8 T cell response to the other 
virus (Brehm et al., 2002).   
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Chapter VII. Non-reciprocal heterologous protection between LCMV 
and VACV 
 The protection conferred by heterologous immunity is not necessarily reciprocal.  
Immunity to pathogen A being protective against pathogen B does not guarantee that the 
immunity to pathogen B will protect against pathogen A.  A history of infection with 
LCMV, MCMV, PV, BCG or influenza A virus provides a certain level of heterologous 
protective immunity against VACV in the form of reduced organ viral titer by one to two 
log pfu early (day 3-4) after infection (Chen et al., 2003; Mathurin et al., 2009; Selin et 
al., 1998).  However, a prior history of VACV infection does not protect against 
subsequent challenge with LCMV, MCMV or PV (Selin et al., 1998). 
 Protection against VACV in LCMV-immune mice is mediated by both CD8 and 
CD4 T cells through IFNγ.  IFNγ-producing CD8 and CD4 T cells are recruited in 
LCMV-immune mice to the site of VACV infection (Chen et al., 2001a; Selin et al., 
1998).  Anti-IFNγ-treated or IFNγR KO LCMV-immune mice are no longer protected 
against VACV, and recipients of CD8 or CD4 T cell-depleted LCMV-immune 
splenocytes are much less protected from VACV than recipients of whole splenocytes 
from LCMV-immune donors (Selin et al., 1998).  
Cross-reactive T cells are thought to be involved in immunoprotection against 
VACV.  LCMV NP205-212, GP34-41, GP118-125 and VACV A11R198-205 are identified as 
cross-reactive between LCMV and VACV (Cornberg et al., 2010; Kim et al., 2005).  
Upon VACV infection, the cross-reactive LCMV-specific CD8 T cells greatly increase in 
number, although the magnitude of the response may vary between mice due to the 
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private specificity of the individual mouse (Kim et al., 2005).  A11R198-205 cell lines from 
LCMV-immune mice can bind to both VACV A11R198-205 and LCMV GP118-125 or GP34-
41 tetramers, proliferate in response to VACV infection in vivo, and reduce VACV viral 
load in naïve recipients (Cornberg et al., 2010).  
There are biological differences between the VACV and LCMV infections.  
VACV replicates preferentially in peripheral organs like the ovaries while LCMV 
replicates primarily in the lymphoid organs.  IFNγ inhibits VACV replication (Harris et 
al., 1995; Karupiah et al., 1993; Liu et al., 2004), and the frequency of IFNγ-producing 
memory CD8 T cells correlate directly with protection against VACV (Moutaftsi et al., 
2009), but LCMV is not as sensitive to IFNγ (van den Broek et al., 1995).  LCMV is 
controlled by contact-dependent perforin-mediated cytotoxicity, but perforin or Fas have 
little role in the clearance of VACV (Kägi et al., 1995; Walsh et al., 1994).  Therefore, I 
investigated what kinds of memory T cells are being generated in VACV- and LCMV-
infected mice.  Since it has been shown in homologous LCMV infection that the number 
of cytolytic CD8 T cells correlates directly with target killing (Ganusov et al., 2011), I 
also examined the relationship between number of cross-reactive T cells and 
heterologous immunoprotection in VACV-challenged LCMV-immune mice. 
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Results 
Memory CD8 T cells from VACV-GP-immune mice display phenotypes of stronger 
proliferative recall potential 
 Memory T cells of different qualities can be generated by different infections or 
vaccinations due to the different cytokine environments and antigen abundance.  If these 
memory T cells were to be re-activated during subsequent infection, they may influence 
the host response and disease outcome differently.  To see if memory CD8 T cells 
generated from LCMV and VACV infections are different in quality, I adoptively 
transferred P14 splenocytes containing 1-3x104 CD8 T cells into C57BL/6 mice and 
inoculated the recipients i.p. with either 5x104 pfu LCMV strain Armstrong or 5x106 pfu 
recombinant VACV containing LCMV glycoprotein (VACV-GP) on the same day.  Six 
weeks or more later, P14 memory CD8 T cells were analyzed from the spleen using their 
congenic marker Thy1.1 in phenotypic and functional assays so that the same transgenic 
T cells being activated in the context of two different infections were examined. 
 Killer cell lectin-like receptor G1 (KLRG1) signaling in CD8 T cells impairs 
proliferation, and its expression correlates with proliferative incapacity of antigen-
experienced CD8 T cells (Gründemann et al., 2006; Voehringer et al., 2001).  CD127 is 
important for homeostatic proliferation of memory CD8 T cells (Schluns et al., 2000).  
The combination of KLRG1 and CD127 has been used to classify memory CD8 T cells: 
CD127hi KLRG1lo as long-term memory T cells, CD127hi KLRG1hi as effector 
memory T cells, and CD127lo KLRG1hi as terminally differentiated effectors (Belz & 
Kallies, 2010).  In both LCMV- and VACV-GP-immune hosts, over 50% of the memory 
137
P14 CD8 T cells showed a long-term memory phenotype (CD127hi KLRG1lo) at 7 
weeks post infection (Fig. 7.1a).  A higher proportion of P14 memory CD8 T cells from 
LCMV-immune mice was KLRG1hi (both 127hi and 127lo), suggesting that LCMV-
immune memory T cells may have a lower proliferative potential.   The phenotype of the 
memory population changed over time, and over 90% of P14 memory CD8 T cells from 
both immune groups displayed the long-term memory phenotype at 23 weeks post 
infection (data not shown). 
 Activation marker expression pattern on memory CD8 T cells has been shown to 
correlate with recall response potential in terms of accumulation at the site of infection 
and IL-2 production (Hikono et al., 2007), and the phenotypes of cells exhibiting recall 
response potential from high to low are as follows: CD27hi CD43lo > CD27hi CD43hi > 
CD27lo CD43lo.  In LCMV-immune mice, there was a lower frequency of P14 memory 
CD8 T cells that expressed the higher recall potential phenotype (CD27hi CD43lo), and 
about 50% expressed the lower recall potential phenotype (CD27lo CD43lo) at 6 weeks 
post infection (Fig. 7.1b).  On the other hand, about 60% of P14 memory CD8 T cells 
from VACV-GP-immune mice expressed the higher recall potential phenotype and 
relatively small percentage of cells were of the lower recall potential phenotype.  Both 
groups had a relatively low percentage of CD27hi CD43hi P14 memory CD8 T cells, but 
over time, the frequency of these cells would gradually increase while the frequency of 
lower recall potential P14 memory CD8 T cells would decline.  At 23 weeks post 
infection, a higher percentage of the CD27hi CD43lo P14 memory CD8 T cells was 
found in LCMV-immune mice (data not shown). 
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 The P14 memory CD8 T cells from LCMV- and VACV-GP-immune hosts are 
phenotypically different.  The analysis by surface markers suggested that memory T cells 
from VACV-GP-immune mice were more capable of recall responses and should 
theoretically have the capacity to protect against subsequent LCMV infections.  
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Figure 7.1. LCMV and VACV-GP infections generate memory CD8 T cells of 
different phenotype compositions.  C57BL/6 mice received Thy1.1 P14 splenocytes 
were infected i.p. with 5x104 pfu LCMV or 5x106 pfu recombinant VACV-GP.  
Splenocytes were analyzed for (a) CD127 and KLRG1 expression at week 7 post 
infection, and for (b) CD27 and CD43 expression at week 6 post infection.  Data are 
representative of at least two separate experiments at similar timepoints. 
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More memory CD8 T cells from LCMV-immune mice are multiple-cytokine producers 
  To evaluate the effector functions of the memory CD8 T cells, splenocytes from 
LCMV- and VACV-GP-immune mice were examined by ICS after in vitro stimulation 
with GP33-41 synthetic peptide.  The majority of Thy1.1 P14 memory CD8 T cells from 
both immune groups were able to produce IFNγ and TNF upon peptide stimulation (Fig. 
7.2).  A greater proportion of P14 memory CD8 T cells from LCMV-immune mice than 
those from VACV-GP-immune mice produced three cytokines, IFNγ, TNF and IL-2, in 
the same cells.  More P14 memory CD8 T cells from VACV-GP-immune mice produced 
IFNγ alone when stimulated.  The cytokine production profile revealed that LCMV 
infection generated memory CD8 T cells of more versatile effector functions. 
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Figure 7.2.  Greater proportion of memory CD8 T cells from LCMV infection is 
capable of producing multiple cytokines in the same cells upon re-stimulation.  
C57BL/6 mice receiving Thy1.1 P14 splenocytes were infected i.p. with 5x104 pfu 
LCMV or 5x106 pfu recombinant VACV-GP.  Splenocytes harvested at day 46 (weeks 
6.5) post infection were analyzed for cytokine production by ICS after GP33-41 peptide 
stimulation for 5 hr.  Data are representative of three separate experiments. 
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Memory CD8 T cells from both immune groups proliferate and produce granzyme B 
upon stimulation in vitro 
 To compare the proliferative responses to re-stimulation in vitro, CFSE-labeled 
splenocytes from LCMV- and VACV-GP-immune mice were stimulated with GP33-41 
peptide in a 96-well plate for 4-6 days.  The frequency of Ly5.1 P14 memory CD8 T cells 
was higher in the LCMV-immune host than in the VACV-GP-immune host.  Therefore, 
using the frequency determined for each mouse prior to CFSE-labeling, the P14 memory 
CD8 T cells were plated in equal numbers along with supplementary naïve splenocytes to 
make up equal total number of cells in each well.  After peptide stimulation, P14 memory 
CD8 T cells from both LCMV- and VACV-GP-immune mice proliferated, and the 
frequencies of CFSE-diluted P14 memory CD8 T cells in both immune groups were 
above 80% by day 6 of in vitro stimulation (Fig. 7.3a). 
Upon re-stimulation, memory cells produce granzyme in vesicles in preparation 
for target cell killing.  The accumulation of lytic granules in memory CD8 T cells was 
evaluated along with the in vitro proliferation experiment.  Peptide stimulation caused 
similar proportions of P14 memory CD8 T cells from the LCMV- and the VACV-GP-
immune mice to produce granzyme B after 4 days (Fig. 7.3b).  At day 6 post stimulation, 
over 80% of P14 memory CD8 T cells in both groups have accumulated granzyme B. 
In contrast to the different marker phenotypes and cytokine profiles, P14 memory 
CD8 T cells from LCMV- and VACV-GP-immune hosts responded to re-stimulation 
with similar levels of proliferation and granzyme B accumulation in vitro.   
  
143
(a) 
      
 
(b) 
      
 
Figure 7.3.  P14 memory CD8 T cells from LCMV- and VACV-GP-immune mice 
proliferate and accumulate granzyme B upon in vitro stimulation.  C57BL/6 mice the 
received Ly5.1 P14 splenocytes were infected i.p. with 5x104 pfu LCMV or 5x106 pfu 
recombinant VACV-GP.  Splenocytes harvested at day 85 (week 12) post infection were 
CFSE-labeled and stimulated with GP33-41 peptide for 4-6 days.  The numbers of Ly5.1 
P14 memory CD8 T cells were equalized for each well using supplementary naïve 
splenocytes.  Cells were analyzed for (a) proliferation and (b) granzyme B accumulation.  
Data are representative of two separate experiments. 
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Greater number of potentially cross-reactive memory CD8 T cells in LCMV-immune 
mice 
The magnitude of a T cell response is influenced by the precursor frequency, and 
the proliferative response may determine the outcome of infections.  If cross-reactive 
memory CD8 T cells mediate heterologous immunoprotection between LCMV and 
VACV, the number of potentially cross-reactive memory CD8 T cells in the immune 
mice may be critical.  On average, there were about 1.2x104 A11R198-205-specific memory 
CD8 T cells in a VACV-immune mouse per spleen (Table 7.1).  The virus-specific 
memory CD8 T cell frequency was generally higher in the LCMV-immune mice.  
Combining the memory CD8 T cell populations that recognize the three cross-reactive 
epitopes GP34-41, GP118-125 and NP205-212, there are approximately 1.2x105 potentially 
cross-reactive CD8 T cells per LCMV-immune spleen.  However, due to the phenomenon 
of private specificity, only a fraction of these cells may actually cross-react and respond 
during heterologous infection.  Nevertheless, there are still 10 times more memory CD8 
T cells that may potentially cross-react with VACV in the LCMV-immune mice.  The 
lower number of potentially cross-reactive memory CD8 T cells may be one of the 
reasons why a history of VACV infection is not protective during subsequent LCMV 
infection. 
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Table 7.1.  LCMV-immune mice possess a greater number and frequency of 
memory CD8 T cells that are specific for the cross-reactive epitopes between LCMV 
and VACV.  C57BL/6 mice were inoculated with 5x104 pfu LCMV Armstrong or 106 
pfu VACV.  The frequency of epitope-specific memory CD8 T cells were determined in 
the spleen of the immune mice after at least 8 weeks post infection by ICS. 
 
 VACV-immune LCMV-immune 
Specificity: A11R198-205 GP34-41 GP118-125 NP205-212 
 17795 (0.09%) 147362 (1.0%) 22956 (0.15%) 30442 (0.20%) 
 20258 (0.16%) 45323 (0.49%) 10277 (0.11%) 14194 (0.15%) 
 5164 (0.06%) 50350 (0.5%) 25229 (0.26%) 35223 (0.35%) 
 8019 (0.09%) 30518 (0.77%) 16436 (0.41%) 5712 (0.14%) 
 8199 (0.09%) 93536 (1.2%) 38985 (0.50%) 22293 (0.29%) 
Average: 11887 (0.1%) 73418 (0.8%) 22776 (0.3%) 21573 (0.2%) 
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DC(A11R)-immunization boosts A11R-specific memory and confers heterologous 
immunoprotection 
 To examine whether the number of potentially cross-reactive memory CD8 T 
cells is critical for protection during heterologous infection between LCMV and VACV, I 
attempted to increase the number of A11R198-205-specific memory CD8 T cells in a 
VACV-immune mice by DC-immunization and tested whether the higher number of 
cross-reactive memory CD8 T cells may confer protection against LCMV.  Immortalized 
DC2.4 cells were pulsed with A11R198-205 peptide, irradiated, and administered 
subcutaneously (s.c.).  Seven days later, pulsed DC-immunized and mock-immunized 
(HBSS-injected) mice were infected i.p. with 106 pfu VACV.  After 6 weeks, mice were 
screened for A11R198-205-specific memory CD8 T cell frequency in the blood.  Peptide-
pulsed DC-priming greatly increased the frequency of A11R198-205-specific memory CD8 
T cells in the VACV-immune mice (Fig. 7.4a).  The frequency of A11R198-205-specific 
memory CD8 T cells in VACV-immune mice was less than 0.1%, and DC-immunization 
without VACV infection did not generate appreciable A11R198-205-specific memory CD8 
T cells.   
Immune mice were subsequently challenged i.p. with 5x104 pfu LCMV 
Armstrong.  Viral titer and virus-specific T cell response were evaluated at 6 days post 
LCMV infection.  Protection was determined for each experiment separately.  Mice were 
considered protected when their LCMV titers in the spleen at day 6 post infection were 
lower than three times the standard deviation below, and at least half a log below, the 
geometric mean LCMV titer in the VACV-immune control group.  In the DC-immunized 
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VACV-immune group, some of the mice were protected and had lower LCMV titers at 
day 6 post infection (Fig. 7.4b).  
Among the DC-immunized VACV-immune mice that achieved a higher A11R198-
205-specific memory CD8 T cell frequency, only some of them reduced LCMV titer after 
challenge (Fig. 7.4c).  The elevated A11R198-205-specific memory CD8 T cell frequency 
seemed to contribute to the protection against LCMV infection because none of the 
VACV-immune mice, whose A11R198-205-specific memory CD8 T cell frequency was 
low, reduced LCMV titer.  However, a high pre-bleed frequency did not guarantee 
immunoprotection from LCMV challenge.  The phenomenon of private specificity 
probably plays an important role in governing which immune T cell population can 
respond to the cross-reactive LCMV epitopes and protect against heterologous LCMV 
infection.   
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Figure 7.4.  
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(c) 
        
 
Figure 7.4.  Immunization with irradiated A11R198-205-pulsed DC2.4 greatly 
increases the frequency of A11R198-205-specific CD8 T cells in VACV-immune mice 
and correlates with protection of some mice during heterologous LCMV challenge.  
C57BL/6 mice were immunized s.c. with A11R198-205-pulsed irradiated DC2.4 and 
infected i.p. with 106 pfu VACV after 7 days.  (a) At week 6 post VACV infection, the 
frequency of A11R198-205-specific memory CD8 T cells was measured in blood by ICS 
before i.p. challenge with 5x104 pfu LCMV Armstrong.  (b) LCMV titer was determined 
in the spleen at day 6 post heterologous challenge.  Mice with LCMV titers lower than 
three times the standard deviation below, and at least half a log below, the geometric 
mean LCMV titer in the VACV-immune control group were considered protected.  (c) 
Combined data from four similar experiments comparing LCMV titer at day 6 post 
infection to frequency of A11R198-205-specific memory CD8 T cells in blood prior to 
LCMV challenge suggested that high pre-bleed A11R198-205-specific CD8 T cell 
frequency could not guarantee immunoprotection during heterologous LCMV challenge. 
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Virus-specific CD8 T cell response correlates with protection against LCMV 
 The frequency and number of cross-reactive T cells may change when the T cells 
respond to a subsequent heterologous infection.  Comparing the A11R198-205-specific 
memory CD8 T cell frequency after background subtraction (net frequency) at day 6 post 
LCMV challenge between mice that were protected during LCMV infection and those 
that were not within the DC-immunized VACV-immune group, a threshold of 0.59% of 
CD8 T cells was found to correlate with protection against LCMV infection (Fig. 7.5a).  
The segregation was more obvious when all mice regardless of their history of infection 
were included in the analysis (Fig. 7.5b).  The animals that were protected during LCMV 
infection tend to have 0.59% or higher frequency of CD8 T cells that were A11R198-205-
specific at day 6 post LCMV infection. 
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(a)                  DC-immunized VACV-immune mice 
         
 
 
(b)                                          All groups 
       
 
Figure 7.5.  A11R198-205-specific CD8 T cell frequency of at least 0.59% at day 6 post 
LCMV infection correlates with protection.  DC-immunized VACV-immune mice and 
controls were infected i.p. with 5x104 pfu LCMV.  LCMV viral titer in the spleen and 
A11R198-205-specific CD8 T cell frequency were evaluated at 6 days post LCMV 
infection.  Mice with LCMV titers lower than three times the standard deviation below, 
and at least half a log below, the geometric mean LCMV titer in the VACV-immune 
control group were considered protected.  Net A11R198-205-specific CD8 T cell frequency 
in the spleen between the protected and the unprotected animals in (a) DC-immunized 
VACV-immune group (p = 0.0272) and (b) all groups (p = 0.0107) were analyzed by 
Fisher’s exact test.  Dotted lines in each graph marked the 0.59% threshold frequency. 
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The relative proportional response to the major LCMV-specific epitopes was 
calculated from the CD8 T cell responses to GP34-41, GP118-125, NP205-212, NP396-404 and 
GP276-286 at day 6 post LCMV infection.  DC-immunized VACV-immune mice that were 
protected during LCMV infection mounted a significantly higher proportional response to 
NP396-404 than the VACV-immune control mice did (Fig. 7.6a), and they displayed a 
significantly lower proportional response to NP205-212 and GP118-125 (Fig. 7.6b), while the 
proportional responses to GP34-41 and GP276-286 were not significantly different between 
groups (Fig. 7.6c).  In this regard, the response of the DC-immunized VACV-immune 
mice that were not protected during LCMV infection resembled that of the VACV-
immune mice, which were similarly not protected during LCMV infection.  Higher viral 
loads may have caused exhaustion of the NP396-404-specific CD8 T cells, and in these 
experiments some mice would produce less TNF and mount a lower CD8 T cell response 
than others.  However, the occurrence of partial exhaustion was rare, and was not 
particularly associated with the group of mice that were not protected during LCMV 
infection.  On the other hand, the adoptively transferred NP396-404-specific CD8 T cell line 
has been shown to be the most effective, in comparison to the GP276-286- and GP33-41-
specific CD8 T cell lines, in clearing LCMV infection in mice (Gallimore et al., 1998), 
consistent with the observation here that the higher NP396-404-specific proportional 
response correlated with better protection.   
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Figure 7.6.   
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(c) 
          
 
Figure 7.6.  Proportional responses to LCMV-specific epitopes show significant 
difference between DC-immunized VACV-immune and VACV-immune mice.  DC-
immunized VACV-immune mice were infected i.p. with 5x104 pfu LCMV.  Proportional 
responses to LCMV epitopes were calculated from CD8 T cells responding to GP34-41, 
GP118-125, NP205-212, NP396-404 and GP276-286 at day 6 post LCMV infection.  DC-
immunized VACV-immune mice protected from LCMV infection displayed a 
significantly higher proportional response to NP396-404 (a) but lower proportional 
responses to NP205-212 and GP118-125 (b).  Proportional responses to GP34-41 and GP276-286 
were not significantly different between groups (c).  (*) denotes statistical significance (p 
< 0.05) between groups.   
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Discussion 
Heterologous immunity, the immunity that can be developed to one pathogen 
after a host had been exposed to a different unrelated pathogen, is not necessarily 
reciprocal.  A history of LCMV infection protects mice during VACV infection but a 
history of VACV infection does not protect against LCMV.  Cross-reactive CD8 T cells 
from LCMV-immune mice have been shown to mediate heterologous protection against 
VACV (Cornberg et al., 2010).  By increasing the number of A11R198-205-specific 
memory CD8 T cells, here I showed that the number of cross-reactive CD8 T cells can 
influence the outcome of heterologous infection, implying that the low frequency of 
A11R198-205-specific memory CD8 T cells in VACV-immune mice may be part of the 
reason why a history of VACV infection does not protect against LCMV infection. 
The memory CD8 T cells generated from LCMV and VACV infections were 
phenotypically different, but the phenotypic differences failed to explain the non-
reciprocity of heterologous immunoprotection.  The phenotype of the VACV B8R20-27-
specific memory CD8 T cells from VACV-GP- and WT VACV-immune mice were 
similar, with comparable frequencies of multiple cytokine-producing cells and similar 
composition of cells of different recall potential phenotypes by their CD27 and CD43 
expressions (data not shown).  Therefore, the phenotypes of the memory CD8 T cells 
generated from LCMV- and VACV-GP-infected mice were compared using adoptively 
transferred P14 CD8 T cells with a congenic marker so that the memory generated in the 
same pool of cells in two different infection environments might be compared.  The 
observation that LCMV infection generated more memory CD8 T cells that produce 
156
multiple cytokines in the same cells may explain why LCMV-specific CD8 T cells are 
efficient in eliminating VACV-infected targets.  However, the memory CD8 T cells 
generated by VACV-GP infection displayed a phenotype of higher recall potential 
(CD27hi CD43lo) and little proliferative incapacity (KLRG1lo), suggesting their 
readiness to respond to subsequent infections, and contradicting their inability to reduce 
LCMV viral titer.  Further experiments showed that the memory CD8 T cells from both 
LCMV- and VACV-GP-immune hosts could proliferate and produce granzyme B upon in 
vitro re-stimulation, ultimately arguing against any relationship between the phenotypic 
differences in the memory CD8 T cells generated from the two infections and the non-
reciprocity of heterologous immunoprotection between LCMV and VACV. 
Cross-reactive LCMV-specific memory CD8 T cells can respond to subsequent 
heterologous VACV infection, and so can cross-reactive VACV-specific memory CD8 T 
cells to LCMV infection.  It has been shown that the cross-reactive T cells from LCMV-
immune mice can proliferate during acute VACV infection (Kim et al., 2005), but LCMV 
only minimally elicits proliferation of VACV-specific memory T cells at day 6 post 
infection (Kim et al., 2002).  The low frequency of the cross-reactive memory CD8 T 
cells in the VACV-immune mice probably made the detection of their proliferation 
difficult.  However, a more specific focus on the A11R198-205-specific CD8 T cells 
revealed their proliferative response upon LCMV infection.  When CFSE-labeled whole 
splenocytes from VACV-immune mice were adoptively transferred into naïve congenic 
hosts, which were subsequently infected with LCMV, only 0.5% of the donor splenocytes 
were found to be A11R198-205-specific by ICS at day 6 post LCMV infection, but all of the 
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A11R198-205-specific CD8 T cells were CFSE low (data not shown), suggesting that the 
A11R198-205-specific memory CD8 T cells had proliferated during LCMV infection.  
Moreover, the expanded cross-reactive T cells can be detected when T cells return to 
homeostasis.  In VACV-LCMV double immune mice, the number of cross-reactive 
A11R198-205-specific memory CD8 T cells at 9 weeks post LCMV infection was on 
average 10 times higher than the number in VACV-immune mice (Fig. 4.7 in Chapter 
IV).  If antigens from both LCMV and VACV can activate the cross-reactive memory T 
cells and cause them to proliferate upon heterologous infection, the cross-reactive 
memory T cells should theoretically be protective regardless of the sequence of 
infections.  However, the number of cross-reactive memory CD8 T cells may be much 
lower in the VACV-immune mice than in the LCMV-immune mice.  The limited number 
of proliferated cross-reactive memory CD8 T cells may not make any difference in 
protecting VACV-immune mice during LCMV infection, since LCMV infection can by 
default elicit a strong CD8 T cell response in naïve mice.   
In this study, I show that the number of cross-reactive memory CD8 T cells can 
influence the outcome of heterologous infection.  A11R198-205-pulsed DC-immunization 
greatly increased the frequency of A11R198-205-specific CD8 T cells in VACV-immune 
mice.  Although the frequency of A11R198-205-specific CD8 T cells before LCMV 
challenge did not predict or correlate with protection, the net frequency (after background 
subtraction) of A11R198-205-specific CD8 T cells at day 6 post LCMV infection did.  This 
is consistent with the phenomenon of private specificity, where not every T cell 
population recognizing a cross-reactive epitope in one virus will react with the cross-
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reactive epitope in the cross-reactive virus.  Therefore, a high frequency of A11R198-205-
specific memory CD8 T cells before LCMV challenge may not predict protection.  It has 
been shown that a certain number of T cells are required to eliminate the infected targets 
and control viral spread.  Calculation from a previous study suggested that 104 LCMV-
specific effector CD8 T cells could reduce virus titer by 1.5 log and 105 cells could 
eliminate the virus in the first 20 hrs post inoculation (Ehl et al., 1997).  Either the pre-
existing virus-specific memory T cells or their progeny can meet the required T cell 
number early during infection.  Factoring in the probability of private response and the 
different avidity of interaction between the infected targets and the A11R198-205-specific 
memory CD8 T cells, the cutoff at 0.59% CD8 T cells of A11R198-205-specificity that 
correlated with LCMV titer reduction falls within the range of that previous calculation.  
Although this cutoff frequency does not have any predictive value, it shows that the 
protection by a relatively higher frequency of A11R198-205-specific memory CD8 T cells 
at day 6 post LCMV infection is not a random event.  Therefore, both private specificity 
and the number of cross-reactive memory CD8 T cells determine the outcome of 
heterologous infection between LCMV and VACV. 
Further analysis revealed that the higher proportional response to NP396-404 at day 
6 post LCMV infection correlated with better protection.  Although NP396-404 is not as 
cross-reactive as NP205-212, GP34-41 or GP118-125 in LCMV-immune mice after VACV 
challenge (Kim et al., 2005), NP396-404-specific memory CD8 T cell frequency is often 
higher in the LCMV-VACV and VACV-LCMV double immune mice than in the LCMV-
immune mice (Fig. 4.9 in Chapter IV and data not shown).  Since the adoptively 
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transferred NP396-404-specific CD8 T cell line is the most sensitive to its cognate antigen 
and the most effective in lysing target cells in vitro and clearing LCMV infection in vivo 
(Gallimore et al., 1998), it is conceivable that the higher proportional response to NP396-
404 would correlate with better protection against LCMV infection.  The A11R198-205-
specific memory CD8 T cells may have cross-reacted with and caused a relatively higher 
proportional response to NP396-404, NP205-212, GP34-41 or GP118-125 according to the private 
specificity of the memory CD8 T cell repertoire, but the mice attaining a higher 
proportional response to NP396-404 were relatively more protected.   
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Chapter VIII. Discussion 
In this thesis, I studied the generation and stability of CD8 T cells in the context 
of viral infections and investigated the influence of the history of infections in subsequent 
heterologous infections.  I found that the immunoproteasomes were important in 
determining the magnitude and diversity of CD8 T cell response and memory.  Besides 
the presence of cross-reactive memory T cells, changes in the endopeptidase activities of 
the immunoproteasomes can also alter the immunodominance hierarchy of CD8 T cell 
response.  Memory CD8 T cells were previously shown to be reduced after heterologous 
infections.  In this study, I re-examined the phenomenon, and additionally I showed that 
memory CD44hi CD4 T cells were also reduced by heterologous infections.  In contrast 
to the susceptibility of memory CD44hi CD8 and CD44hi CD4 T cells to apoptosis and 
attrition, I found that Treg cells were more resistant to virus infection-induced apoptosis, 
and were more stable in number than CD44hi CD8 and CD44hi CD4 T cells early during 
LCMV infection. 
The memory developed to one pathogen can influence the immune response to 
subsequent infections with unrelated pathogens and deviate the disease course and 
outcome.  In this thesis, I examined the phenomenon of heterologous immunity in 
persistent MCMV infection, and found that LCMV-immune mice showed more severe 
immunopathology in the visceral fat pads early during MCMV infection, elevated viral 
titers, and fewer MCMV-specific inflationary memory CD8 T cells at 12 weeks post 
infection.  Previously it has been established that the immunoprotection between LCMV 
and VACV is not reciprocal.  As I studied the reasons behind this non-reciprocity of 
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heterologous immunity, I found that memory CD8 T cells generated from LCMV and 
VACV (VACV-GP) infections were phenotypically different, but the differences did not 
explain the non-reciprocity of the immunoprotection between LCMV and VACV.  
However, by increasing the cross-reactive A11R198-205-specific memory CD8 T cells, 
more VACV-immune mice showed reduced titers on day 6 post LCMV challenge, and I 
found that protection correlated with higher net frequency of A11R198-205-specific CD8 T 
cells and proportional response to NP396-404 on day 6 post LCMV infection. 
 
Shaping the CD8 T cell response and memory generation 
 Both the CD8 T cell response and memory CD8 T cell generation can be shaped 
by the immunoproteasomes.  During infections, T cells “see” the pathogens through 
antigen presentation by MHC molecules.  Both the T cell repertoire and the peptides 
presented can determine the magnitude and breadth of the T cell response.  
Immunoproteasomes are instrumental in generating peptides for presentation on MHC 
class I molecules, and their expression in the medullary thymic epithelial cells (Nil et al., 
2004) also implies their role in T cell selection.  In Chapter III, I showed that mice 
genetically lacking all three immunoproteasome subunits were greatly impaired in their 
response to LCMV infection.  The overall defect was much more severe than the sum of 
all defects previously reported in the singly deficient mice (Basler et al., 2006; Nussbaum 
et al., 2005).  Antigen presentation in the triple KO mice was not as effective as the WT 
mice in activating the responding CD8 T cells, resulting in a lower percentage of 
activated CD8 T cells and thus a reduced response.  Further analysis revealed a 
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differential impact of the deficiency of immunoproteasomes on different LCMV epitopes.  
GP33-41 and GP34-41 can probably be processed by both constitutive proteasomes and the 
immunoproteasomes and hence the GP33-41- and GP34-41-specific responses were reduced, 
but existent in the triple KO mice.  However, GP118-125 is completely dependent on the 
immunoproteasome for processing, and therefore the triple KO mice could not trigger 
any T cell response to GP118-125.  On the other hand, the reduced CD8 T cell responses to 
NP205-212 and GP276-286 were probably a combined result of the altered T cell repertoire 
and reduced presentation, while the T cell repertoire may have played a larger role in the 
response to GP92-101, since the WT adoptively transferred T cells responded to GP92-101 
similarly in the WT hosts and the triple KO hosts.  As a result, the immunodominance 
hierarchy is different in the triple KO and WT mice.  The hierarchy of memory CD8 T 
cells largely reflected the acute CD8 T cell response to LCMV.  Therefore, both the acute 
CD8 T cell response and memory generation were altered in the triple KO mice.  The 
presentation by non-hematopoietic cells participates in the clonal expansion of CD8 T 
cells during LCMV infection (Thomas et al., 2007), and therefore both constitutive 
proteasome and immunoproteasome subunits may influence the generation of CD8 T cell 
response and memory.  MCMV has been shown to be dependent on the 
immunoproteasome for peptide processing, and the day 7 responses to M45985–993, 
m14116–23, m139419–426 and M38316-323 are greatly diminished in the LMP7 KO mice 
(Hutchinson et al., 2011).  I suspect that the triple KO may have a more deleterious effect 
on the acute response to MCMV infection. 
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 Besides intrinsic factors like the T cell repertoire and antigen presentation, the 
history of infections may influence the immunodominance hierarchy of the T cell 
response.  Pre-existing cross-reactive memory T cells expanding upon infections with the 
cross-reactive heterologous viruses can greatly shift the immunodominance hierarchy.  It 
has been shown that the cross-reactive NP205-212-specific CD8 T cells would dominate the 
T cell response to LCMV in PV-immune mice (Brehm et al., 2002).  In this study, I 
identified a novel potentially cross-reactive epitope pair between LCMV and MCMV.  
Approximately one in every five MCMV-immune mice responded exceedingly well to 
the otherwise subdominant LCMV epitope L2062-2069, and shifted the immunodominance 
hierarchy with about 50% of the responding T cells being L2062-2069-specific.  A BLAST® 
search against the MCMV protein sequence identified M57727-734, which can stimulate a 
large percentage of CD8 T cells from mice mounting a dominant response to LCMV 
L2062-2069.  LCMV L2062-2069 and MCMV M57727-734 share 50% sequence homology, and 
the rest of the sequences are biochemically similar, suggesting the same TCR might have 
recognized the two peptides through molecular mimicry (Hagerty & Allen, 1995; Welsh 
& Selin, 2002).  M57727-734 was not identified in the published epitope screen (Munks et 
al., 2006b).  I found in a preliminary experiment that both acutely MCMV-infected and 
long-term MCMV-immune mice responded to M57727-734 at a very low frequency of 
around 0.2% or less CD8 T cells.  This is similar to the low frequency response of 
VACV-infected mice to VACV A11R198-205, which was also found by cross-reactivity to 
LCMV but did not come up in the epitope prediction screen (Kim et al., 2005; Moutaftsi 
et al., 2006). 
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Trimming the pre-existing memory populations by heterologous infections 
Memory CD8 T cells are normally maintained in the periphery as a stable 
population by cytokines such IL-7 and IL-15 (Schluns et al., 2000; Selin et al., 1996; Tan 
et al., 2002).   Myeloid cells can also enhance CD8 T cell survival through co-stimulatory 
molecule CD70 signaling to CD27 on the CD8 T cells (Frasca et al., 2010).  However, 
this stability of CD8 T cell populations can be perturbed in some situations.  
Heterologous viral infections can cause reduction of pre-existing memory CD8 T cells 
(Kim & Welsh, 2004; Liu et al., 2003; Selin et al., 1996; 1999).  In Chapter IV, I re-
examined the phenomenon in the resting epitope-specific memory CD8 T cells by ICS in 
infection sequences LCMV-MCMV, VACV-LCMV, VACV-LCMV-MCMV, VACV-
MCMV, LCMV-VACV.  Consistent with published data, I found that LCMV GP33-41-, 
NP396-404-, GP276-286-, GP118-125- and NP205-212-specific memory CD8 T cells were 
significantly reduced after MCMV infection.  Pre-existing VACV B8R20-27- and E7R130-
137-specific memory CD8 T cells were also significantly reduced after LCMV infection.  
The reduced B8R20-27-specific population by LCMV infection could be further reduced 
by subsequent MCMV infection.  Although memory CD4 T cells spontaneously decline 
over time (Homann et al., 2001), I showed that they can also be further reduced by 
heterologous infections.  In this study, I showed that LCMV GP61-80- and NP309-328-
specfic memory CD4 T cells were reduced after MCMV infection, and also after VACV 
infection.  Therefore, heterologous infections can reduce the number of both CD8 and 
CD4 memory T cells. 
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I found that persistent MCMV infection did not further erode pre-existing 
memory populations.  The influence of persistent infection on T cell memory may vary 
depending on the nature of the infections.  Chronic Leishmania donovani infection can 
promote the accumulation of CD8 T cells of central memory phenotype (Polley et al., 
2005), while chronic BCG and Salmonella typhimurium infections reduce pre-existing 
memory CD8 and CD4 T cells (Dudani et al., 2008; Smith et al., 2002).  Persistent 
LCMV clone 13 infection has been shown to cause continuous attrition of pre-existing 
CD8 T cell memory even at 3 weeks post infection (Kim & Welsh, 2004); however, no 
continuous erosion of pre-existing memory was found in this study with an MCMV 
infection.  It is possible that the cytokine environment in the MCMV-infected mice is 
more supportive for homeostatic survival of memory T cells while a low level of type I 
IFN in the LCMV clone 13-infected mice (Lee et al., 2009) may promote apoptosis of 
memory T cells.  Type I IFN is associated with early attrition of memory CD8 T cells 
(McNally et al., 2001), and is also the third signal for clonal expansion of CD8 T cells 
especially after LCMV infection (Aichele et al., 2006; Curtsinger et al., 2005).  The early 
memory attrition caused by type I IFN may make room for subsequent clonal expansion 
of the responding T cells and prevent pre-existing cross-reactive memory CD8 T cells 
from dominating a T cell response (Bahl et al., 2006).  The re-activation of MCMV genes 
can stimulate MCMV-specific memory inflation, but it probably does not elicit strong 
enough cytokine signals to reduce the pre-existing memory. 
 Heterologous infections can increase the number of cross-reactive memory T 
cells.  Cross-reactive NP205-212-specific memory CD8 T cells has been shown to increase 
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in LCMV-PV and PV-LCMV infection sequences (Brehm et al., 2002).  Proliferation of 
cross-reactive LCMV GP33-41/GP34-41-, GP118-125-, NP205-212, NP396-404-, GP276-286-specific 
CD8 T cells has been shown in LCMV-immune mice after VACV infection (Kim et al., 
2002; 2005).  However, the cross-reactive VACV A11R198-205-specific memory CD8 T 
cells persist at a very low frequency in VACV-immune mice, and therefore their 
proliferation during LCMV infection is very difficult to detect amidst the vigorous 
LCMV-specific T cell response.  In Chapter IV of this thesis, I showed the expansion of 
A11R198-205-specific memory CD8 T cell population in VACV-LCMV double immune 
mice when T cells returned to homeostasis.  The proliferation of cross-reactive A11R198-
205-specific memory CD8 T cells was virus-specific because subsequent infection with 
MCMV, which does not cross-react with VACV, did not increase the A11R198-205-
specific memory CD8 T cells, but actually reduced the population.  Because of the 
private specificity of T cell repertoires, the expansion of the A11R198-205-specific memory 
CD8 T cells varied among the same group of mice with the same transgenic background.  
A similar phenomenon of private specificity was observed with the memory CD8 T cells 
specific for the novel potentially cross-reactive pair of epitopes identified between 
LCVM and MCMV.  After LCMV infection, the frequency and number of MCMV 
M57727-734-specific memory CD8 T cells was greatly increased in some MCMV-immune 
mice. 
In Chapter IV, I showed that memory CD4 T cells were reduced by heterologous 
infections.  In Chapter V, I also showed that early after LCMV infection, CD44hi CD4 T 
cells were significantly reduced in number and became more apoptotic than their 
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uninfected counterparts, similar to CD44hi CD8 T cells previously reported (Bahl et al., 
2010).  The reduction of memory CD8 T cells during viral infection is thought to be the 
result of apoptosis early during infection, in association with the peak of type I IFN at 
day 2 post infection (McNally et al., 2001).  Similar to memory CD44hi CD8 T cells, 
CD44hi CD4 T cells also undergo apoptosis after treatment with type I IFN inducer 
poly(I:C) (Bahl et al., 2010).  In parallel comparison with CD44hi CD8 T cells, the 
reduction of virus-specific memory CD4 T cells shown could also be the result of 
apoptosis and attrition of CD44hi CD4 T cells early during infection.  A longitudinal 
study of epitope-specific memory CD4 T cells following a heterologous infection will be 
needed to confirm this. 
 
Resistance of Treg cells to virus infection-induced apoptosis 
In contrast, although Foxp3+ CD4+ Treg cells exhibit a partial memory 
phenotype with an intermediate to high expression of CD44 (Min et al., 2007), I found 
that Treg cells are more resistant to early apoptosis than CD44hi memory CD8 and CD4 
T cells, and were not significantly reduced after LCMV infection.  Infections have been 
implicated as a potential trigger of autoimmune diseases (Huber, 2006; Sherbet, 2009; 
Van Der Werf et al., 2007; Zipris et al., 2003) but the underlying mechanism is still 
unknown.  Transient reduction of Treg cell numbers can lead to the development of 
autoimmunity (Setoguchi et al., 2005), leading us to suspect the role of infections in 
reducing the memory-like Treg cells and contributing to autoimmunity.  However, the 
results in this study indicated that the Treg cells were more resistant to virus infection-
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induced apoptosis, and the survival of Foxp3+ CD4+ Treg cells was not compromised 
early during infection.  Studies have shown that Treg cells are able to survive insults from 
gamma-irradiation or topoisomerase inhibitors (Qu et al., 2010; Winzler et al., 2011), and 
Treg cells are resistant to activation-induced cell death (Banz et al., 2002; Fritzsching et 
al., 2005).  Although the mechanism is not known, the survival of Treg cells seems to be 
regulated very differently from conventional CD4 T cells.  Further studies will be needed 
to identify the differences in the cell death signaling pathways that will correlate with the 
susceptibility of memory CD44hi CD8 and CD4 T cells and the relative resistance of 
Treg cells to virus infection-induced apoptosis observed in this work.  Nonetheless, the 
resistance of Treg cells to apoptosis during infection may explain the low incidence of 
autoimmunity among infected patients.  Although self-reactive antibodies can be 
generated during infections (Berlin et al., 2007; Sane et al., 2012; Sjöwall et al., 2012), 
most patients survive viral infections without autoimmune consequences.   
Treg cells are worth maintaining, even apart from the concern for autoimmunity 
development, because they play a critical role of regulating effector T cells, NK cells, 
neutrophils, monocytes, and macrophages early during viral infections (Bedoya et al., 
2013; Fulton et al., 2010; Lund et al., 2008; Veiga-Parga et al., 2012).  The presence of 
virus-specific memory Treg cells can preserve lung function by limiting CD8 T cell 
response and reducing pathology during homologous influenza re-challenge (Brincks et 
al., 2013).  However, in heterologous infections, the nature of their persistence may also 
pose a problem, as demonstrated in the influenza-immune mice during intranasal LCMV 
challenge, where the higher number of Treg cells contribute to more severe 
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immunopathology in the immune mice by preventing exhaustion of responding CD8 T 
cells and supporting migration of CD8 T cells into the lungs (Kraft et al., 2013). 
I found that Treg cells continue to express functional high-affinity IL-2 receptors 
on the cell surface and speculated that might provide a survival advantage to Treg cells 
during viral infections.  Upon LCMV infection, the already low expression of CD127 
was further reduced on Foxp3+ CD4+ Treg cells but the expression of CD25, CD122 and 
CD132 was either increased or unchanged.  The IL-2 receptors were also functional, and 
IL-2 stimulation in vitro could instantly phosphorylate STAT5 in the Treg cells.  It has 
been shown that the maintenance of Treg cells in the periphery depends on IL-2 secreted 
by other cells (Setoguchi et al., 2005).  The continuous expression of high-affinity IL-2 
receptors on the cell surface might enable Treg cells to compete for IL-2 in the 
environment with other activated T cells during infections and ensure the survival of Treg 
cells.  
 
Influencing the disease outcome by the history of infections 
Previous studies have shown that prior infections with LCMV, MCMV, PV, BCG 
or influenza A virus can provide certain levels of heterologous protection during VACV 
infection, but the history of influenza infection impedes the clearance of LCMV and 
MCMV infections (Chen et al., 2003; Mathurin et al., 2009; Selin et al., 1998).  In 
Chapter VI, I showed that the history of LCMV infection had long-term effects on 
MCMV persistent infection.  MCMV titers were higher in multiple organs in the LCMV-
immune mice than in the BHK sham control mice.  However, fewer inflationary memory 
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CD8 T cells were found at 12 weeks post infection.  The higher viral titers and fewer 
inflationary memory T cells contradict the general understanding that higher viral load 
would enhance memory inflation.  As memory inflation depends on the processing by the 
constitutive proteasomes and presentation by MHC class I molecules on non-
hematopoietic cells (Hutchinson et al., 2011; Seckert et al., 2011; Torti et al., 2011a), 
future studies will have to determine what remote effects LCMV might have, after the 
infection has long been cleared, on the proteasomes and/or the non-hematopoietic cells 
that affect only the establishment of the inflationary memory T cells but not of the non-
inflationary memory T cells.  One previous study suggests that the infected non-
hematopoietic cells responsible for stimulating inflationary memory T cells reside in the 
lymph nodes, where MCMV does not persist (Torti et al., 2011a).  It may be possible that 
these cells become less susceptible to infection by MCMV in the LCMV-immune mice, 
and hence are less active in promoting memory inflation.  Identifying the cell type 
responsible for memory inflation may be an important next step to solving this mystery.  I 
found that the history of LCMV infection also caused more severe immunopathology in 
the fat pads early during MCMV infection.  Enhanced or altered lung immunopathology 
has been demonstrated in VACV-infected LCMV-immune mice and LCMV- or MCMV-
infected influenza-immune mice, and is found associated with the infiltration of CD8 T 
cells and macrophages (Chen et al., 2001a; 2003).  In preliminary analysis of the 
MCMV-infected mice, I found increased presence of macrophages, CD8 T cells and 
NK1.1+ cells in the fat pads of LCMV-immune mice, but their association with necrosis 
and tissue damage after MCMV infection is yet to be confirmed with more experiments. 
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My study with the LCMV-infected DC-immunized VACV-immune mice 
suggested a link between the number of cross-reactive CD8 T cells and the 
immunoprotection during heterologous infections.  It has been shown that VACV 
clearance is more efficient in the LCMV-immune mice; however, VACV-immune mice 
were not protected during LCMV infection (Selin et al., 1998).  Cross-reactive CD8 T 
cells from LCMV-immune mice have been shown to mediate heterologous 
immunoprotection against VACV (Cornberg et al., 2010).  The CD8 T cell response is 
important in the control of LCMV infection.  Therefore, we hypothesized that the 
difference in the CD8 T cell populations might explain the non-reciprocity of 
heterologous protection between LCMV and VACV.  In Chapter VII, I showed that the 
memory CD8 T cells generated from LCMV and VACV (VACV-GP) infections were 
phenotypically different, but they both proliferated and produced granzyme B upon in 
vitro peptide stimulation.  The memory phenotype analysis also suggested that the 
memory CD8 T cells from VACV-immune mice should be capable of rapid proliferative 
recall response.  Since the number of known potentially cross-reactive CD8 T cells is ten 
times less in the VACV-immune mice, I tested whether increasing the cross-reactive 
memory CD8 T cells in the VACV-immune mice might protect the mice during LCMV 
infection.  DC-immunization successfully increased the frequency of the cross-reactive 
A11R198-205-specific CD8 T cells in VACV-immune mice, some of which were able to 
reduce the LCMV titers.  However, the frequency of A11R198-205-specific CD8 T cells in 
blood before LCMV challenge did not predict protection.  The private specificity of T 
cell repertoire likely dictates the probability of recognizing a cross-reactive epitope.  A 
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previous study has found a more stringent requirement on the peptide sequences 
recognized by the A11R198-205-specific CD8 T cell lines generated from VACV-immune 
mice compared to those recognized by the GP34-41-specific CD8 T cell lines generated 
from LCMV-immune mice, suggesting that the differences in the TCR repertoire may 
explain the reduced likelihood of the A11R198-205-specific CD8 T cell lines cross-reacting 
with LCMV GP34-41 peptide (Shen et al., 2013).  Although the possibility of the A11R198-
205-specific CD8 T cell lines responding to the other potentially cross-reactive LCMV 
epitopes were not shown in that study, it is still arguable that the memory CD8 T cells 
from VACV-immune mice may not be as cross-reactive to LCMV as the memory CD8 T 
cells from LCMV-immune mice are to VACV.  Further analysis of the A11R198-205-
specific CD8 T cells from the DC-immunized VACV-immune mice after LCMV 
challenge found a correlation between protection and the net frequency of A11R198-205-
specific CD8 T cells after background subtraction at day 6 post LCMV infection.  Mice 
that could clear LCMV infection more efficiently tended to have 0.59% or higher 
percentage of CD8 T cells being A11R198-205-specific at day 6 post infection, and the 
cutoff was significant by Fisher’s exact test.  Therefore, both private specificity and the 
number of cross-reactive memory CD8 T cells determine the outcome of heterologous 
infection between LCMV and VACV.   
I also found that a higher proportional response to NP396-404 after LCMV 
challenge might be more protective.  The analysis of the CD8 T cell specificity in 
VACV-immune mice at day 6 post LCMV infection suggested a correlation between the 
proportional responses and immunoprotection.  DC-immunized VACV-immune mice 
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that were protected during LCMV infection had a significantly higher proportional 
response to NP396-404 and lower proportional responses to NP205-212 and GP118-125.  This is 
consistent with the observation that NP396-404-specific T cell lines are more sensitive to 
cognate antigen and are more efficient in eliminating infected targets (Gallimore et al., 
1998), and may explain why some mice with cross-reacted A11R198-205-speicfic memory 
CD8 T cells were not protected during LCMV infection because cross-reactivity that 
results in a lower proportional response to NP396-404 may not be as effective in controlling 
LCMV infection.  Although the GP34-41-specific memory CD8 T cells are the second 
most cross-reactive to VACV during acute infection (Kim et al., 2005), no difference in 
the GP34-41-specific proportional responses at day 6 post LCMV infection was found 
between the VACV-immune and the DC-immunized VACV-immune groups regardless 
of protection status during LCMV infection.  It is possible that the cross-reactivity of 
VACV-specific memory CD8 T cells towards GP34-41 may be weak and hence 
infrequently affects the proportional response during LCMV infection. 
 
In conclusion, I have shown in this thesis that the immunoproteasomes were 
important in shaping LCMV-specific CD8 T cell response and memory.  I confirmed that 
the number and frequency of memory CD8 T cells could be reduced by heterologous 
viral infections, and showed that memory CD4 T cells might suffer the same fate; 
however, persistent MCMV infection did not cause continuous erosion of pre-existing 
memory CD8 or CD4 T cells, suggesting that memory T cell loss was an active process 
mainly due to IFNαβ-associated early events.  I also found that Treg cells remained 
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relatively stable in numbers and were resistant to apoptosis during LCMV infection.  The 
relative stability of Treg cells may explain why infections do not lead to high incidence 
of autoimmunity.  I found that the history of LCMV infection had detrimental effects on 
MCMV infection, and the low number of potentially cross-reactive CD8 T cells in 
VACV-immune mice might have played a part in the non-reciprocity of 
immunoprotection between LCMV and VACV.  These findings illustrate the dynamic 
interaction between T cell immunity and viral infections.  With the multiple aspects 
involved, a wide spectrum of responses to an infection is possible in a population with 
diverse genetic backgrounds and histories of infections.  Moreover, the immune system is 
continuously modulated by infections, changing the response to subsequent challenges. 
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Appendix – Peptide sequences used in this thesis 
Table 1. MCMV-specific MHC I-restricted peptides (Munks et al., 2006a, b).
 
MCMV Kb-restricted 
m139419–426 TVYGFCLL 
M57816–824 SCLEFWQRV 
m14116–23 VIDAFSRL 
M38316-323 SSPPMFRV 
M788–15 VDYSYPEV 
M10072–79 RIIDFDNM 
m164283–290 GTTDFLWM 
M97210–217 IISPFPGL 
M3838-45 STYTFVRT 
M102446–455 SIVDLRFAVL 
M31297–305 VAPDFGVRM 
IE3416-423 RALEYKNL 
* M57727-734 KSVEFERI 
 
MCMV Db-restricted 
M45985–993 HGIRNASFI 
M861062–1070 SQNINTVEM 
M3347–55 GGPMNFVVL 
M112171–179 AAVQSATSM 
M44130–138 ACVHNQDII 
m164267–275 WAVNNQAIV 
M77474–482 GCVKNFEFM 
m041–9 MSLVCRLVL 
M36213–221 GTVINLTSV 
 
 
 
 
* Novel cross-reactive epitope identified in this work. 
 
 
Table 2. LCMV-specific MHC I-restricted peptides (Kotturi et al., 2007). 
 
LCMV Kb-restricted 
GP34-41 AVYNFATC 
L349-357 SSLIKQSKF 
GP118-125 ISHNFCNL 
NP205-212 YTVKYPNL 
L2062-2069 RSIDFERV 
NP238-248 SGYNFSLGAAV 
L156-163 ANFKFRDL 
L1878-1885 GPFQSFVS 
L1428-1435 NSIQRRTL 
LCMV Db-restricted 
GP33-41 KAVYNFATC 
NP396-404 FQPQNGQFI 
GP276-286 SGVENPGGYCL 
L455-463 FMKIGAHPI 
L689-697 KFMLNVSYL 
L338-346 RQLLNLDVL 
GP92-101 CSANNSHHYI 
NP166-175 SLLNNQFGTM 
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Table 3. LCMV-specific MHC II-restricted peptides (Homann et al., 2001) . 
 
GP61-80 GLNGPDIYKGVYQFKSVEFD 
NP309-328 SGEGWPYIACRTSVVGRAWE 
 
 
Table 4. VACV-specific MHC I-restricted peptides (Kim et al., 2005; Moutaftsi et al., 
2006). 
 
VACV Kb-restricted 
B8R20-27 TSYKFESV 
A47L138-146 AAFEFINSL 
E7R130-137 STLNFNNL 
A11R198-205 AIVNYANL 
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